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ABSTRACT  
 
Angiotensin converting enzyme is an ectoprotein prone to regulated proteolytic 
solubilisation by an as yet unknown protease or sheddase. Proteolytic cleavage of 
membrane proteins is an essential cellular process that controls their expression and 
function, and modulates cellular and physiological processes. Testis ACE (tACE) is shed at a 
higher rate than somatic ACE and it has been proposed that regions in its ectodomain direct 
its shedding. Discrete secondary structures on the surface of the distal ectodomain of tACE 
were replaced with their N-domain counterparts to determine their role in the ectodomain 
shedding of ACE. None of the regions investigated proved to be an absolute requirement for 
shedding, but the mutant ACE proteins were subject to variations in shedding compared to 
wild-type tACE. 
 





mutated to alanines, causing a decrease in shedding. An extension of this mutation on the 
N-terminal side to seven alanines resulted in a reduction in ACE activity and, more 
importantly, it affected the processing of the protein to the membrane, resulting in 




 was mutated to the 
homologous region of the N-domain, processing was normal and shedding only marginally 
reduced. These data suggest that this region is more crucial for the processing of ACE than is 
for regulating shedding. Construction of a P
628
L mutation in tACE showed an increase in 
shedding. Furthermore, MALDI analysis of a tryptic digest established that the putative 
glycosylation site N
620
WT became glycosylated. Further mutagenesis of the P
628
L mutant to 
remove the newly formed glycosylation site, resulted in an even greater increase in 
shedding. 
 
Soluble fluorogenic peptides mimicking the ACE stalk were used in a cell-based assay to 
characterise the contribution of the stalk to ACE shedding. Hydrolysis of the wild-type 
peptide Abz-NSARSEGPQ-EDDnp was not responsive to phorbol ester or the hydroxamate 
inhibitor (TAPI), however, it was inhibited by EDTA. The aminopeptidase inhibitor bestatin 




cleavage of the ACE stalk peptides is likely different to the sheddase responsible for ACE 
shedding. Substitution of the P1 and P1’ sites of the peptides did not significantly influence 
the rate of cleavage. All the peptides were cleaved at the E-G bond, which is C-terminal to 
the physiological R-S cleavage site. Removal of the fluorogenic capping groups resulted in no 
cleavage of the peptides and lengthening of the peptide did not result in cleavage. This 
confirms the need for the ACE sheddase and its substrate to be anchored in the membrane 
and suggests the use of soluble peptide substrates in a cell assay has limited application for 
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CHAPTER 1: Literature Review  
 
 
1.1. Ectodomain shedding 
  
The cell membrane is in constant state of flux due to the action of proteases which cleave 
ectoprotein domains of membrane-anchored proteins. Cell surface proteins such as Pro-
transforming growth factor -α (TGF-α , a yloid p e u so  p otei  APP), L-selectin, 
interleukin-6 receptor (IL-6R) and tumour necrosis factor-α (TNF-α  are released from the 
cell membrane by proteolysis, usually at or near a region proximal to the membrane. This 
event is termed ectodomain shedding. Moreover, ectodomain shedding is exploited 
ubiquitously to regulate activity and spatial location of chemokines, cytokines, receptors 
and growth factors involved in inflammation, immunity, cancer, cellular development and a 
host of other physiologically relevant processes (Hayashida et al., 2010; Overall and Blobel, 
2007).  
Therefore, the investigation into how ectodomain shedding is controlled has far reaching 
influences on its role in various cellular processes and disease progression (Overall and 
Blobel, 2007). Determining the site of cleavage, the enzyme kinetics of the proteolytic 
action, the susceptibility to antagonists and agonists, may link the function of a protease to 
its specific substrate in vivo and vice versa. This will expose the cellular pathway involved 
and may lead to new or alternative avenues that may be evaluated as therapeutic 
interventions.  
The elucidation of common systems and pathways have shown that unrelated proteins are 
regulated in a similar manner. For example, a common pathway to stimulate shedding may 
be via protein kinase C-dependant (PKC) and independent mechanisms as evidenced by 
shared phenotypes displayed by shedding mutants. Serine protease inhibitors, 3,4-
dichloroisocoumarin (3,4-DCI), tosylphenylalanine chloromethyl ketone (TPCK) and 
diisopropyl fluorophosphate (DFP), inhibit shedding of Pro-TGF-α, ut ot L-selectin and 
therefore can be used to differentiate between substrates. Testing of the hydroxamate 
inhibitor TNF-α Protease Inhibitor 2 (TAPI-2), inhibits TNF-α as ell as TGF-α shedding. The 
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general metalloprotease inhibitor 1,10–phenanthroline inhibited  phorbol-12-myristate-13-
acetate (PMA) -activated shedding, yet EDTA and EGTA were ineffective (Arribas et al., 
1996; Hayashida et al., 2010; Merlos-Suárez and Arribas, 1999).  
 
Therefore, it is the purpose of this review to highlight the most appropriate cases that put 
into context the important physiological role of ectodomain shedding. It will show that there 
is a multitude of parameters over and above the catalytic activity of the sheddase, i.e. the 
protease responsible for cleaving the substrate, which influences ectodomain shedding. It 
will especially concentrate on the structural constraints of the substrate mediating protein-
protein interactions to regulate shedding.  
 
1.2 Regulation of ectodomain shedding 
There are many contributing factors of both the substrate and sheddase that influence how 
shedding is regulated. Ectoproteins have been shown to have specific requirements in terms 
of their stalk length, cytoplasmic domain, transmembrane domain and ectodomain. There 
exists a complex interplay between these structures that offers a myriad of combinations of 
regulation conditions or parameters that can result in specific cleavage secretion as it is 
required.  
1.2.1 Stalk length 
 L-selectin, a glycoprotein expressed in neutrophils, initiates leucocyte migration in 
inflammation and is downregulated by shedding off the membrane by ADAM 17 (where 
ADAM is a disi teg i  a d etallop otei ase (Smalley and Ley, 2005; Wang et al., 2009). A 
study by Zhao et al., (2001) attempted to investigate the structural determinants for the 
regulation of its shedding. It was found that L-selectin was cleaved 11 residues from the 
transmembrane domain but this cleavage site had very little sequence specificity. However, 
proline substitution C-terminal to the cleavage site caused blocking of phorbol-induced 
shedding (Zhao et al., 2001). The EGF domain, which is distal to the cleavage site, directs 
phorbol-induced cleavage, but not constitutive shedding. The cleavage site for mouse L-
selectin was at the R321-S322bond (Zhao et al., 2001) and in human it is at K321-S322 (Migaki et 
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al., 1995). Additionally, an 8-amino acid deletion in the juxtamembrane region caused a 
significant reduction in shedding that was likely due to the reduction in the stalk length 
(Zhao et al., 2001). This suggests that certain residues around the cleavage site influence the 
cleavage of L-selectin. Other studies have also confirmed the important contribution of the 
stalk length in controlling the shedding of L-selectin (Hinkle et al., 2003). For example, point 
mutations around the cleavage site did not affect L-selectin proteolysis neither did alanine 
mutations of the region K327EGDY in the juxtamembrane stalk. However, short deletions 
around this region had an effect indicating that the stalk length, not sequence, influenced 
shedding.   
L-selectin shedding was examined in the absence of active ADAM 17 and it was found that 
constitutive shedding still occurred by another metalloprotease that is dependent on an 
accessible juxtamembrane stalk of a specific length (Walcheck et al., 2003). Syndecans are 
transmembrane proteins with a multiplicity of roles in tumour progression. They are cleaved 
by tumour-related matrix metalloproteinases (MMPs) and regions proximal to the 
membrane were shown to favour cleavage. In addition syndecans are also cleaved at 
multiple sites occurring 6 and 15 residues from the transmembrane domain and another 
was mapped to the region 35-40 residues C-terminal f o  the hepa i  sulphate do ai  
(Manon-Jensen et al., 2013).  
  
To identify a sequence length that affects shedding, the cleavage site regions of TNF-α a d 
TGF-α were substituted into gp130, which is not usually shed. This resulted in a cleavable 
gp130. This emphasises once again the need for ample stalk length, allowing access to the 
substrate. Furthermore, a study by Arribas et al.  (1997) used cleavage site regions of TGF-α 
and amyloid precursor protein (APP) to i g a out the sheddi g of β-glycan, as the 14 
amino acid exchange gave sufficient stalk length to allow shedding to occur. While the 
correct stalk length is important for the shedding of a number of ectoproteins, the 
conformation and/or flexibility of the juxtamembrane region is also essential (Althoff et al., 
2001).  
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The contribution of the transmembrane, cytoplasmic and juxtamembrane domains of 
macrophage colony stimulating factor 1 (CSF-1) to its ectodomain shedding was investigated 
using deletion mutants. Substitution mutations of the 5-residue stretch P161QLQE in the 
juxtamembrane region was discovered to regulate shedding (Deng et al., 1996). The 
deletion mutations proved that the stalk length is of utmost importance as it influences the 
steric availability of the stalk region for the appropriate sheddase. Additional studies 
whereby residues were inserted into the juxtamembrane stalk, revealed that the amino acid 
sequence regulated the site of cleavage (Deng et al., 1998). The N-linked glycosylation as a 
result of the mutations interfered with cleavage, implicating changes in steric conformation 
and how this influences shedding. Shedding of these cleavable and non-cleavable variants 
highlighted the importance of stalk length, sequence and glycosylation on the regulation of 
CSF-1 ectodomain shedding (Deng et al., 2000, 1998). 
 
1.2.2 Regulation of ectodomain shedding by secondary sheddase-substrate interactions  
The substrate recognition model for Ephrin A5/EphA3- is an excellent example of a 
substrate-sheddase complex that requires the ligand to be bound by its receptor in order to 
be cleaved. Eph is a family of receptor tyrosine kinases which are bound by their ligands 
called ephrins. They are an important set of proteins that create complexes involved in 
intercellular communication in development as well as cancer (Nievergall et al., 2012; 
Surawska et al., 2004). ADAM 10 is the cognate sheddase of ephrins and the shedding 
process is tightly regulated to ensure that only ephrins bound by an eph receptor is cleaved 
by ADAM 10. For example, ADAM 10 constitutively associates with the receptor EphA3 
(figure 1.1) but does not recognise the individual proteins. The association between Ephrin 
A5 (ephrin) and Eph A3 (receptor) creates a new molecular recognition motif for the ADAM 
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Figure 1.1: Schematic representation of the shedding of Ephrin. ADAM 10 is shown to cleave ephrin on the 
adjacent cell only when ephrin is bound by Eph. The kinase domains positions Eph in correct orientation to 
bind to ADAM 10. Mutating ADAM 10 to shorten distance to membrane, resulted in cleavage as ADAM 10 




































An Eph A3 juxtamembrane mutation resulted in the kinase domain being closer to the 
plasma membrane. This decreases the ADAM 10 interaction and consequently ephrin 
shedding. Mutations that extend the domain increase ephrin cleavage even if there is no 
kinase activity. When the Eph kinase domain is closer to the membrane shedding by wild-
type ADAM 10 is inhibited. However when ADAM 10 is shortened at the cytoplasmic 
domain, shedding is restored. This is as a result of the steric hindrance that occurred 
between a truncated Eph and a full length ADAM 10, which was alleviated by the mutated 
ADAM 10 (figure 1.1) (Janes et al., 2009). Thus, ephrin shedding by ADAM 10 requires a 
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sheddase recognition motif to form via the interaction of Eph and ephrin, in conjunction 
with an accessible stalk region.  
Epidermal growth factor receptor (EGFR) is an essential component in the progress of cell 
growth, development and cancer. Many EGFR ligand precursors are shed, such as 
amphiregulin precursor (proAREG).  By means of immunoprecipitation, deletion mutants 
and fluorescence or confocal microscopy, its interaction with annexins was established. For 
example, knock-down of annexin 2 increased shedding of proAREG. In contrast, knockdowns 
of annexin 8 and 9 caused a decrease in shedding of proAREG. These data suggest that 
annexins create shedding complexes which mediate substrate selectivity by ADAMs such as 
ADAM 17 (Nakayama et al., 2012) and offers further evidence for sheddase recognition sites 
created by the protein-protein interactions between substrate, sheddase and chaperone 
proteins.  
Many well-studied sheddase substrates have structural arrangements which enable them to 
regulate their processing. Collagen XVII is a type II ectoprotein with a 1008-amino acid 
ectodomain (Franzke et al., 2004). It has a flexible loop-like triple helical structure and 
studies have shown that amphipathic residues in its sheddase recognition motif direct 
shedding and triple helical folding. Coiled-coil heptads are motifs located within the 
juxtamembrane in the non-collagenous 16Å domain and are responsible for regulation of 
shedding (Nishie et al., 2012). Deletion studies in this region have shown that the stretch of 
residues 528-547 is essential for regulating shedding and folding, which in turn influences 
steric availability (Franzke et al., 2004). The authors propose that due to the positive net 
charge created in the deletion mutants, the sheddase recognition motif is abolished, as 
there is a negative net charge in the wild-type.  
 
Kit ligand (KitL) is a membrane-anchored tyrosine receptor and KitL1 and 2 are shed by 
ADAM 17 and 19. When ADAM 19 is overexpressed it reduces ADAM 17-dependant 
shedding, which implies that one ADAM competes against the other. Exploration of the 
ectodomain to determine which domains or motifs are required for shedding indicated that 
the juxtamembrane of KitL2 was not required, however two non-adjacent stretches of 4 
a i o a ids, ““TL…KAAK, were. When this motif was knocked out, shedding was abrogated 
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which demonstrates that these residues are secondary binding sites required for shedding 
(Kawaguchi et al., 2007).  
 
 
1.2.3 Role of disulphide bonds and redox agents in ectodomain shedding 
Many sheddases and their substrates have surface thiol groups in their extractracellular 
domains. It was proposed that protein disulphide isomerase (PDI) plays a regulatory role in 
shedding by rearranging disulfide bonds in the stalk region. On the one hand, reducing 
agents such as dithiothreitol (DTT) blocks shedding, whereas thiol oxidising agents, such as 
hydrogenperoxide (H2O2), increase shedding. Phenylarsine oxide (PAO) is said to be a PDI 
inhibitor and induces rapid shedding of L-selectin (Bennett et al., 2000). Besides the 
substrate L-selectin, the sheddase ADAM 17 is influenced by reducing and oxidising 
conditions in its  cleavage of L-selection via its extracellular region, especially the highly 
conserved disintegrin/cysteine rich region (Wang et al., 2009).   
 
It was suggested that PDI regulates ADAM 17 by keeping ADAM 17 in an inactive form. 
Down regulation of PDI by the phorbol ester PMA, which alters the redox environment, 
could render ADAM 17 active. Due to ADAM 17 having 16 cysteine residues, alterations in 
the redox environment can also result in the isomerisation of disulphide bonds, which 
causes conformational changes, leading to alterations in shedding. Bacitracin is a general 
thiol isomerase inhibitor and inclusion of this inhibitor increased only PMA-induced 
shedding and not constitutive shedding.  Furthermore, ELISA binding studies revealed that 
PDI isomerises disulphide bonds in the non-catalytic domains of ADAM 17 (Willems et al., 
2010).  
 
A physiological example of this method of regulation is the activating receptor natural killer 
group2, D (NKG2D). Their ligands, such as the major histocompatibility complex (MHC) class 
I-related chain (MIC), are subject to solubilisation by ADAM 17. The soluble ligands are 
found in cancer sera and lead to the detrimental situation of having reduced levels of 
natural killer cells and cytotoxic leucocytes. The solubilisation of MICa by ADAM 17 is 
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dependent on ERp5, a thiol isomerase, which rearranges disulphide bonds and could be 




1.2.4 Cellular control of shedding via calcium/calmodulin 
The shedding of L-selectin is negatively controlled by calmodulin (CaM) which binds to its 
cytoplasmic tail. A crystal structure of Ca2+-CaM bound by a peptide mimicking the 
cytoplasmic tail and transmembrane domain of L-selectin illustrated their role in shedding in 
conjunction with calcium (Gifford et al., 2012). Similarly, CaM in its extended conformation 
binds a peptide consisting of the transmembrane and cytoplasmic domain of L-selectin 
(Deng et al., 2013). However, phosphorylation of the L-selectin cytoplasmic tail did not 
cause CaM to dissociate. During ADAM 17 mediated shedding of L-selectin, different parts 
of the protein bind and interact to regulate shedding, but CaM does not bind directly to L-
selectin. In addition, certain shedding regulation was dependent on PKC signalling and 
others on p38 mitogen-activated protein kinase (MAPK) signalling Killo k a d I etić, . 
Thus, L-selectin utilises binding partners, phosphorylation and signalling to moderate its 
solubilisation from the membrane.  
 
1.3 ADAMs  
The ADAMs are a group of proteases that are responsible for the proteolytic release of 
membrane bound cytokines, growth factors and cell adhesion molecules. They are involved 
in a vast array of cellular functions such as immunity, development and tumour progression. 
ADAMs consist of metalloprotease, disintegrin, cysteine rich and EGF domains and 
aremembrane anchored (figure 1.2).  ADAM 17 and 10 are well-characterised examples of 
the ADAMs group and have 50% sequence similarity within their catalytic domains. ADAM 
17 was identified as responsible for cleaving the cytokine TNF-α and it also releases 
epidermal growth factor (EGF), transforming growth factors (TGF) and HB-EGF from the cell 
membrane. ADAM10 has been shown to be critical in development, Notch signaling and the 
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α–secretase cleavage of APP (Blobel, 2002; Deuss et al., 2008; Kuhn et al., 2010). They play a 
role in the pathological mechanism of disease and therefore the ADAMs are potential 















1.3.1 ADAMs as sheddases  
EGFR signalling is involved in development of disease and is regulated by shedding of EGFR 
ligands such as TGF-α. It was shown that the intact ectodomain is required, but not the 
cytoplasmic domain or transmembrane domain for phorbol-stimulated cleavage of TGF-α by 
ADAM 17. The cleavage site of TGF-α as suffi ie t fo  PMA-dependant shedding (Le Gall et 
al., 2010). Similarly, ADAM 17 is responsible for the stimulated shedding of IL-6R. It was 
shown that when the cleavage site of Pro-TNF-α is su stituted i  IL-6R, it is still shed. 
However, when the cleavage site of IL-6R is substituted into Pro-TNF-α, o sheddi g o u s, 
suggesting  that the cleavage site of Pro-TNF-α is necessary and sufficient to yield a 















Figure 1.2:  Schematic diagram of an ADAM. Blue, M-Metalloprotease, Brown, Disintegrin and Cysteine 
rich, Grey, EGF-epidermal growth factor, Green, HVR- hypervariable domain.  
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EGFR is shed by ADAM 9, 10, 12, 15 and 17. ADAM 17 shedding of EGFR stimulation is rapid, 
reversible and does not require removal of a pro-domain. (Le Gall et al., 2010). A similar 
method of regulation is observed in prion disease. Cellular Prion protein (PrPc) is 
glycosylphosphatidylinisotol (GPI)-anchored and proteolytically shed by ADAM 10. 
Interestingly, ADAM 9 plays a role in activating ADAM 10 (Parkin and Harris, 2009), thereby 
involving ADAM 9 indirectly in  the shedding of PrPc via ADAM 10 (Altmeppen et al., 2011; 
Taylor et al., 2009). In contrast, shedding via ADAM 10 of EGFR ligands is stimulated by 
calcium which is dependent on its cytoplasmic domain (Horiuchi et al., 2007). ADAM 10 
functions as both a metalloprotease when bound to the membrane and a potential 
signalling molecule once cleaved by ADAM 9.  
 
Redundancy within the shedding mechanism is widespread and often more than one 
sheddase is able to cleave a particular substrate. Calcium stimulation of the purinergenic 
receptor P2X7(P2X7R) signalling pathway activated ADAM 10 in ADAM 17-/- cells (Le Gall et 
al., 2009). However, ADAM 17 is the major sheddase of P2X7R as ADAM 10 inhibition had no 
effect on its shedding when ADAM 17 was expressed endogenously. Prolonged treatment 
with the ADAM 17 inhibitor SP26 resulted in knockdown of ADAM 17 and thereafter ADAM 
10 became the principal sheddase of P2X7R. This interplay between ADAM 10 and 17 
demonstrates the importance of ectodomain shedding and the important role it plays in 
cellular signalling by controlling the spatial availability of a variety of proteins (Le Gall et al., 
2009). ADAM 17 and ADAM 10 also act on Desmoglein 2 and activated leucocyte cell 
adhesion molecules (ALCAM), which are transferrin receptors involved in cell adhesion. 
These sheddases have been implicated in regulating signalling pathways in tumour 
development, as loss of cell adhesion is an early indicator in tumour development (Bech-
Serra et al., 2006).  
 
ADAM 19 has also been identified as the sheddase of numerous substrates. Recombinant 
ADAM 19 was shown to cleave myelin basic protein (MBP) and insulin B chain (Chesneau et 
al., 2003). It is sensitive to the hydroxamate class of inhibitor batimastat (BB94) but not to 
tissue inhibitor of metalloproteinases (TIMPs) 1 and 3. Overexpression of ADAM 19 in COS7 
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cells increased shedding of TNF-related activation-induced cytokine (TRANCE) and is a 
negative regulator of KL-1 in mouse embryonic fibroblasts (Chesneau et al., 2003). ADAM 19 
is activated by lipopolysaccharides (LPS) as opposed to PMA and has autocatalytic 
processing activity in its cysteine domain (Tanabe et al., 2010). An increase in ADAM 19 
expression is involved in cancers, inflammation, and fibrosis of the lung and kidney. 
Therefore, it may be targeted for cell specific inhibition in some tumours (Qi et al., 2009).  
1.3.2 The contribution of secondary substrate binding site (exosite) interactions of ADAMs  
Vascular apoptosis-inducing protein (VAP) 1 is a snake venom metalloproteinase (SVMP) 
and a structural analogue of ADAMs. It has a MDC structure similar to ADAMs consisting of a 
metalloprotease domain (M-domain), a disintegrin domain and a cysteine rich domain (C-
domain). A crystal structure of VAP1 showed that the M-domain does not create stable 
dimers and has calcium binding sites opposite the active cleft (Takeda et al., 2006). The 
distintegrin domain is structured like a C-shaped arm, where the shoulde  po tio  has 3 
disulphide bo ds a d the a  po tio  has  disulphide o ds. Together, the calcium 
binding and disulphide bonds provide a stabilising function. The C-domain consists of the C–
hand and C-wrist, but none of these structures are amenable to binding other proteins. The 
hypervariable region (HVR) points toward the catalytic site and is stabilised by a hydrogen 
bond network. It is said to be the region that takes part in the secondary engagement or 
binding with the substrate and is the most divergent part of the structure (figure 1.3) 
(Takeda et al., 2012, 2006).  




The crystal structure of ADAMTS-13, which cleaves von Willebrand factors involved in 
thrombosis, has multiple exosites in non-catalytic domains to recognise its substrates 
(Akiyama et al., 2009). Mutational analysis proved that particular residues in the HVR loop  
of ADAMTS-13 was essential for cleavage secretion of von Willebrand factors (Takeda et al., 
2006). Similarly, ADAM 12; a sheddase implicated in cancer; was proven to be regulated by 
non-catalytic domains possibly via its EGF loop (Kveiborg et al., 2010). This demonstrates 
that ADAMs are regulated by domains outside of their catalytic domains and that the HVR 
domain is structurally adept at providing such a site.  
 
1.3.3 Cellular trafficking of ADAMs 
ADAM 17 needs to be processed to its mature form by furin and the proprotein convertase 
PC7 (Althoff et al., 2001; Peiretti et al., 2003). However, addition of PMA, which increases 
ADAM 17 shedding, decreased the maturation of ADAM 17. It does not activate furin 
activity, indicating that PMA does not increase shedding via activation of ADAM 17 (Endres 
et al., 2003). CHO-K1 cells defective in ectodomain shedding, had ADAM 17 remain in its 
inactive form and did not have its prodomain removed. This was not due to lack of furin 
















Figure 1.3: Proposed model of HVR binding indirectly to the substrate (grey) via a chaperone protein (red). 
(Adapted from Takeda et al., 2010).  
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inactivity was due to its inability of ADAM 17 to exit the endoplastic reticulum (ER) (Borroto 
et al., 2003).  
Furthermore, it was found that ADAMs are trafficked through the ER and cell signalling via 
their interaction with catalytically inactive pseudoproteases called rhomboids (Zettl et al., 
2011). An important member of this family of intramembrane proteins is iRhom2, which 
binds ADAM 17 and promotes exit from the ER. If no iRhom2 binds to ADAM 17, it does not 
exit from the ER and furin activation of ADAM 17 is prevented. Therefore ADAM 17  does 
not reach the cell surface in a mature and active form (Adrain et al., 2012).  A functional 
example of iRhom2 s role in ADAM 17 maturation is its vital role in LPS-stimulated shedding 
of TNF-α. It as sho  that i‘hom2 plays a role in ADAM 17 maturation using TNF-α le els 
in serum as an indication of how the immune system responds to it (McIlwain et al., 2012). 
Physiologically, ADAM 17 regulates TNF-α depe da t diseases su h as heu atoid a th itis 
and aids in the protection of the skin and the intestinal barrier. Inactivation of the iRhom2 
gene,  resulted in the disruption of immune cell function (Issuree et al., 2013). This process 
of arresting the ADAM 17 maturation in the ER, is another regulatory mechanism of 
shedding.  
 
1.3.4 Use of synthetic peptides in the characterisation of ADAMs in ectodomain shedding 
To enable high throughput analysis of proteases and their substrates, soluble synthetic 
peptides were synthesised and the peptide sequences mimic the region that is cleaved by 
the protease. Fluorogenic peptides contain groups that fluoresce and have been routinely 
used as substrates in the development of assays to characterise proteases. Commonly used 
nomenclature for denoting the residues in the peptide substrate is P1-P2-P3-…P  on the N-
terminal side of the cleavage site scissile bond. Similarly, the C-terminal residues are 
assig ed P -P -P -…P  (Schechter and Berger, 1967).  
Through the analysis of 10 fluorogenic peptides of TNF- α, it was found that ADAM 17 
prefers hydrophobic residues at the P  site su h as V, L a d I (Table 1.1) . In many of the 
peptides secondary cleavage products were also identified. Even though ADAM 17 prefers 
the physiological A-V cleavage site (Black et al., 1997), its substrate specificity is not limited 
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to this site a d ay tole ate alte ati e hyd opho i  esidues ai ly i  the P  positio . (Jin 
et al., 2002). 
Table 1.1: Cleavage of fluorogenic peptides by ADAM 17. 10 nM of enzyme was incubated with 50 µM of each 
peptide in a buffer of 50 mM Tris, pH 7.4, 25 mM NaCl, and 4% glycerol. The reaction was monitored by 
fluorescence and HPLC. The reaction was terminated after 140 min and percentage cleavage was determined 
by HPLC using A220 nm (Adapted from Jin et al., 2002).  
Peptide P  and P ’ residues  % Cleavage 
Abz-LAQAVRSSSR-Dpa  AV 90% 
Abz-LAQALRSSSR-Dpa AL 92% 
Abz-LAQAIRSSSR-Dpa AI 66% 
Abz-LAQAFRSSSR-Dpa  AF 22% 
Abz-LAQFVRSSSR-Dpa  QF 39% 
Abz-LAQLVRSSSR-Dpa  QL 34% 
Abz-LAQGVRSSSR-Dpa GV 11% 
Abz-LAQVARSSSR-Dpa AR 19% 
Abz-LAQdAVRSSSR-Dpa dAV 0% 
 
In ADAM 17-expressing cells, only PMA-stimulated cells were able to cleave the TNF-α 
peptide (Dnp-SPLAQAVRSSSR-NH2). Moreover, PMA does not increase the expression of 
ADAM 17, it only increases its activity. Interestingly, the comparison of peptide hydrolysis by 
the recombinant ADAM 17 and cell lysate, showed that considerably less product was 
generated using cell lysate (Doedens et al., 2003).  
This agrees with the study by Becker et al. (2002) where cleavage of fluorogenic and non-
flurogenic TNF-α peptides were analysed with recombinant human ADAM 17 as well as cells 
endogenously expressing ADAM 17. Cleavage by recombinant ADAM 17 was TAPI-2 
inhibitable. In contrast, incubation with HUVEC cells, a human mast cell line-1 (HMC-1) and 
peripheral blood lymphocytes (PBL) for 1 hour resulted in only 50% peptide reduction and 
after 24 hours there was no peptide remaining. No specific cleavage products were 
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identified and stimulation or inhibition by TAPI-2 was not observed (Becker et al., 2002). On 
the other hand, cleavage was inhibited by an inhibitor cocktail and metalloprotease inhibitor 
ortho-phenanthroline. HMC-1 in suspension could cleave the fluorogenic peptides but no 
TAPI-2 inhibition was seen. This clearly indicates that the cleavage of the peptide may differ 
significantly. This is dependent on whether a purified recombinant protein or a cell lysate 
with endogenous levels of the enzyme of interest is used.  
 
Peptide mimetics corresponding to the stalk of MBP revealed that ADAM 8 cleaved the 
peptide TTHYGSLPQKAQGQ at the P-Q site (Schlomann et al., 2002). To find additional 
substrates for ADAM 8, 10-mer peptides based on extracellular domains of various 
membrane proteins were synthesised and exposed to soluble ADAM 8 purified from E.coli 
(figure 1.4). Fourteen out of 34 peptides were cleaved and some were derived from 
peptides involved in inflammation and neurodegeneration proteins e.g. APP. MBP variants 
were also synthesised ith su stitutio s i  thei  P ,P , P  a d P  sites, although ADAM 8 
cleaved these peptides at different efficiencies (Naus et al., 2006). This extensive study 
demonstrates that basic residues at P1 such as R and K increase cleavage (figure 1.4) 
(peptide 3 and 4), implying that ADAM 8 has a relaxed sequence specificity at P1 and is less 
tole a t of ha ges i  P .  
 
 
Figure 1.4: Cleavage site mutations of MBP peptides.  R or K substitution in P1 increases shedding. 
Mutations in P1  and P2  decreases shedding considerably. Adapted from Naus et al., 2006.  
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An ADAM 33 substrate profile was determined in a similar manner. It was found that a 10-
residue APP peptide (YEVHHQKLVF) was also cleaved by ADAM 33 but at a non-physiological 
site of H14-Q15. However a KitL peptide was cleaved by ADAM 33 at its physiological site (Zou 
et al., 2004). The most stringent residues for cleaving the APP substrate (YEVHHQKLVF) were 
V at P3, Ala at P2 and Q at P1. Changing H at P2 increased cleavage by ADAM 33. It was also 
found that the minimal length of the peptide for cleavage to occur was 9 residues. 
 
To try and uncover potential substrates for ADAM 8 and ADAM 15, peptide libraries were 
employed. This method proved unsuccessful for ADAM 15 and only with the overexpression 
of ADAM 15 could a substrate be identified. ADAM 15 was not stimulated by PMA or Ca2+ 
ionophores but was inhibited by TAPI-2, GM6001 and TIMP3 (Maretzky et al., 2009). This 
demonstrates that soluble fluorogenic substrates are not always amenable to hydrolysis by 
recombinant proteases and the characterisation of ADAM 15 could only be achieved via 
overexpression studies. 
 
To fine map the active site requirements for recognition by ADAM 17 and ADAM 10, peptide 
libraries were once again utilised. The main differences between these sheddases, lie within 
their preference for certain residues of the P  positio  of the substrate. It was shown that 
ADAM 17 prefers aliphatic hydrophobic residues whereas ADAM 10 prefers larger residues 
such as leucine (Krstenansky et al., 2004). Furthermore, ADAM 17 and ADAM 10 select 
hyd opho i  esidues at the P  site, asi  a d aliphati  esidues at P  site a d s all 
esidues at the P site. ADAM  a d ADAM  a e the ost sele ti e at the P  site. ADAM 
17 prefers a hydrophobic residues such as V and ADAM 10 prefers L which is much larger. 
Selectivity of substrates could be determined more by the residues around the cleavage site 
than by the cleavage motif itself (Caescu et al., 2009). 
 
1.4 ACE  
Angiotensin-converting enzyme (ACE) is a vital component of the renin-angiotensin system 
(RAS) and its most established role is in blood pressure regulation via its dicarboxypeptidase 
activity. It cleaves the decapeptide angiotensin I (Ang I) to produce the octapeptide 
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angiotensin II (Ang II), a potent vasoconstrictor, resulting in an increase in blood pressure 
(figure 1.5) (Skeggs et al., 1956; Yang et al., 1970). It also cleaves and inactivates bradykinin, 
a vasodilator. It is for these reasons that ACE is a major drug target in hypertensive patients.  
ACE has numerous other substrates, such as the APP peptide Aβ-42 and Acetyl-SDKP, an 
antifibrotic agent (Douglas et al., 2013)  proving important with respect to ACE inhibition 
and its peripheral effects.     
 
ACE 2 is single domain homologue of ACE, which produces Ang 1-7. These peptides are 
vasodilatory and act against the effects of the vasoconstrictor Ang II (Donoghue et al., 2000; 
Guy et al., 2005). Interestingly, ACE2 was shown to be the functional receptor of the severe 
acute respiratory syndrome (SARS) coronavirus, which causes a potentially lethal lung 
infection (Kuba et al., 2005; Wong et al., 2004). 
 
ACE is a highly glycosylated zinc metalloprotease and type I membrane-bound ectoprotein. 














Figure 1.5: Renin angiotensin aldosterone system (RAAS). Simplified schematic to highlight the most 
important elements of the system. ACE is represented as the double domain membrane anchored protein. 
The red circles represent the catalytic sites. Ang II binds to the AT1 receptor (AT1R) and results in 
vasoconstriction (pink). Ang 1-7 and bradykinin both lead to vasodilation (green). The ACE homologue, ACE2, 
cleaves Ang II to Ang 1-7, promoting vasodilatory parameters.  
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transmembrane domain by a stalk region and has a short cytoplasmic domain (Alhenc-Gélas 
et al., 1989). There are two forms of ACE that we will mainly refer to, somatic and testis 
ACE. Somatic ACE (sACE) consists of the N- and C-domains (Soubrier et al., 1988), whereas 
testis ACE (tACE) consists only of the C-domain. These are transcribed from the same gene 
off two different promoters (Hubert et al., 1991; Lattion et al., 1989). Both domains are 
catalytically active (Soubrier et al., 1988; Wei et al., 1992, 1991a), yet the N- and C- domains 
have varying inhibitor binding profiles, due to their active sites differing slightly in structure 
(Nchinda et al., 2006; Watermeyer et al., 2010). To aid in the design of domain-selective 
inhibitors, the crystal structure of tACE was resolved (Natesh et al., 2003), assessing the key 
residues participating in ACE activity. Based on this information, inhibitors may be more 
specifically designed to bring about higher potency with fewer side-effects.  
 
Glycosylation disrupts the crystallisation of protein for x-ray diffraction, therefore minimally 
glycosylated mutants aid in the crystallisation and structure-function analysis of ACE. It was 
found that there are seven glycosylation sites in tACE: three are fully glycosylated, three are 
partially glycosylated and one site (N620) is not glycosylated at all. Testis ACE expressed in 
the presence of glycosidase inhibitor, NBDNJ, was still fully active, indicating that 
glycosylation of tACE is not essential for its activity (Yu et al., 1997). More recently, the 
structure of a minimally glycosylated N-domain mutant was resolved with only sites three, 
eight and nine available for glycosylation as opposed to the usual eight. It was crystallised 
with the N-domain selective inhibitor RXP407 (Anthony et al., 2010).  The full sACE structure 
has not been determined, but the C-domain in sACE has been shown to be less dependent 
on glycosylation than tACE. This is said to be due to the N-domain having stabilising effects 
on the C-domain within sACE O Neill et al., . 
 
Both ACE isoforms undergo cleavage secretion (Ehlers et al., 1997; Wei et al., 1991b) and 
are shed from the membrane by a sheddase that cleaves within the stalk region. The as yet 
unknown sheddase has been shown to be a zinc (Zn) metalloprotease, known to be 
stimulated by phorbol esters and inhibited by hydroxamates. Testis ACE is cleaved more 
efficiently than somatic ACE. It is therefore imperative to understand the complex 
structure/function relationships of ACE, and investigate how the posttranslational 
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mechanisms contribute to other physiological processes in addition to its classical role in 





1.4.1 Beyond the RAS   
ACE has numerous roles besides its dicarboxypeptidase activity. It is perhaps through the 
suppression of these alternative pathways that the numerous side effects of ACE inhibitors 
are mediated.  
1.4.1.1 Signalling  
Casein kinase 2 (CK2) phosphorylates the cytoplasmic tail of ACE at S1270 and sets in motion 
a signalling cascade via mitogen-activated protein kinase (MAPK) and c-Jun N-terminal 
kinases (JNK). This signalling cascade brings about  an increase in ACE expression (Kohlstedt 
et al., 2002) and incubation with ACE inhibitors has also been linked to the increase in this 
signalling response (Kohlstedt et al., 2004). Phosphorylation of ACE as well as dimerisation 
are induced by inhibitors, which could have far reaching physiological impacts and could 
influence the unknown effects that are related to ACE inhibitors (Fleming, 2006; Fleming et 
al., 2005).  
1.4.1.2 Fertility  
Testis ACE or germinal ACE, is essential to male fertility (Fuchs et al., 2005; Kondoh et al., 
2005). Kondoh et al., (2005) have previously reported that ACE sheds other GPI-anchored 
proteins, which are required for fertilization (Kondoh et al., 2009). Furthermore, sperm 
which expressed a GPI-anchored fluorescent protein and solubilised by ACE, was shown to 
acquire fertility after the acrosome reaction, an essential step in fertilization. (Watanabe 
and Kondoh, 2011). This is in agreement with the study that used the monoclonal antibodies 
1E10 and 4E3 to identify tACE on sperm and it was shown to be on the post-acrosomal 
region (Nikolaeva et al., 2006). More recently, the GPI-anchored protein, TEX101, was 
shown to be regulated by ACE and is currently under further investigation as a mechanism 
to control male fertility (Fujihara et al., 2013).  
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1.4.1.3 Amyloid as a substrate  
A u ulatio  of the Aβ  peptide, a product of APP cleavage, is believed to contribute to 
plaque formation in the brain leadi g to eu odege e atio  i pli ated i  Alzhei e s 
disease (AD). The Aβ  peptide has a p ote ti e ole i  AD and reduces plaque deposition. 
ACE o e ts Aβ  to Aβ , a d ACE i hi itio  has ee  sho  to i ease Aβ  
depositio  a d lo e  the p ote ti e effe ts of Aβ  (Zou et al., 2007). The N-domain of ACE 
has ee  sho  to deg ade the Aβ peptide to Aβ  o e effe ti ely tha  the C-domain 
(Oba et al., 2005; Zou et al., 2009). However, another study conducted in CHO-K1 and HEK 
cells fou d that oth do ai s of ACE deg aded Aβ  a d Aβ 42 similarly. Morerover, 
inhibition with the non-selective ACE inhibitor aptop il sho ed a  a u ulatio  of Aβ 
peptides (Hemming and Selkoe, 2005). This supports the need for C-domain selective ACE 
inhibition and will allow the N-do ai  atalyti  site to e f ee to deg ade the Aβ 42 peptide 
to the neuro-p ote ti e Aβ 40. 
 
1.5 ACE ectodomain shedding 
ACE has been shown to undergo regulated proteolytic release of its ectodomain into the 
extracellular environment, however the physiological relevance for its shedding is unknown. 
The differences between tACE and sACE are critical as a large proportion of ACE research 
has been dedicated to the regulation of shedding by delineating the regions of ACE and how 
they impact the modulation of shedding.  
Soluble endothelial ACE was found in serum and it was suggested that ACE could be used as 
a model to study its associated sheddase. Through the characterisation of tACE expressed in 
CHO –K1 cells, a soluble form of the enzyme in the medium as well as a membrane-
anchored form was discovered (Ehlers et al., 1991a, 1991b). The removal of the first 36 
residues of tACE, which is S/T rich and heavily O-glycosylated, did not affect activity or 
stability (Ehlers et al., 1992). The addition of the phorbol ester phorbol-12,13-
dibutyrate (PDBu), increased the level of soluble ACE nearly 50-fold and possibly via the PKC 
mechanism, as a PKC inhibitor diminished the phorbol-induced shedding (Ehlers et al., 
1995). To characterise the regulation and shedding of rabbit tACE, it was transfected into 
mouse epithelial cells. They found that it accumulates at the cell surface and is then cleaved 
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off at a slow rate. The phorbol ester PMA stimulated shedding, but not directly through the 
PKC machinery as PKC inhibitors did not inhibit shedding (Ramchandran et al., 1994). This 
suggests that other mechanisms are at play to stimulate shedding. Therefore rabbit tACE 
and human tACE undergo stimulated shedding via different mechanisms.  
1.5.1. The effect of the cytoplasmic domain  
The characterisation of the ACE tACE mutant with the cytoplasmic domain deleted displayed 
no phorbol effect, however TAPI decreased shedding (indicating a similar sheddase to wild-
type). Addition of cytochalasin D increased basal shedding of wild-type ACE, with little effect 
on ACECYT. This suggests that the cytoplasmic domain of ACE interacts with actin 
cytoskeleton. It suggested that there are inhibitory proteins that negatively regulates 
shedding via the cytoplasmic tail (Chubb et al., 2004). 
ACE is serine phosphorylated at S730 (tACE numbering) which is situated on the cytoplasmic 
tail. A CaM inhibitor and CaM kinase inhibitor increased shedding which implicates CaM as 
associating with the cytoplasmic tail. When S730 was mutated to alanine it was not 
phosphorylated,  but was still bound by CaM (Chattopadhyay et al., 2005). Calmodulin 
therefore regulates shedding of membrane proteins. In an attempt to determine how 
signalling occurs via ACE, the phosphorylated serine at 1270 (sACE numbering, equivalent to 
S730) was mutated to an alanine. The resultant loss in phosphorylation of S1270A increased 
the ate of sheddi g of ACE, i  a si ila  a e  to ACEΔCYT. The additio  of yto halasi  D 
disrupted the association with non-muscle myosin heavy chain 9 (MYH9) (Kohlstedt et al., 
2006b). These data demonstrate that the cytoplasmic tail plays an important role in 
regulating ACE shedding and demonstrates the possible mechanism by which signalling is 
controlled. 
 
1.5.2 The role of the juxtamembrane stalk  
Deletions in the juxtamembrane stalk were made to ascertain its level of involvement in 
shedding. ACE JM-Δ  esulted i  a -fold increase in shedding, ACE JM-Δ  a -fold 
decrease in shedding and ACE JM-Δ  as ot a ti e a d i o e tly p o essed to the cell 
membrane (Table 1.2). ACE JMLDL, a mutant where the stalk was replaced with that of the 
stalk of low density lipoprotein receptor was also cleaved 15 or 17 residues from the 
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membrane. Wild-type cleavage (as well as ACE JM-Δ  as shown to occur at the R627-S 
bond, 24 residues from the membrane. ACE JM-Δ  as lea ed  esidues f o  the 
membrane (Table 1.2). This suggests that the sheddase requires a minimum of 10 residues 
in the stalk for cleavage to occur. Significantly, purified full length ACE is not cleaved by 
CHO-K1 fractions as the sheddase needs the protein to be embedded in membrane (Ehlers 
et al., 1996).  In addition, solubilised ACE 89 cells (which cleave transfected rabbit tACE) and 
rabbit lung homogenate did not cleave tACE in solution, again suggesting a requirement for 
ACE to be anchored in the membrane (Sadhukhan et al., 1999). Furthermore, a Triton-X- 100 
solubilised pig kidney sheddase preparation did not solubilise ACE, implicating the need for 
ACE and its sheddase to be anchored in the membrane (Parvathy et al., 1997). 
 
Table 1.2: Effect of deletions in the juxtamembrane stalk region of tACE (Ehlers et al., 1997, 1996). 
Mutant Shedding Cleavage site/distance from membrane 
ACE JM-Δ 7 12-fold increase R627/10 residues from membrane 
ACE JM-Δ 4 17-fold increase R627/24 residues from membrane 
ACE JM-Δ47 No shedding, no activity  
ACE JMLDL Yes A628/15-17 residues from membrane 
 
Many secreted ectoproteins possess a specific sequence that is preferred by its sheddase, as 
is the case in Pro-TNF-α, which is cleaved preferentially at an A-V site (Althoff et al., 2001; 
Jin et al., 2002). The determination of the ACE cleavage site was essential in learning more 
about the shedding requirements of the sheddase.  
 
The cleavage of rabbit ACE occurs between R663 and S664, similar to human ACE 
(Ramchandran et al., 1994). Two cleavage sites were found in mouse and ACE shedding in 
yeast was inhibited by the hydroxamate inhibitor  compound 3 (Sadhukhan et al., 1996). 
tACE expressed in E.coli was underglycosylated and inactive, and a mutant with five of the 
N-linked glycosylation sites mutated was inactive and degraded. However, the same mutant 
expressed in yeast was active (Sadhukhan and Sen, 1996). This suggests that ACE is 
susceptible to varying expression conditions and cleavage sites may differ. 
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The cleavage site of human sACE was mapped to R1203-S1204 which is 24 residues proximal to 
the membrane anchoring domain. Trypsin cleaved at the same site and hydroxamate 
inhibitors showed that ADAM 17 was not involved in constitutive or regulated  cleavage of  
ACE (Hooper and Turner, 2000). This is in agreement with the cleavage site found in human 
tACE as well as sACE (Woodman et al., 2000). An important finding in this study was that 
tACE is shed at a much higher rate than sACE, even though they are cleaved at identical sites 
in the stalk and confirmed the observation that the N-domain of sACE negatively regulates 
its shedding (Beldent et al., 1995). The initial data accumulated about the ACE sheddase was 
that it did not require a specific cleavage site sequence, but preferred cleavage after an R or 
K residue. From these early investigations the ACE sheddase was revealed to be sensitive to 
protease inhibitors and is inducible.  
 
To investigate whether the ACE sheddase prefers an open, unfolded stalk, an EGF-like 
domain was introduced into the stalk region of ACE. This mutant was poorly processed and 
shedding was reduced. However, a phorbol response was still evident. Interestingly, the 
cleaved protein remained on the cell surface as it was still attached to the stalk via 
disulphide bonds. The protein was cleaved at the G652-F653, 11 residues proximal to the 
transmembrane domain (Schwager et al., 1998).  
 
Glycosylation could change the conformation and accessibility of the stalk. To test this 
theory, serine/threonin(S/T) rich regions (for O-glycosylation) were introduced in the stalk.  
This mutant, called JGL had increased basal shedding but reduced phorbol shedding. 
Therefore a modulation of shedding was seen, but not abrogation and the cleavage site 
shifted to 14 residues from the membrane. Introduction of an N-linked glycan by deleting 6 
residues N-terminal from the cleavage site resulted in a cleavage site at the F640-L641, which 
is C-terminal to the endogenous R627-S628. This shift in cleavage site was probably due to this 
new glycosylation site as other deletion mutants  cleavage sites were not altered. Removing 
the S/T region from the N-terminus of tACE did not affect shedding or the cleavage site 
(Schwager et al., 1999). A further study into the effect of disulphides in the stalk region of 
ACE revealed that a mutant with the EGF domain of factor IX, (ACE-JMfIX) was only sensitive 
to DCI and resistant to the effects of PDBu and TAPI. These studies highlight the previous 
efforts taken to define the involvement of the stalk region to the regulation of tACE 
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shedding. It is clear that the disulphide bonds and glycosylation modulates shedding and at 
times shifts the cleavage site. Nevertheless, cleavage still occurs despite the alterations to 
the stalk region.  
 
In an attempt to determine the boundaries of the tACE ectodomain, sequentially longer 
deletions of the N and C-termini of tACE were made (Chubb et al., 2002). A mutation 
between D40 and E61 (ACE-Δ  abolished shedding as well as enzymatic activity, suggesting 
that this region was critical for correct folding of the enzyme and not that it was necessarily 
involved in the regulation of shedding. D40 is the first conserved residue between N and C-
domain. ACE-Δ  had  esidues N-terminal of the cleavage site deleted (T605- N620) and 
this rendered this protein inactive in the cell lysate and no activity or protein was present in 
the medium. ACE-Δ  had residues W616- A626 deleted, which caused lowered activity but 
shedding still occurred. These mutants gave us great insight into the involvement of the 
juxtamembrane stalk region and proximal ectodomain on the processing and stability of 
ACE. Thus, Chubb et al. (2002) proposed that the C-terminal boundary of the ectodomain 
occurred between T 605-W616. 
 
1.5.3 The contribution of the ACE ectodomain 
 In an effort to understand the role of the ectodomain of ACE in shedding, Beldent et al. 
(1995) investigated the shedding rates of somatic ACE versus a truncated form that 
consisted only of the C-domain. They noted that the form lacking the N-domain was shed 
10-fold more efficiently than the two domain form which is in agreement with the findings 
of Woodman et al. (2000).  They went on to establish that cleavage occurred at the cell 
membrane and not at the endoplasmic reticulum. This study suggested that the N-domain 
negatively regulates ACE shedding. Cleavage site of ACE CF (C-domain only) was mapped to 
R1227-V1228 (Beldent et al., 1995).  
 
Rabbit tACE has a major (R663-S664) and minor cleavage site, the former mimicking the 
endogenous cleavage site found in human ACE. Furthermore, rabbit tACE shedding is 
sensitive to the hydroxamate-based inhibitor Compound 3 indicating that a metalloprotease 
is responsible for its shedding (Sadhukhan et al., 1996). Sadhukhan et al. (1998) carried out 
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an extensive study on rabbit testis ACE to tease out which regions of ACE augments the 
shedding process. They made swop-over chimeric proteins consisting of different 
permutations of the ACE stalk or ectodomain with the stalk or ectodomain of CD4, which is 
usually not cleaved. The chimeric protein which consisted of the ACE ectodomain with the 
juxtamembrane stalk, transmembrane domain (TM) and cytoplasmic domain of CD4 was 
cleaved efficiently. ACE deletion mutants were used to determine which region of the 
ectodomain is responsible. The chimeric protein required residues 1-655 of ACE for 
shedding to occur and 62 residues of the C-terminal of CD4. 
 
tACE 1-691/CD4-1 which has the full length ACE ectodomain is shed at 95%, tACE1-655/CD4-
3 has a reduced ACE ectodomain and a CD4 stalk region of 22 residues. This reduces 
shedding, but increasing the CD4 stalk to 42 residues, increases shedding. Sixty-two residues 
of the CD4 stalk in conjunction with residues 1-655 of the ACE ectodomain allows shedding 
to occur at 99 % (figure 1.6). This once again alludes to a theory that an accessible stalk 
length is required and that a particular structure created by certain ectodomains and stalk 
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Figure 1.6: ACE/CD4 constructs. Swop-over constructs showing most important constructs. Adapted from 
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The region in the ectodomain of ACE proximal to the stalk region said to direct cleavage 
secretion  was fine-mapped via alanine mutagenesis (Sadhukhan et al., 1998). A five residue 
motif was shown to be vital for the cleavage of rabbit tACE (Chattopadhyay et al., 2008). 
This provides definitive evidence that shedding of ACE not only requires the availability of a 
suitable cleavage site, sufficient stalk length and membrane anchorage, but also a specific 
secondary binding site for the candidate sheddase.  
 
To further investigate the roles of the stalk and extracellular domain of ACE in shedding, 
Pang et al. (2001) replaced the  GPI anchor of membrane dipeptidase (MDP), which is not 
usually shed, with the ACE stalk and transmembrane region (Pang et al., 2001). MDP-STM 
was shed, but the MDP-TM chimera with no stalk was not, suggesting that the 
juxtamembrane stalk is critically important for shedding. Importantly, another construct 
comprising of N-do ai  fused to the stalk a d TM i.e. Δ C  as ot shed, ut as a ti e at 
the cell surface (Pang et al., 2001)indicating that a sheddase recognition motif (RM) within 
the C-domain is an essential requirement for shedding. This supports the hypothesis that 
the overall structure of the ectodomain, stalk and transmembrane domain combination 
results in a conformation that allows access for the sheddase to cleave the stalk (Deng et al., 
1998). 




Based on the knowledge that tACE is shed more efficiently than sACE (Woodman et al., 
2000), the N-domain negatively regulates shedding (Beldent et al., 1995) and that the ACE 
ectodomain elicits shedding of non-shed proteins (Pang et al., 2001; Sadhukhan et al., 
1998), N- and C-domain swop-over mutants were constructed to determine if shedding was 
regulated by merely the presence of two domains, or whether the N-domain occludes a 
sheddase recognition domain in the C-domain (figure 1.7). The construct with the C-domain 
fused to the N-terminus of the N-domain (CN-ACE) was not shed  (Woodman et al., 2005).  
The CC-ACE, which had two C-domains attached by the linker region, was cleaved off the 
membrane at the stalk as well in the linker region. This suggests that the C-domain contains 
a motif that could direct the sheddase to cleave within the linker as well as the stalk. It was 
also proposed that the conformation of two C-domains is more favourable than having an 
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Figure 1.7: ACE isoforms and mutant constructs. Representative figure of ACE isoforms, viz, sACE and tACE 
highlighting the N- (yellow) and C-domain (blue) in sACE and the single C-domain in tACE. The catalytic site 
is represented in red. The swop-over constructs are shown alongside it. Red arrows indicate the site of 
cleavage (Woodman et al., 2005).  
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N-domain in the construct. These findings clearly show that the shedding of ACE is highly 
regulated and its structural conformation plays a pivotal role in directing cleavage. As the C-
domain was identified to potentially harbour a sheddase recognition domain, the single 
domain tACE was further investigated to identify this domain. Homologous regions between 
the N- and C-domains were sequentially swopped in order to determine which region 
restricts shedding (Woodman et al., 2006). It was found that a region corresponding to 
residues 164-416 in tACE was crucial for the shedding as well as activity of ACE. A smaller 
mutation within this region also rendered the protein inactive and not shed, suggesting that 
this region requires further investigation. 
 
1.5.4 The ACE sheddase 
The characterisation of the ACE sheddase activity from kidney microvilli, lung, testis (pig) and human 
lung and placenta tissue showed that the sheddase activity was membrane associated and occurred 
at a pH of 8.4. Serine, thiol or aspartic protease inhibitors did not affect ACE sheddase activity, 
though 2.5mM of EDTA and phenatroline inhibited ACE sheddase activity by 50%, signifying a clear 
role for metalloproteases in the sheddase activity (Oppong and Hooper, 1993).  From ADAM 17 
deficient mice,  mouse fibroblasts were made and tACE cDNA was transfected into this cell line, but 
shedding of ACE remained normal (Sadhukhan et al., 1999) demonstrating that ADAM 17 was not 
involved in shedding of ACE. To investigate its role in the shedding of ACE and APP, antisense (ASO) 
technology was used to silence the activity of ADAM 10 and 17.  APP shedding by ADAM 10 and 
ADAM 17 was reduced by 60% and 30%, respectively, but ADAM 10 and ADAM 17 ASO had no effect 
on ACE shedding (Allinson et al., 2004). APP and ACE have similar shedding profiles and are activated 
by DCI. This is evidence that ADAM 10 and ADAM 17 are not involved in ACE shedding (Parkin et al., 
2002; Parvathy et al., 1998).  
After many attempts to identify the ACE sheddase, one team of investigators yielded 
positive results. The study focussed on the shedding of endogenous sACE in HUVEC cells. 
They found that shedding was stimulated by LPS and not PMA, as was the case with most 
ACE shedding. Shedding of ACE was analysed in the medium after 16 hours. It was inhibited 
by the metalloprotease inhibitor BB-94 and ADAM 9 was identified as the LPS-stimulated 
sheddase of via siRNA. HEK cells transfected with ACE and ADAM9 showed that ADAM9 
needs to be anchored in the membrane with a catalytic domain in order for it to be shed as 
ACE. Interestingly, TNF-α a d TNF‘I e e i ol ed in the stimulation of ACE shedding via 
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ADAM9. It was concluded that ADAM 9 is most likely not involved in unstimulated shedding 
of ACE in HUVEC (English et al., 2012). Therefore ADAM 9 is unlikely the primary sheddase of 
ACE. BB94 inhibits ACE shedding at an IC50 of 0.47µM and TAPI-2 has an IC50 of 18µM. This 
indicated that the inhibitors of ACE shedding are separate from the matrix metalloproteases 
(Parvathy et al., 1997).  
 
1.5.5 ACE 2 shedding  
The ACE homologue ACE 2, is membrane-anchored and undergoes regulated ectodomain 
shedding. Extensive studies has been conducted on this newly identified homologue and 
ADAM 17 was identified as the sheddase responsible for constitutive shedding in various cell 
lines (Iwata et al., 2009). ACE 2 is shed into two forms a larger soluble form (LSF) and a 
smaller soluble form (SSF). The shedding of LSF is decreased in ADAM 17 mutant CHO-M2 
cells as well as EC-2 cells from ADAM 17-null mice. Rescued ADAM 17 activity in EC-2 cells 
reinstated the shedding of LSF but not SSF. ACE 2 juxtamembrane stalk deletion mutants 
were made and also affected the appearance of the LSF in the medium. This indicates that 
ADAM 17 is the main protease involved in the cleavage of the LSF and in conjunction with 
the juxtamembrane stalk regulates the shedding of the soluble forms of ACE2 (Iwata et al., 
2009). Calmodulin was also shown to regulate shedding as CaM inhibitors increased ACE2 
shedding (Lambert et al., 2008). The juxtamembrane and cytoplasmic domains were non-
essential in the regulation of shedding and the cleavage site was mapped to the region 716- 
741 (Jia et al., 2009). As with ACE, a region distal to the transmembrane domain was 
identified to be essential for shedding.  As a result, a point mutation at L584 was discovered 
via sequential mutagenesis to be a requisite for ACE 2 shedding. 
 
 
To i estigate the P  a d P  e ui e e ts of ADAM  i  the sheddi g of ACE , -amino 
acid peptides corresponding to the stalk region of ACE2 were incubated with ADAM 17 (Lai 
et al., 2011). Substitutions were used to determine the effect on peptide cleavage of alanine 
a d gluta ate i  the P  a d P  positio s, espe ti ely. Clea age as esta lished to o u  
at R708, and a glutamate substitution at position 708 and/or 710 resulted in an attenuation 
of cleavage. When these mutations were made in full length ACE2, only PMA induced 
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shedding was decreased and basal shedding was unaffected (Lai et al., 2011). This further 
demonstrates that multiple levels of regulation are involved in the shedding of ectoproteins 
such as ACE2. It is apparent that some shedding mechanisms are shared between ACE and 
ACE 2, while some remain different. These similarities and differences can be investigated 
for further characterisation of ACE shedding.  
 
1.5.6 Polymorphisms that affect the ectodomain shedding of ACE 
A polymorphism was found in unrelated individuals which increased the level of serum ACE 
but with no clinical abnormalities (Kramers et  al., 2001). This was said to be due to an 
increase in shedding possibly as a result of a point mutation at Pro1199Leu, which is found 
in the stalk region. The Pro1199Leu mutants expressed in CHO-K1 and COS cells were shed 
1.5-fold more efficiently than wild-type after 24 hours. An increase in the PMA response was 
also evident (Eyries et al., 2001). The cleavage site was mapped to R1137-L1138, however the 
cleavage site from the serum ACE  was cleaved at the endogenous ACE site of R-S. The role 
of proline in the structure of ACE was predicted via a hydrophobic cluster analysis (HCA) 
plots due to the lack of three-dimensional structural information. Proline is predicted to 
form twists in the structure and the replacement with a leucine relieves this constraint and 
the loop becomes more flexible, allowing for a more favourable conformation of the ACE 
stalk for the sheddase. It is also interesting to note that the P1199 is the last conserved 
residue between the N- and C– domains before the C-domain specific loop with the 
cleavage site. 
The Y465D polymorphism in N-domain of somatic ACE causes an increase in plasma ACE. 
Analysis of this mutation suggested conformational changes in sACE causes the N- and C-
domains to open up and allow access for the sheddase, leading to an increase in the rate of 
shedding (figure 1.8) (Danilov et al., 2011). A stop codon at W1197 lead to a dramatic increase 
in serum ACE (Nesterovitch et al., 2009). It is important to be aware of these polymorphisms 
that cause increased serum ACE due to aberrant shedding as these could lead to 
misdiagnosis of sarcoidosis which is identified via elevated serum ACE, but is caused by 
disparities in immune responses.  
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1.5.7 ACE shedding and dimerisation 
ACE is involved in protein-protein interactions that could have implications in its activity, 
signalling and ectodomain shedding. To study these interactions, a large set of monoclonal 
antibodies directed to the various epitopes on the surface of ACE was used (Balyasnikova et 
al., 2005; Balyasnikova et al., 2003; Gordon et al., 2010; Kost et al., 2003). The monoclonal 
antibodies 9B9 and 3G8 blocked ACE dimerisation in reverse micelles via a proposed 
carbohydrate recognition domain. 3G8 blocked shedding and 9B9 increased shedding (Kost 
et al., 2003). 3G8 is likely shielded by the C-domain and is carbohydrate dependent, but 9B9 
is not affected. This implies that this region of the N-domain negatively regulates shedding. 
These studies have shown that dimers occur via two interactions, one that is non-covalent 
occurring through the N-domain and the other disulphide-linked dimerisation occurring via 
the C-domain (Gordon et al., 2010). The dimerisation of ACE was found to be a key initiator 
of the signalling cascade, particularly ACE inhibitor-induced dimerisation. Interestingly, an 
enzymatically active C-domain was essential for inhibitor-induced dimerisation (Kohlstedt et 
al., 2006a).  
 
 Stauroporine, an inhibitor of PKC, stimulated antibody induced shedding, but inhibits PMA 
shedding suggesting that there are different signaling pathways for PMA-induced and 
antibody-induced shedding (Balyasnikova et al., 2002). This study also showed the 
sequential epitope for 5C8 is P1193-R1203 and residues within this region create the three 
dimensional epitope for 1B3, along with the distal motif of A837-H839 (tACE numbering). IB3 
binds the C-terminus of sACE in its catalytically active form, whereas 5C8 binds its denatured 
form indicating that this epitope is prone to protein-protein interactions. Also, based on a 
molecular representation of ACE, it was found that these residues possibly interact with the 
stalk region (figure 1.8)(Irina V Balyasnikova et al., 2005) as the stalk deletio  uta t Δ 
11JM abolishes the epitope for 1B3. Furthermore, epitopes for 1B3, 1B8 and 3F10 are 




























1.6 Aims of research 
It is evident that ectodomain shedding is an important and vital cellular mechanism that is 
used by the cell to modulate the cell surface expression of ACE in response to various 
stimuli. Moreover, ACE shedding is influenced by amino acids in the juxtamembrane region 
as well as the conformation of the stalk in respect of promoting access and binding to ACE 
by its cognate sheddase. Fine-mapping of the structural contribution of the C-domain 









Figure 1.8: Model of human sACE with relevant epitopes and residues highlighted. 1B3 epitope coloured in 
green showing orientation towards stalk and putative sheddase.  Epitopes for 1B8/3F10 in turquoise and 
9B9/3G8 in red.  Y465 is indicated by a black dot, P1199 in red, R1203 (cleavage site). Adapted from Danilov et al., 
2011.   
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sheddase recognition motif. Therefore, it is the aim of this investigation to characterise the 
structural motifs necessary in the ectodomain cleavage of ACE.  
This will be addressed by these main research objectives: 
1. To analyse the distal ectodomain of ACE for a sheddase recognition motif 
2. To investigate residues in the proximal ectodomain of ACE and their effect on 
shedding  
3. To investigate the role of stalk glycosylation in the ACE shedding 
4. To use soluble peptides mimicking the juxtamembrane region of ACE to understand 
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2.1. Recombinant DNA analysis  
2.1.1. Plasmids and primers 
Plasmid pcDNA 3.1 (-/+) and pGEM 117f (-/+) were purchased from Invitrogen (USA). 
Primers were purchased from Inqaba Biotech (South Africa). Primer sequences are listed in 
the appendix (table A3.1, A3.2, A3.3, A3.4). The restriction enzymes were purchased from 
Fermentas Life Sciences (Canada) or Roche (Switzerland).  
2.1.2 Agarose gels  
1% (w/v) agarose in 1X TBE (89mM Tris base, 89mM boric acid, 2mM EDTA) containing 
0.2mg/ml ethidium bromide. Electrophoresis took place over approximately 1 hour at 70 
volts in 1X TBE buffer. The gels were exposed to UV light at 260nm to visualise DNA bands. 
Images were captured on a gel documentation system (Syngene, UK) and analysed with 
GeneSnap and GeneTools software. 
2.1.3 Restriction enzyme digestion 
1µg of DNA was incubated with 10 units of enzyme/s (being less than 10% of the total 
volume), 1X compatible buffer and sterile water to bring up to the final volume. Reactions 
were incubated at 37°C for 2-4 hours and stopped with 6X loading dye.  
 
2.1.4 DNA purification from agarose gels 
The desired DNA bands were excised from agarose gels using a sterile blade. The DNA was 
purified from the gel slice using the Wizard SV
®
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2.1.4 DNA ligations 
A 10:1 ratio of insert to vector was used, 2 units of T4 DNA ligase (Promega, USA) and 1X 
ligation buffer, thawed and well-mixed, and water made up to a final volume of 20µl. The 
ligation was incubated at room temperature overnight and transformed in competent E.coli 
cells. The Kapa Biosystems DNA ligase was also used, but incubation was allowed up to 6 
hours.  
 
2.1.5 DNA quantitation 
DNA was diluted 1:100 and the absorbance was measured at 260nm and 280nm using a 
spectrophotometer. This was used to calculate its concentration and purity. Low 
concentrations of DNA were measured via the Nanodrop (Thermo Scientific) and 1.5µl was 
used. 
 
2.1.6 DNA sequencing 
Sequencing reactions were performed by the Molecular and Cell Biology DNA Sequencing  
Service,  UCT (South  Africa) utilising the  Big  Dye®  Terminator  v3.1  Cycle  Sequencing kit  
(Applied  Bio systems,  USA)  and  Half-dye  Mix  (Bioline,  UK). Further analysis was 
performed by Macrogen Inc. (Korea) using a 3730XL DNA sequencer (Applied Biosystems, 
USA). 
 
2.1.7 Preparation of competent E.coli cells 
A 5ml overnight culture of E.coli was inoculated into 100ml flask of LB (1% (w/v) tryptone, 
0.5% (w/v) yeast extract, 0.5% (w/v) NaCl). The flask was incubated at 37°C until the culture 
reached an OD530nm of 0.35. The culture was chilled on ice for 15 minutes before the cells 
were collected by centrifugation at 4000 × g for 5 minutes. The supernatant was removed 
and the cell pellet was resuspended in 10ml of  chilled TFBI (30mM KOAc; 100mM RbCl; 
10mM CaCl2; 50mM MnCl2; 15% (v/v)glycerol; adjusted to pH 5.8). These cells were again 
incubated on ice for 90 minutes and centrifuged at 4000 × g for 5 minutes. The collected 
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cells were resuspended in 3.5ml of chilled TFBII (10mM MOPS; 10mM RbCl2; 75mM CaCl2; 
15% (v/v) glycerol; adjusted to pH 6.5). The final suspension as di ided i to μl fra tio s 
and flash frozen in liquid nitrogen. The competent cells were stored at -80°C until used. 
 
2.1.8 DNA transformation 
Competent cells were thawed on ice where after a maximum of 20µl of plasmid DNA was 
added. These were left on ice for 20 minutes and heat shocked in a 42°C waterbath for 45 
seconds. The tubes were then incubated on ice for a further 2 minutes. Luria broth (LB) 
medium was added to bring the volume to 1ml and then were incubated at 37°C with 
shaking for at least an hour. After this growth period, the cells were centrifuged at high 
speed for 2 minutes. The supernatant was removed and the pellet was resuspended in 
100µl of medium. This was plated out under sterile conditions onto Luria Agar (LA) plates 
supplemented with 100µg/ml of the antibiotic Ampicillin, which allows for selection of 
plasmid-containing cells. 
2.1.9 Plasmid DNA isolation from E.coli transformed cells 
Crude plasmid preparation for use in screening of mutant constructs: 
One ml of an overnight E.coli culture was pelleted by centrifugation for 2 minutes at 
maximum speed in a microcentrifuge. The supernatant was discarded and the pellet was 
resuspended in μl of ell lysis uffer M Tris, pH . ; M EDTA; 5% /  su rose; 
100μg/ l BSA; μg/ l ri o u lease A; 2mg/ml lysozyme). This was incubated at 37°C for 
30 minutes and then boiled for 1 minute. An incubation period of 10 minutes followed on 
ice. The suspension was centrifuged at maximum speed for 10 min. The resultant 
supernatant was used in subsequent restriction digests.  
 
Large quantities of DNA plas ids ere prepared a ordi g to the a ufa turer’s proto ol 
supplied with the Qiagen Plasmid Midi Kits (GmbH, Germany).  
2.1.10 Site-directed mutagenesis   
Site-directed mutagenesis reactions were performed according to an amended protocol 
from the PCR-based Quickchange® Site-Directed Mutagenesis protocol (Stratagene La Jolla, 
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CA, USA). Sets of complementary primers (Table 4.1) were designed using the WATCUT 
programme (http://watcut.uwaterloo.ca/watcut, University of Waterloo, Canada) and 
synthesised by Inqaba Biotechnical Industries (South Africa). The desired mutations were 
introduced as well as silent mutations to create restriction enzyme sites which were 
necessary for the screening of the mutation of interest (Table 4.1). High Fidelity Taq 
polymerase from Kapa Biosystems, (South Africa) were used in all reactions and they were 
carried out using either a HybaidExpress thermocycler (Hybaid Ltd, UK) or a Bio-Rad 
MyCycler
TM
 thermal cycler (Bio-Rad Laboratories, Inc, USA). To confirm that the correct 
sized PCR was produced, a small aliquot of the PCR was separated on a 1% agarose gel. The 
remaining portion of the reaction was incubated with the restriction enzyme DpnI overnight 
at 37°C to remove the un-mutated, unmethylated template DNA (Zheng et al., 2004). The 
reaction was then transformed (2.1.8) into either E.coli  JM109  competent  cells  (2.1.7) or 
the methylation deficient JM110 if the  restriction enzyme is sensitive to methylation 
patterns (such as BclI) and  plated  on  LA plates  supplemented with 100 µg/ml ampicillin. 
Colonies were picked from the plates and grown overnight in 5ml LB. The plasmid DNA was 
then isolated and screened with the appropriate restriction enzyme (listed with respective 
primers). Positive colonies were prepared for DNA sequencing (2.1.6) by DNA isolation using 
the Zyppy Plasmid Miniprep Kit (Zymo Research, USA).   
2.2 Tissue culture  
2.2.1 Maintenance of cells  
The cell culture of choice was Chinese Hamster Ovary K1 (CHO-K1) cells and these were 
grown in an incubator at 37°C with 85% humidity and 5% carbon dioxide (CO2). The growth 
medium used comprised of 10% foetal calf serum [(FCS)(Gibco)] heat inactivated at 56°C for 
30 minutes, 50% Dulbeccos modified eagles medium(DMEM), 50% Hams F12 (Sigma, USA), 
20mM N-2-hydroxyethylpiperazine-N’-2-ethanesulphonic acid (HEPES) pH 7.5. Cells were 
seeded into a 75mm
2 
flask (Nunc) containing 30% FCS growth medium. After the cells 
attached, the medium was replaced with 10% FCS growth medium. Cells were grown until 
confluent and cells were split into culture dishes as needed.  
 
 
CHAPTER 2: Materials and Methods 
38 
 
2.2.2. Lifting of cells 
Cells were split by adding trypsin-EDTA (0.5% trypsin in phosphate-buffered saline (PBS)) 
and incubating for 2 minutes. The lifted cells and trypsin suspension were centrifuged for 30 
seconds at 2000 x g and the pellet was resuspended in the appropriate medium. This was 
used to seed flasks or dishes for further use.  
To store cells under liquid nitrogen, the pellet was resuspended in a solution of 10% 
dimethyl sulphoxide (DMSO) in FCS.  
 
2.2.3 Transfections 
Stable transfections with pcDNA 3.1 constructs were conducted using the calcium 
phosphate method according to the Pro
®
Fection Mammalian Transfection System (Promega, 
USA) technical manual. Cells grown to approximately 40% confluency in 100mm dishes were 
used with 10-15µg of DNA.  A glycerol shock was done 4 hours after DNA was added to cells. 
The antibiotic G418 (Sigma, USA) was used to select for resistant clones (Graham and van 
der Eb, 1973). These individual clones were isolated with cotton swabs dipped in trypsin-
EDTA to lift them off the dish and then grown and tested for appropriate enzyme activity 
using hippuryl-L-His-L-Leu (HHL) or benzyloxycarbonyl-Phe-His Leu (Z-FHL) as a substrate.  
2.2.4 Shedding assay 
CHO-K1 cells expressing tACE proteins were grown to confluence in a 6-well plate. The 
complete growth medium was removed, cells were washed with PBS and replaced with 
500µl Optimem (Gibco), supplemented either with 1µM of phorbol 12, 13-dibutyrate (PDBu) 
or 50µM TAPI (Peptides International). Cell lysates were harvested by adding 500µl of triton 
lysis buffer [1% Triton X-100, 50mM Hepes pH 7.5, 0.5M NaCl, 1mM phenylmethylsulphonyl 
fluoride (PMSF)] to each well and after cells started lifting, the lysates were pipetted to a 
sterile microfuge tube. The assay was conducted over 4 hours. The percentage ACE shed 
was calculated as the ratio of total ACE activity in the medium to total ACE activity in the 
medium and cell lysate [% ACE shed=ACE activity in the medium/ (ACE activity in the 
medium + ACE activity in the cell lysate)]. 
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2.3 Western blot analysis 
2.3.1 Protein concentration 
The Bradford method was used to quantify proteins. Samples were diluted to a final volume 
of 800µl of water and then mixed with 200µl of Bradford reagent (BioRad) (Bradford, 1976). 
After a 5 minute incubation the sample was read at 595nm on a spectrophotometer blanked 
against a zero protein sample. These absorbance readings were converted to concentrations 
in µg/ml against standard curve of IgG or albumin (Appendix A2.2). 
2.3.2 SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
The BioRad PROTEAN 

II gel system was used to cast and run the polyacrylamide gels 
(Laemmli, 1970). For shedding experiments, 20µl of medium samples and 15µl of cell lysate 
samples were used with 5µl of SDS sample buffer (62.5 mM Tris-HCl pH 6.8, 2% SDS, 10% 
glycerol, 0.001% bromophenol blue, 5% β-mercaptoethanol). This was boiled for 5 minutes 
and kept on ice until loaded onto gel. The 10% stacking gel consisted of running gel buffer 
(0.375M Tris pH8.8, 0.1% SDS), 0.1% ammonium persulphate (AMPS) and 7µl TEMED made 
to a final volume of 10ml with water. The 3% stacking gel was made up of stacking gel buffer 
(0.125M Tris pH6.8, 0.1% SDS), 0.3% AMPS and 20µl TEMED. The gels were run in 1X 
running buffer (0.025M Tris pH 8.3, 0.192M glycine, 0.1% SDS) at 50 mAMPs.  
2.3.3 Coomassie staining of gels 
Gels were incubated in a staining solution of 50% (v/v) methanol, 10% (v/v) acetic acid, 
0.25% (w/v) Coomassie brilliant blue and then destained in 25% (v/v) ethanol, and 10% (v/v) 
acetic acid until background was clear.  
2.3.4 Western blotting 
The separated proteins from the SDS-PAGE were transferred to nitrocellulose membranes 
(Hybond-C, Amersham Biosciences) using the BioRad blotting apparatus. Transfer occurred 
at 100 volts for 1 hour. The system was cooled by an ice pack and stirring and the blotting 
buffer composed of 25mM Tris pH 8.2, 200mM Glycine, 20% v/v methanol.  
The membrane was blocked in 5% (w/v) skimmed milk in Tris-buffered saline [(TBS) 0.05M 
Tris pH 7.4, 0.2M NaCl)]. The primary antibody (rabbit polyclonal anti- ACE) (Ehlers et al., 
1991a) was added at a dilution of 1:1000 in 5% skimmed milk in TBS and incubated 
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overnight at 4°C with shaking. Thereafter the antibody was removed and washed for 15 
minutes thrice with 5% skimmed milk in TBS. The secondary antibody [anti-rabbit 
conjugated to horse-radish peroxidase (Amersham Biosciences, Sweden)] was added at a 
dilution of 1:2000 in 5% skimmed milk in TBS and incubated for 1 hour at room temperature 
with shaking. The membrane was then washed as before but with TBS containing 0.1% 
Tween-20. The detection reagent (Immun-Star™ HRP Che ilu i es e e kit  as the  
applied for 5 minutes. The membranes were drained of excess reagent and placed between 
clear plastic sheets. The chemiluminescent bands were captured on a G-BOX (Syngene) and 
analysed via GeneTools.  
2.4 ACE activity assay of transfected membrane-bound tACE   
  
The peptide Z-FHL (Sigma, USA) was used as a synthetic substrate to detect ACE activity 
(Depierre and Roth, 1975). O-phthaldialdehyde (Sigma, USA) was used to derivatise the His-
Leu (HL) released (Friedland and Silverstein, 1976). 6µl of each sample to be analysed for 
ACE activity was placed in a 96-well microtitre plate (Schwager et al., 2006) and 30µl of the 
Z-FHL (1mM) substrate was added to each well. For the blank zero time (BZT), no sample 
was added. The plate was incubated at 37°C in a plate incubator with shaking 30-60 
minutes. 120µl of 0.4M NaOH was added to stop the reaction. An ACE sample was added to 
the BZT and mixed. 10µl of 24mg/ml (in methanol) of o-phthaldialehyde was added and 
incubated for 10 minutes. 30µl of 3N HCl was added to stop the reaction. Fluorescence was 
detected in a fluorescence spectrophotometer (Varian Inc., USA) with an excitation 
wavelength of 360nm and an emission wavelength of 485nm. 1 milliunit (mU) of ACE activity 
was calculated as nmol His-Leu (HL) formed/minute from a standard curve of fluorescent 
units (FU) versus HL concentration (refer to Appendix A1.1 for composition of reagents and 
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A large body of work has been carried out to determine the structural requirements of the ACE 
sheddase(s) (Ehlers et al., 1995, 1992, 1991b; Sadhukhan et al., 1998). Recombinant ACE 
expressed in CHO-K1 cells was found in a soluble form, leading to the initial suggestion that ACE 
is shed off the membrane in a regulated manner (Ehlers et al., 1991b). Removal of the O-
glycosylation region at the N-terminus of tACE had no effect on its shedding  (Ehlers et al., 
1992) and the addition of the phorbol ester dramatically increased shedding (Ehlers et al., 1995; 
Ramchandran and Sen, 1995) . Deletions of the juxtamembrane stalk showed that a minimum 
stalk length was required for ectodomain shedding. It was proposed that the stalk needed to be 
accessible to the sheddase as well as have a minimum length of 11 amino acids (Ehlers et al., 
1996). Inclusion of the O-glycosylation region and disulphide bridge in the stalk did not abolish 
shedding but altered the regulation and rate of shedding. This argues that even though they 
modulate the shedding profile, the regions mutated did not abrogate shedding and therefore 
are not the primary sites of regulation for the shedding process (Schwager et al., 2001, 1999). 
These mutations in the stalk suggested that the modulation of shedding was directed by other 
regions of the ACE protein. Moreover, Chubb et al., (2002) determined that the cytoplasmic tail 
was not an absolute requirement for shedding.  
 
An investigation into the role of the two domains of ACE demonstrated that a single C-domain 
variant was cleaved at a much faster rate than sACE (Beldent et al., 1995). Further studies have 
shown that tACE is cleaved 2-3 fold more rapidly than sACE even though they are cleaved at the 
same site in the stalk (Woodman et al., 2000). This points towards the N-domain of sACE 
negatively regulating shedding and that the single domain tACE/C-domain is shed more 
efficiently. However, a mutant where the N-domain was fused to the stalk and anchored in the 
membrane was not shed at all and suggested that the mere presence of a single domain was 
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not sufficient for cleavage off the membrane (Pang et al., 2001). This led to the theory that the 
C-domain may have a recognition motif that interacts with the sheddase and regulates 
ectodomain cleavage. Domain swop-over mutants reinforced the notion of a sheddase 
recognition motif within the ectodomain of the C-domain as the double C-domain mutant was 
cleaved within the linker region as well as at the stalk, which does not occur in sACE. The 
inverse orientation of the N- and C-domains of sACE was shed poorly and had very low activity, 
implying that the conformation was not conducive to proper processing and shedding 
(Woodman et al., 2005). This, taken together with the fact that sACE is shed less efficiently than 
tACE, suggests that the recognition motif may be occluded in the C-domain of sACE. It was also 
shown using monoclonal antibodies that certain epitopes within the N-domain may be involved 
in the control of shedding. The monoclonal antibody 3G8, whose epitope was mapped to the lid 
region of the N-domain, was shown to decrease shedding upon binding to sACE (I V 
Balyasnikova et al., 2005; Balyasnikova et al., 2002). This indicates that perhaps these 






















Figure 3.1: Schematic representation of constructs utilised in the study from Woodman et al., (2006). A) Grey 
boxes represent the 36 residue O-glycosylated region of tACE. The various colours represent the regions 
substituted with N-domain residues. A) is a linear representation and in B) are the corresponding regions in 
relation to its three-dimensional structure (Picture reproduced from (Woodman et al., 2006).   




The shedding profiles of swop-over chimeras between rabbit tACE and the unshed ectoprotein 
CD4, suggested that the ACE ectodomain directed cleavage of the CD4 stalk (Sadhukhan et al., 
1998). To fully examine the tACE/C-domain ectodomain, five chimeric tACE proteins were 
constructed by substituting regions of tACE with the corresponding regions from the N-domain 
in an attempt to identify the sheddase recognition domain, namely, C1-163Ndom-ACE, C164-
416Ndom-ACE, C197-214 Ndom-ACE, C417-579 Ndom-ACE and C583-623Ndom-ACE (figure 3.1) 
(Woodman et al., 2006). The C164-416Ndom-ACE chimera was neither processed nor shed, 
proposing that a putative sheddase recognition motif within the distal ectodomain of testis ACE 




. This region of ACE spatially 
influences the entire protein when viewing the three dimensional structure of ACE (Natesh et 
al., 2003) and would explain why such a substitution mutation with the N-domain residues 
might result in an inactive protein. The region disrupts the active site, removes 2 glycosylation 
sites and affects the junction of the 2 subdomains of tACE. It also introduces another potential 
gl os latio  site ithi  α-helix 11. The various mutants made in the Woodman study (2006) 
were designed by sequentially substituting regions of the entire C-domain with the 
corresponding region of the N-domain (figure 3.1). Because these mutants were designed 
without the benefit of a three dimensional structure of the enzyme, the secondary structural 
elements were not taken into consideration. The smaller C197-214 Ndom-ACE chimera was made 
based on the fact that it had the lowest homology between the C and N-domains, and it was 
postulated that it would be the most likely candidate region for a putative recognition motif as 
it was further away from the active site. This mutant was also catalytically inactive 
demonstrating that this region was also necessary for folding and processing of the protein.  
 




 with the aim of identifying a recognition 
motif within this region. The following regions could be excluded due to reasons listed here: 1) 




 causes a loss of enzymatic activity and 
poor cellular processing, indicating that this region is essential for correct processing (figure 
3.2)(Woodman et al., 2005), and 2) a mutation reported by Williams et. al., (1996) of the  







 (figure 3.2) resulted in an active, correctly processed protein. Thus, it was 
decided to focus efforts on finding suitable regions that could coordinate shedding without 
negatively affecting the processing or activity of the protein. Residues 164-196 make up helix 5-
6 of tACE and helix 5 of tACE is highly homologous with helix 5 of the N-domain. Furthermore, 
helix 6 forms part of the 197-214 chimera, which was inactive. This suggests that this region is 





 incorporates helix 9-12 which also displays high sequence homology between the N- 
and C-domains, as well as the glycosylation sites that could affect processing if mutated. The 
only other potential candidate region, which had low homology to N-domain, as α heli   as 
it only had 50 % homology between the N and the C domains. However, it was not studied 
further due to the fact that it borders the subdomain junction which could affect folding 
(Woodman et al., 2006). The regions chosen to be mutated were located on the N-terminal 
subdomain and more proximal to the cleavage site according the three-dimensional crystal 
structure (Natesh et al., 2003) (figure 3.3).   
 
Incorporating the knowledge learnt from previous attempts to locate the recognition motif, 
several factors were taken into account to rationally design further chimeras. An alignment was 
done between the C-domain and the N-domain of the 164-416 regions (figure 3.2). To further 
investigate this region, smaller N-domain substitutions were made by focussing on regions of 
least homology between the N- and the C-do ai  of hi h α heli   D215-Y225) and 8 (S228-H258) 
met these criteria. The proximity of these regions to the cleavage site of tACE on the crystal 
structure was also taken into account. The basis for this was to identify regions most likely to 
interact with the sheddase secondary to the cleavage site interaction (Woodman et. al. 2000). 
The secondary structure of ACE was also taken into account where helices and loops were 
depicted (Natesh et al., 2003). This was done to prevent disrupting structures and thereby 
possibly preventing inactivation. Regions that included important features such as active sites 
and glycosylation sites were also avoided as mutations to these areas could lead to inactive 
p otei s o  i o e tl  folded a d p o essed p otei s. Besides α heli  7 and 8, another three 
residue motif, A
261
QH, immediately after helix 8 was also analysed. A
261
QH creates a motif that 
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is closely associated with the most C-terminal residues of the ACE structure making it an 
excellent candidate for a recognition motif. Furthermore, it was also shown previously to be a 
part of a functional epitope for the monoclonal antibody 1B3 (Irina V Balyasnikova et al., 2005a; 
















A more recent publication confirmed our predictions that the secondary contact region with 
the sheddase would occur in closer proximity to the cleavage site (Chattopadhyay et al., 2008). 
They hypothesised that a 5-residue motif in the ectodomain directly proximal to the cleavage 
site alters shedding of rabbit tACE. The implications of their findings will be detailed and 
discussed further with respect to the human tACE cleavage in chapter 4.  
 
3.1.1 Project objectives 
The main aim of this study was to identify residues or regions within the distal ectodomain of 
testis ACE that interact with the ACE sheddase and directs its proteolytic activity. This was 
achieved via the following objectives: 
1. Examining the role of the region encompassing residues D164-V416 in tACE by 
constructing chimeric tACE mutants within this region using overlap PCR and SDM 
Figure 3.2: Alignment of the C-domain residues 164-416 and the complementary N-domain residues 
highlighting key structural features. Regio s u de li ed i  la k ith a o s ep ese t α heli es, egio s 
underlined with purple dashed  lines are 310 helices, the residue boxed in black represents the chloride 1 site; 
the residues boxed in turquoise represents the glycosylation site that would be removed with the substitution 
of N-do ai  esidues. Blue dashed li es ep ese t β sheets, the egio  o ed i  lue is the -214 mutation, 
and the region boxed in green represents the 353-413 mutation. The mutations made pertaining to this 
chapter a e o ed i  pu ple α heli  , ed α heli   a d A261QH (yellow). This will highlight how these 
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2. Determining the effects of the above mutations on the enzymatic activity of ACE 
3. Analyse the shedding profiles of the mutants with respect to their response to 






















3.2 Materials and Methods 
 





further evaluated for potential sheddase recognition motifs. Three mutants were made to 
determine their contribution to the regulation of shedding using the methods summarised in 











Figure 3.3: Selected mutants represented on the structure of tACE. A) Ribbon representation of tACE structure 
(Natesh et. al. 2003). Green represents the residues 164-416, α helix 7 is coloured in orange, α helix 8 is 
coloured in pink, the 3-residue motif AQH is coloured in yellow. The C-terminal end of the structure ends at (Pro 
623) and is circled in white. B) Surface representation of the tACE structure with the mutations made coloured 
in purple (H7), red (H8) and yellow (AQH). The stalk residues are coloured in pink and a schematic 
representation has been added to orientate the structure in the relation to the transmembrane and cytoplasmic 
domains. 




Table 3.1: List of mutants made and method used.  
Mutant Construct  Method used to introduce N-domain residues 
pcDNA tACE H7 Overlap PCR 
pcDNA tACE H8 Overlap PCR 
pcDNA tACE AQH Site directed mutagenesis 
 
3.2.1 Cloning of swop-over ACE mutants 
3.2.1.1 Subcloning of tACE into pGEM -Z11f (-) and pcDNA 3.1 (-) 
Human wild-type tACE was cloned into pGEM -Z11f (-) via compatible BamHI and HindIII 
restriction sites from pLENtACE (Ehlers et al., 1991a). From pGEM -Z11f (-) tACE, the insert was 
cloned into pcDNA 3.1(-) with BamHI and HindIII.  
3.2.1.2. Cloning of pcDNA-tACE H7 
The D164-V416 region of tACE was flanked  the est i tio  sites BglII at the 5’ site a d NheI at 
the ’ site. T o sets of p i e s e e desig ed a d utilised o e lap PCR (Urban et al., 1997) to 
utate the p α-helix 7 of tACE to the N-domain residues (figure 3.4). Mid For and Mid Rev 
primers (table A.3.1) contain regions complementary to tACE as well as the N-domain residues 
of α-helix 7. The restriction enzyme EheI was introduced to facilitate screening of colonies with 
the correct mutation. The tACE specific primer BglII For and the Mid Rev primers used in 
conjunction with the BglII-NheI tACE fragment as the DNA template produced a 600bp 
fragment. The Mid For primer and tACE specific NheI Rev primer produced a smaller 186bp 
fragment (figure 3.4, step 1). These PCR products were purified from agarose gels using the 
Wizard® SV Gel and PCR Clean-Up System (Promega, USA). The zippe  ea tio  o sisted of 
5µl of each purified band, dNTPs, PCR buffer, MgCl2 and nuclease free H2O. It was boiled for 10 
minutes, placed on ice for 2 minutes, Pfu polymerase (Promega) was then added and incubated 
at 75°C for 10 minutes (step 2). This reaction was then used as the template with BglII For and 
NheI Rev primers for the reaction to amplify the entire fragment. General PCR conditions were 
used i.e. 95°C for 5 minutes (initial denaturation), 95°C for 30 seconds, 62.7°C for 45 seconds, 
72°C for 1 minute (x25 cycles), 72°C 1 minute. This resultant PCR fragment was gel purified, 
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digested with BglII and NheI, and then subcloned into the tACE fragment with the BglII and NheI 
restriction sites (step 3).  
 
The ligated fragments were transformed into E.coli JM109 competent cells, as previously 
described (chapter 2.1.8). Colonies were screened using small scale DNA preparations and 
digestions of the DNA with the screening enzyme EheI. Positive colonies were sent for 
sequencing and after the mutation was confirmed, the tACE DNA insert was subcloned from 
pGEM tACE H8 into the expression vector pcDNA3.1 (-) using the compatible restriction 
enzymes BamHI and HindIII. The ligated plasmids were transformed into competent JM109 
E.coli cells, positive colonies were identified from them and DNA was isolated using the Qiagen 
Maxi Kit in quantities sufficient for transfections into CHO-K1 cells. 10-15µg of this DNA was 
used to transfect CHO-K1 cells using the calcium phosphate method (refer to chapter 2.2.3). 
Stable cell lines were assayed for changes in shedding under control, PDBu and TAPI conditions 



















































Figure 3.4: Schematic diagram representing the PCR and cloning steps involved in creating the construct pcDNA-
tACE H7.  
 
This zipper reaction 
was used as the 
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reaction with BglII For 
and NheI Rev flanking 
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Gel purified DNA fragments were 
combined with polymerase and 
dNTPs and incubated at 75°C for 
10 minutes.  
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3.2.1.3. Cloning of pcDNA-tACE H8 
Helix 8 is 96 base pairs long and overlap PCR was used to mutate this region to N-domain 
residues. Primers were designed with a portion targeted to the corresponding 96bp N-domain 
region and a portion that will target the surrounding testis ACE flanking regions of helix 8 
(figure 3.5, step 1). The template that was used was Ndomain D629 (P. Redelinghuys, PhD 
thesis, 2006). These primers were used to produce an N-domain fragment with tACE flanking 
regions. The resultant DNA fragment was purified using PCR clean-up kits (Wizard kit, Promega) 
a d the p f ag e t o  e o es a egap i e  he  used i  o ju tio  with tACE 
specific primers to produce two larger tACE fragments (fragments A and B) each with the 
complementary N-do ai  egio  at the ’a d 5’p i e egio s, respectively (figure 3.5, step 2).  
 
Optimisation of the megaprimer reaction required that the megaprimer concentration needed 
to be in excess compared to the flanking primer and PCR conditions needed to favour the 
megaprimer initially. Therefore, an initial 5 cycles of the PCR was conducted at an annealing 
temperature specific to the megaprimer. Thereafter the annealing temperature is reduced to 
50°C for a further 25 cycles (Wu et al., 2005). This DNA fragment was cut out and purified. The 
overlap zipper reaction was set up using both fragments and adding Pfu and dNTPs. This was 
incubated for 10 minutes at 75°C, which is the optimal temperature at which Pfu acts as a 
polymerase (step 3). This reaction was used as the template for a PCR reaction with BglII and 
NheI primers to create DNA fragments incorporating N-domain residues with BglII and NheI 
restrictions sites. This fragment was cut out and gel purified. It then underwent restriction 
e do u lease digestio  ith BglII a d NheI to eate the o e t 5’ a d ’ e ds e ui ed fo  








































Gel purified DNA fragments were combined with 
polymerase and dNTPs and incubated at 75°C 
for 10 minutes.  
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and NheI Rev 
flanking primers to 
produce the entire 
BglII-NheI fragment 
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Figure 3.5: Schematic diagram representing the PCR and cloning steps involved in creating the construct 
pcDNA- tACE H8. 
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N domain (D629) ← 
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The ligated fragments were transformed into E.coli JM109 competent cells as previously 
described. Colonies were screened using small scale DNA preparations and digestions of the 
DNA with the screening enzyme SphI. Positive colonies were sent for sequencing and after the 
mutation was confirmed, the tACE DNA insert was subcloned from the pGEM- tACE H8 into the 
expression vector pcDNA3.1 (-) using the compatible restriction enzymes BamHI and HindIII.  
3.2.1.4 Site-directed mutagenesis of pcDNA-tACE AQH 
The 3 residue motif was mutated via site-directed mutagenesis using the primers presented in 
Appendix, table A3.3 according to the method outlined in chapter 2. 
3.2.1.5 Expression of mutants in CHO-K1 cells 
The ligated plasmids were transformed into competent JM109 E.coli cells, positive colonies 
were identified and from them DNA was isolated using the Qiagen Maxi Kit in quantities 
sufficient for transfections into CHO-K1 cells. 10-15µg of this DNA was used to transfect CHO-K1 
cells using the calcium phosphate method (refer Method and materials). Stable cell lines were 
assayed for changes in shedding under control, PDBu and TAPI conditions. Western blot 
analysis and ZFHL enzyme assays were conducted.  
 
3.3 Results   
3.3.1 Cloning of tACE mutants 
3.3.1.1 Subcloning of tACE into pGEM -Z11f (-) and pcDNA 3.1 (-) 
In preparation for the subcloning of the mutated fragments into wild-type tACE, the wild-type 
tACE DNA insert was subcloned from pLEN-tACE into pGEM -Z11f(-) and then into the 
expression vector pcDNA 3.1 (-). pLEN-tACE has 3 HindIII restriction sites (figure 3.6 A) and 
BamHI and ClaI sites flanking the tACE insert. However, ClaI could not be used in the subcloning 
as it is not compatible with pGEM -11Zf (-). Therefore HindIII was used in conjunction with 
BamHI. The fragment released with the digestion of BamHI and ClaI (figure 3.6 B, lane 1) was 
gel purified and ligated with a similarly digested pGEM 11Zf (-). Digestion of pGEM 11Zf (-)-tACE 
with BamHI and HindIII produced a fragment of approximately 2500bp (figure 3.6 D, lane 2), 
indicating the successful ligation of tACE and pGEM 11Zf (-).   
 






















Figure 3.6: Cloning of tACE into pGEM -l1Zf(-). A) pLEN -tACE plasmid map highlighting the posit ion of Cia] 
and Hind lll restriction sites. B) 1% agarose gel showing digested pLEN-tACE; lane 1- BamH I and Cla l, lane 2-
BamHI and Hindili. h DNA digested with Hindlll and EcoRI are used as the DNA sizing marker as indicated 
on the left in kjlobases (kb). C) pGEM -llZf(-) tACE plasmid map highlighting Bam HI and Hind ll] restriciton 
sites. DJ 1% agarose gel of restriction digested pGEM l1Zf(-) tACE; lane 1- Hindlll, lane 2- BamHI and 
Hind ili. A DNA digested wi th Hind ll] and EcoRI are used as the DNA sizing marker as indicated on the left in 
kilobases (kb). 
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3.3.1.2 Subcloning of pcDNA-tACE H7 
pGEM -Z11f(-) tACE was used as template for construction of all the chimeras. The tACE H7 





 to corresponding N-domain residues according to the strategy outlined in 
figure 3.4 and using the primers in table A3.1 (Appendix). The resultant fragment with BglII and 
NheI est i tio  sites at the 5’ a d ’ te i i was subcloned into pGEM Z11f(-)-tACE and the 
correct insertion verified by DNA sequencing. The tACE H7 insert was then subcloned into the 
pcDNA 3.1 (-) using compatible restriction sites BamHI and HindIII. An EheI restriction site was 
engineered into the primer to assist in screening for the mutation. Thus, digestion of pcDNA-
tACE H7 with EheI yielded two fragments of 4.8kb and 3.1kb, indicating the correct 



















Figure 3.7: Restriction digest and plasmid map of pcDNA 3.1 (-) tACE H7. On the left is a 1% DNA agarose gel 
of EheI digests of wild-type tACE (lane 1) and tACE H  la e . λ DNA digested ith Hi dIII a d E oRI a e used 
as the DNA sizing marker as indicated on the left in kilobases (kb). The plasmid map highlights the restriction 
enzyme sites pertinent to the construct. The underline italicised EheI site was introduced to aid in the 
screening of the mutation that was introduced.    
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3.3.1.3 Cloning of pcDNA-tACE H8 
To substitute the N-do ai  esidues of α-helix 8 for the corresponding region in tACE, the 





Ndom/tACE H8 was constructed using Megaprime (Wu et al., 2005) and 








. The PCR 
products depicted in figure 3.5 as fragment A and B, together with primers which flank the 
mutated regions and incorporate BglII and NheI restriction sites, respectively, were used to 
produce a final PCR product that was subcloned into pGEM -Z11f(-) tACE digested similarly with 
BglII and NheI. After confirming the sequence of tACE H8, it was subcloned from the pGEM Z11f 
(-) into the pcDNA 3.1 (-) vector. Digestion with SphI confirmed that the correct residues were 
incorporated as the there was a loss of the C-domain SphI site. The pcDNA vector also 
contributes five SphI sites to the plasmid construct and thus five bands are expected. Lane 1 
represents the wild-type banding pattern, showing all the resultant bands except for a 0.072kb 
that is not visible on the gel represented here. The sizes of the resultant bands were 5.0kb, 
1.2kb, 0.8 and 0.6kb (figure 3.8). When the SphI site is absent, as in tACE H8 (lane 2), the 1.2kb 




















Figure 3.8: Restriction digest and plasmid map of pcDNA 3.1 (-) tACE H8. On the left is a DNA agarose gel of 
SphI digests of wild-type tACE la e  a d tACE H  la e . λ DNA digested ith Hi dIII a d E oRI a e used as 
the DNA sizing marker as indicated on the left in kilobases (kb). The plasmid map highlights the restriction 
enzyme sites pertinent to the construct. The italicised SphI site was removed with the introduction of the N-
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 were replaced with their N-domain counterparts by SDM (chapter 2, 
section 2.1.10) using the primers detailed in table A3.3 (Appendix). DNA sequencing confirmed 
the incorporation of the correct mutation and the DNA insert was subcloned into pcDNA 3.1(-) 
using BamHI and HindIII restriction sites. A unique AgeI restriction enzyme site was included in 
the SDM primers for screening purposes. Thus, digestion of pcDNA 3.1(-) tACE with AgeI did not 
produce any distinct bands (figure 3.9, lane 1), while digestion of pcDNA 3.1 (-) tACE A
261
QH 


























Figure 3.9: Restriction digest and plasmid map of pcDNA 3.1 (-) tACE AQH. On the left is a DNA agarose gel of 
AgeI digests of wild-type tACE (lane 1) and tACE A
261
QH la e . λ DNA digested ith Hi dIII a d E oRI are 
used as the DNA sizing marker as indicated on the left in kilobases (kb). The plasmid map highlights the 
restriction enzyme sites pertinent to the construct. The underlined italicised AgeI site was introduced to aid in 
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3.3.2 Expression and shedding of swop-over mutants 
Mutant and wild-type tACE DNA was stably transfected into CHO-K1 cells. The ectodomain 
shedding of the swop-over tACE H7 and tACE H8 chimeras and the tACE A
261
QH mutant was 
analysed as described before (refer to chapter 2, section 2.2.3 and 2.2.4). Western blot analysis 
was performed in order to confirm the molecular weight of the proteins and their presence in 
the cell medium and lysate. Wild-type tACE in pcDNA 3.1(-) was released into the medium at a 
rate of 25% of the total ACE  (Figure 3.10) which was higher than the pLEN construct previously 
described (Ehlers et al., 1991a). The addition of 1µM of the phorbol ester PDBu results in a two-
fold increase in shedding consistent with previous reports (Ehlers et al., 1995). The addition of 
the hydroxamate inhibitor TAPI reduced shedding to below 5% and this confirmed that the 


















Figure 3.10: Shedding analysis of pcDNA tACE. A) Western blot -Lane 1: control, medium; lane 2: 1µM 
PDBu added medium; lane 3:  50µM TAPI added medium; lane 4: control, cell lysate; lane 5: 1µM 
PDBu, cell lysate; lane 6: 50µM TAPI, cell lysate. B) Activity assays showing percentage shed ACE of 
total ACE activity. Data represented are mean ±SEM, n=2.  
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3.3.2.1 tACE H7 
The ectodomain shedding of tACE H7 was analysed via western blot analysis and ACE activity 
assays using the substrate ZFHL. Shedding was marginally, but not significantly, lower (19%) 
than wild-type (24%) (figure 3.11, B). tACE shedding was stimulated by phorbol ester and 
shedding was inhibited by TAPI. Thus, the epla e e t of α heli   of the C-domain with the 
















3.3.2.2 tACE H8 
The replacement of C-do ai  esidues ithi  α helix 8 with their N-domain counterparts 
increased basal shedding by 8% and the presence of the phorbol ester resulted in stimulated 
shedding of 62% (figure 3.12). This mutation had the unexpected result of increased shedding 
instead of reduced shedding. This puts forward that this region is not vital for the regulation of 
shedding. Nevertheless, the introduction of N-domain residues at this site has modulated 
shedding by causing an increase in shedding to 30%.  
 
 
1               2                  3                4                   5                   6 
Figure 3.11: Shedding analysis of pcDNA tACE H7. A) Western blot- Lane 1: control, medium; lane 2: 1µM 
PDBu added medium; lane 3:  50µM TAPI added medium; lane 4: control, cell lysate; lane 5: 1µM PDBu, cell 
lysate; lane 6: 50µM TAPI, cell lysate. B) Activity assays showing percentage shed ACE of total ACE activity. 








































3.3.2.3 tACE AQH 
Compared to wild-type shedding (figure 3.10, B), basal shedding of tACE AQH was reduced by 
10% according to the activity assay (figure 3.12, B). However, this mutant was still sensitive to 
PDBu as well as TAPI as there is an increase in shedding with the addition of PDBu and decrease 
with TAPI demonstrating a similar shedding profile to the H7 and H8 mutants. The rationale 
behind making this mutant was based on the fact that these residues contribute to a specific 
epitope in the stalk region of ACE for the monoclonal antibody 1B3 (Irina V Balyasnikova et al., 
2005a). They suggested that these residues encompass the 1B3 epitope along with an 11-
residue sequential epitope in the stalk. Therefore, it is likely that these residues create a 
structural motif that is in close enough proximity with the stalk region to possibly interact with 
it, and direct cleavage of ACE in the stalk. Alteration of this motif, however, was not sufficient 
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Figure 3.12: Shedding analysis of pcDNA tACE H8. A) Western blot - Lane 1: control, medium; lane 2: 1µM 
PDBu added medium; lane 3:  50µM TAPI added medium; lane 4: control, cell lysate; lane 5: 1µM PDBu, cell 
lysate; lane 6: 50µM TAPI, cell lysate. B) Activity assays showing percentage shed ACE of total ACE activity. 
Data represented are mean ±SEM, n=2.  
 


































In figure 3.14 the percentage of shed ectodomain of all the mutants is compared. tACE H7 and 
wild-type tACE are most similar in their responses to phorbol stimulation and TAPI inhibition. 
tACE H8 has increased shedding compared to wild-type tACE for all conditions indicating that 
the mutation in helix 8 might have caused a conformational change which promotes shedding. 
The addition of 50µM TAPI did not reduce shedding to the same extent as with tACE AQH and 
wild-type. tACE AQH is also the only mutant whose basal shedding was less than that of wild-
type, although not statistically significant. This may support that these three residues may 
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Figure 3.13: Shedding analysis of pcDNA tACE AQH. A) Western blot - Lane 1: control, medium; lane 2: 1µM 
PDBu added medium; lane 3:  50µM TAPI added medium; lane 4: control, cell lysate; lane 5: 1µM PDBu, cell 
lysate; lane 6: 50µM TAPI, cell lysate. B) Activity assays showing percentage shed ACE of total ACE activity. Data 
represented are mean ±SEM, n=2.  
 
























3.4 Discussion  
 
Previous work has alluded that a putative recognition motif within the distal ectodomain of 




. However, this swop-over mutation 
encompassed 252 residues and resulted in a protein that was incorrectly processed, inactive 
and not shed. This region of ACE spatially influences the entire protein when viewing the three 
dimensional structure of ACE and would explain why such a substitution mutation with the N-
domain residues would likely result in an inactive protein. The region includes the active site 
and two glycosylation sites. The various mutants made in the Woodman study (2006) were 
designed by following the compatible restriction sites between the C and N-domain, so as to 
essentially cover the entire ectodomain. They did not take the secondary structure of the 
protein into account in the design. 
 
Therefore, in this study discreet mutations were made by focussing on regions of least 
homology between N- and C-domains, at the surface of the protein, regions with close 
proximity to the cleavage site (to increase the likelihood of interaction with the sheddase), and 
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Figure 3.14: Comparison of shedding between mutants showing untreated control, stimulated (1µM PDBu) and 
inhibited (50µM TAPI) conditions. The abbreviations H7, H8, AQH and W.T. represent the constructs tACE H7, 
tACE H8, tACE AQH and tACE wild-type, respectively. Data represented are mean ±SEM, n=2. 
CHAPTER 3: Analysis of the distal ectodomain of tACE to identify distinct regions that serve as a sheddase recognition motif 
62 
 
to make sure that structural elements remained intact by referring to the secondary structure 
of ACE. Overlap PCR was successfully used to introduce a desired mutation by replacing C-
domain residues with N-domain residues at helix 7 (figure 3.7). The mutation of helix 7 and 
helix 8 (figure 3.8) did not alter shedding significantly and the protein was processed to the cell 
surface as was seen in the western blot (figure 3.11 and figure 3.12), suggesting that these 
residues do not play a vital role in directing ACE shedding. The replacement of the three residue 
motif A
261
QH i ediatel  follo i g α helix 8 with N-domain residues had the most notable 
influence on shedding. The alteration of the A
261
QH reduced basal shedding, but the mutant 
was active and shed, and responded to the addition of PDBu (figure 3.13), which increased 
shedding. Withi  α heli  , the e as a utatio  of M W, hi h is ithi  the hlo ide  
pocket (Tzakos et al., 2003). This agrees with a more extensive investigation of a point mutation 
of this residue within tACE (C. Yates, PhD thesis 2012). There was no alteration in either 
shedding or ACE activity, indicating that this residue did not play essential role in the chloride 
activation of ACE. With these mutations we have made specific N-domain substitution mutants 




, which has been previously identified as a potential 
sheddase recognition motif (Woodman et al., 2006). We have managed to produce chimeric 
mutants that are catalytically active and correctly processed by maintaining the structural 
integrity of the protein.  
 
Other examples of proteins that show that ectodomains may contribute to their shedding are 
tumour necrosis factor (TNF-) and L-selectin (Zhao et al., 2001; Zheng et al., 2004).  These 
studies demonstrate the presence of a sheddase recognition motif within their ectodomains. 
TNF- is cleaved by TNF- convertase (TACE/ADAM 17) as well as ADAMs 9 and 10. The TNF- 
ectodomain was shown to be responsible for selective stimulated cleavage by ADAM 17 (Zheng 
et al., 2004). L-selectin, a leukocyte transmembrane glycoprotein which undergoes slow, 
constitutive shedding and fast, stimulated shedding was also cleaved by ADAM 17 and it was 
shown that its EGF domain was essential for stimulated shedding (Zhao et al., 2001). 
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Having established a premise for the role of a sheddase recognition motif, it is necessary to 
discuss it in the context of alternative/additional regulatory mechanisms that influence 
shedding such as the dimerisation of ACE. Studies conducted in reverse micelles showed that 
homodimerisation occurs between the two molecules of sACE via their respective N-domains 
(Kost et al., 2003). Furthermore, dimerisation was blocked by monoclonal antibodies 9B9 and 
3G8 (I V Balyasnikova et al., 2005; 2005b) whose epitopes were mapped to the N-terminal lid 
region of the N-domain, and were also found to influence shedding  (Irina V Balyasnikova et al., 
2005b). Deglycosylated ACE did not form dimers (Kost et al., 2003) and 9B9 increased shedding 
in the presence of 5mM galactose. Balyasnikova et al. (2005a) confirmed that 3G8 decreased 
the rate of shedding by 30% and 9B9 stimulated shedding by 2-4 fold. Further studies 
conducted by Gordon et.al. (2010) found that 3G8 is shielded by the C-domain and is 
carbohydrate dependant, establishing that the epitopes for 9B9 and 3G8 form the carbohydrate 
recognition motif that mediate dimerization. They also put forward a model where dimers 
occur via two interactions: namely, non-covalently linked dimers which occur through the N-
domain and disulphide-linked dimerization which occurs via the C-domain (K. Gordon, PhD 
thesis 2011). Collectively, we can see that the epitopes involved in dimerization have a role in 
shedding as well. 
 
In sACE, a cooperative effect may exist between the N- and the C-domains that could result in 
the inhibition of the accessible recognition motif for the sheddase, which does not occur in 
tACE. There are many scenarios where it would be possible to relate these events to the 
recognition motif. It could be possible that the dimerization of sACE does not allow accessibility 
to the sheddase, or even still causes a conformational change that prevents the recognition 
motif from being accessed. Another possibility would be that because the C-domain forms 
disulphide-mediated dimers and the N-domain non-covalent linked dimers, possibly via glycans, 
the C-domain or tACE is more susceptible to changes in the redox environment. It was shown 
that ADAM17 is modulated by protein disulphide isomerise (PDI), which keeps it in an inactive 
form (Bennett et al., 2000; Willems et al., 2010). Perhaps it is this chaperone (PDI) that is 
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required to mediate the disulphide bond rearrangement to facilitate an increase in shedding in 
tACE.  
 
It is also encouraging that it has been hypothesised that many ADAMs or ADAM-like structures 
possess a non-catalytic region called the hypervariable region (HVR), said to be the sight of 
target recognition for ADAMs. Based on homologous structures found in the snake-venom  
homologue VAP1, it was shown that the HVR forms a disulphide bridge-stabilised fold that is 
highly conserved (Takeda et al., 2012, 2006). The authors put forward exciting models of the 
HVR region being the exosite contact with the substrate and thereby coordinating proteolysis at 
the cleavage site distal to the initial contact at the HVR. Once again, there is an indication that 
disulphide bonding may have a critical role in the interaction of the HVR and its substrate, thus 
giving further support to the theory that a change in the redox environment acts as the 
regulation switch in the shedding of ACE.  
 
Another factor that may affect domain interactions and shedding is the complex glycosylation 
that ACE undergoes. There has been consistent effort into the construction of minimally 
glycosylated sACE, which aimed to reduce heterogeneity caused by glycans and promote the 
formation of protein crystals for the crystal structure determination of sACE. However, it was 
shown that when the number of N-linked glycans was reduced in sACE, there is an increase in 
cleavage in the interdomain linker region of sACE (Anthony C., PhD thesis, 2011). It was 
proposed that this was attributable to the lack of glycans protecting the linker region. These 
results shed new light on the analysis of the previously mentioned CC-domain construct. This 
protein consisted of two C-domains joined by the linker region and were shown to be cleaved 
within the linker as well as the stalk (Woodman et al., 2005). This led to the assertion that the 
presence of a sheddase recognition domain in the C-domain directed cleavage in both the linker 
region and stalk. Alternatively, one can argue that considering that the C-domain had less 
glycosylation (6 sites) than the N-domain (9 sites), that it was cleaved in the bridge region. Yu 





, suggesting that this region was more susceptible to proteolysis. It was also found that 
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a non-glycosylated cellulose degrading enzyme from the bacterium C.fimi undergo autolysis, 
which is not seen in the fully glycosylated form, indicating that glycosylation offers protection 
against degradation. If the explanation for the cleavage within the bridge region is that either 
the lack of glycans no longer protects the bridge region or that the conformational change that 
results from having two C-domains creates greater accessibility for the sheddase, we would 
then need to further discuss the contribution of glycans to sACE stability as well as the steric 
relationship between the N-and the C-domain and how it relates to shedding. 
 
Based on previous work, we have further dissected the tACE ectodomain in an attempt to 
identify the sheddase recognition motif. We did not conclusively identify a region within the 
tACE/C-domain that, when substituted with the N-domain, significantly altered its rate of 
shedding. We have thus furthered our body of knowledge about the structural contribution 
that the distal ectodomain of tACE has made. We have succeeded in making swop over 
mutations that resulted in active and fully processed ACE proteins whereby shedding can still 
be analysed and we have managed to maintain the structural integrity of ACE by following the 
structural boundaries based on the published crystal structure. Considering that mutating exact 
secondary structure elements of tACE did not have a dramatic effect on its shedding, we 
refocused our attention (chapter 4) on the proximal ectodomain of ACE and its stalk region. 
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We have previously discussed the stalk and ectodomain contributions to the regulation of 
the shedding of ACE. In this chapter we revisit the important findings of Sadhukhan et al. 
(1998) that showed when the ectodomain and stalk regions of CD4 were swopped with the 
ectodomain or stalk region of testis ACE, the CD4-ACE chimera consisting of the ACE 
ectodomain and CD4 stalk was cleaved within the CD4 stalk region. CD4 is a membrane 
protein that is not usually cleaved from the membrane, hence these experiments proposed 
there were elements in the ACE ectodomain directing a protease to cleave the stalk region 
and shed the protein from the membrane. It must also be reiterated that sACE shedding is 
inefficient compared to tACE as it was suggested to be due to the N-domain shielding the C-
domain or stalk (Beldent et al., 1995). The binding of ACE monoclonal antibodies that 
modulate its rate of shedding demonstrated that certain regions may be involved in 
shedding (Balyasnikova et al., 2005a; Balyasnikova et al., 2005b; Gordon et al., 2010; Kost et 
al., 2003).  It was however the ACE-CD4 study conducted by Sadhukhan et al. (Sadhukhan et 
al., 1998) that prompted further exploration of the distal ectodomain of ACE for a sheddase 
recognition motif (Pang et al., 2001; Woodman et al., 2006, 2005)(Chapter 3 of this thesis).   
 
Further experiments by the same group (Sadhukhan et al., 1998) sought to delineate which 
region/s of the ectodomain were involved in the sheddase recognition by making chimeric 
mutants of the ACE and CD4 ectodomains (Chattopadhyay et al., 2008). They initially tried to 
make sequential deletions of the rabbit tACE ectodomain, but this affected processing to 
the cell surface and they therefore chose to use chimeric proteins instead. The region of ACE 
that was required for processing and shedding was residues 343-655 (rabbit tACE 
numbering). A mutant that contained ACE residues 1-655 was secreted into the medium but 
when the ectodomain was further restricted to residue 640, the protein was expressed in 
cells but was not secreted, indicating that residues 640-655 were important for shedding. 
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They then performed alanine scanning mutagenesis on this 15 residue region and 
established that the 5 residue motif HGEKL attenuated cleavage secretion when these 
residues were changed to alanines (Chattopadhyay et al., 2008). The 5 residue mutation in 
sACE had a similar effect, suggesting that it directs cleavage secretion in the single and 
double domain forms of rabbit ACE. The constructs were expressed in Pichia pastoria as well 
as HeLa cells, showing that they are processed in yeast cells as well as mammalian. It was 
these key experiments that encouraged our investigation of the role of this 5 amino acid 
motif HGEKL in human tACE.  
 
The potential rabbit tACE recognition motif within the proximal ectodomain is underlined in 
figure 4.1. The stalk region starts at residue W
616
 (Chubb et al., 2002). It can be seen that it is 
17 residues N-terminal of the cleavage site, 13 residues N-terminal to P
623
 and 10 residues 
N-terminal to the seventh potential glycosylation site of the C-domain. Therefore, the region 
directly proximal to the cleavage has many important hallmarks. Considering Pro623/1199-
Leu polymorphism was associated with a 5-fold increase in shedding (Kramer et al., 2001), 
we extended our investigations of the stalk region to determine whether glycosylation of 
the N
620









Eyries et al. (2001) conducted further investigations into this polymorphism by generating a 
sACE P
1199
L variant as well as a C-domain variant. In both CHO-K1 and COS cell lines the 
P
1199
L mutant was shed 1.5-fold higher than wild-type. It would seem, from the in vitro data 
that the introduction of the proline has a significant effect on shedding. Based on their 2D 
structural analysis, it was suggested that proline induces conformational constraints by 
forming twists in the structure. Leucine, on the other hand, is more flexible and possibly 
 
   
 
T  E  N  E  L  H  G  E  K  L  G  W  P  Q  Y  N  W  T  P  N  S  A  R  S  
605                                                                                                                                                                               628 
Cleavage site 
Potential glycosylation site Rabbit tACE recognition motif 
Figure 4.1: Proximal ectodomain and stalk region. The stalk region, starting at residue 616 (Chubb et al., 
2002) is indicated in italics. The cleavage site is shown at R
627
 (Woodman et al., 2000), the potential 




 involved in the Pro1199Leu polymorphism (Kramers et al., 2001) and the 
H
610
GEKL motif suggested to be a recognition motif (Chattopadhay et al., 2008).   
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released the stalk from the restricted formation, allowing for better access by the sheddase. 
This plasma ACE polymorphism substantiated the theory of the stalk being more important 
for cleavage secretion than the cleavage site sequence; however the CD4/ACE (Sadhukhan 
et al., 1998) mutants still alluded to the contribution of the ectodomain to the regulation of 
shedding.  
 
These tie in with the suggestions made by Ehlers et al., (1996), which suggested the 
cleavage secretion process to be dependant on topographical parameters. The removal of 
the proline could also allow for the normally unglycosylated N
620
 (Yu et al., 1997) (figure 
4.1), to be glycosylated. This pattern of residues has been extensively researched and using 
peptides containing proline at various positions, it was shown that proline positioned C-
terminal to the N-glycosylation recognition sequence of Asn-Xaa-Thr (Ser) (Bause and Legler, 
1981; Marshall, 1974) resulted in highly diminished glycosylation (Bause, 1983) as it changes 
the conformation of the peptide and affects the potential of glycans attaching. An 
introduction of a glycan in this region could perhaps re-direct the sheddase to a more 
favourable position and thus increase shedding, as shown when an O-glycosylated region 
was introduced into the stalk region (Schwager et al., 1999). Furthermore, basal shedding 
was increased, but stimulated shedding was reduced, suggesting that the glycosylation in 
the stalk did not abrogate shedding but modulated its regulation.  
 
Therefore our aim was to analyse the ectodomain most proximal to the cleavage site as well 
as the stalk region, by testing the effect of mutating the rabbit tACE motif in human tACE. 
We created and analysed the following mutant cDNA tACE constructs: pcDNA tACE Ala 610-
614, pcDNA tACE Ala 608-614, pcDNA tACE Ndom 608-614, pcDNA tACE Pro623Leu and 
pcDNA tACE N620D (figure 4.2).  These constructs were made to determine whether alanine 
mutations in the human testis ACE would affect shedding. The latter two stalk mutants were 
made to address the contribution of glycosylation in shedding and whether the increase in 




L polymorphism is caused by glycosylation of the potential site at 
N
620
























1.  To mutate the rabbit tACE motif H
610
EGKL to alanines in human tACE to elucidate its role 
in shedding 
2. To analyse the effect of a longer motif 7 residue on shedding and comparison between 
Ala substitutions and N-domain substitutions  
3. To investigate the mechanism of shedding when a polymorphism such the Pro1199Leu is 
present in testis ACE ascertain whether glycosylation plays a role in the increase in the 










T  E  N  E  L  H  G  E  K  L  G  W  P  Q  Y  N  W  T  P  N  S  A  R  S  
tACE Ala 610-614       T  E  N  E  L  A  A  A  A  A   G  W  P  Q  Y  N  W  T  P  N  S  A  R  S   
tACE Ala 608-614       T  E  N  A  A A  A  A  A  A   G  W  P  Q  Y  N  W  T  P  N  S  A  R  S 
tACE Ndom 608-614  T  E  N  Q  Q N  G  E   V  L  G  W  P  Q  Y  N  W  T  P  N  S  A  R  S  
 tACE Pro623Leu        T  E  N  E  L  H  G  E   K  L  G  W  P  Q  Y  N  W  T  L  N  S  A  R  S 
tACE N620D               T  E  N  E  L  H  G  E   K  L  G  W  P  Q  Y  D  W  T  L  N  S  A  R  S 
Human tACE 
Figure 4.2: A) Alignment of human and rabbit tACE residues from 605 to 614, as well as the equivalent 
residues in the N-domain. B) Alignment of constructs made and the residue changes within each of mutant 
constructs that were made. The pink residues refer to the alanine mutations based on the rabbit tACE 
mutants. The green residues refer to the N-domain residues substituted at the same position. All sequences 
were confirmed according to Genbank.   
605                                                                                                                                                                        628 
A 
B 
Human tACE   T  E N E L  H G E K L 
 
Rabbit tACE    T  E N G R H G E K L 
 
N-domain        E Q N Q Q N G E V L 





4.2 Materials and Methods 
4.2.1 Site-directed mutagenesis of pcDNA tACE Ala610-614, pcDNA tACE Ala 608-614, 
pcDNA tACE Ndom 608-614, pcDNA tACE Pro623Leu, pcDNA tACE N620D 
 
All constructs were generated from tACE gene fragment in a pGEM -Z11f (-) vector. All 
primers are detailed in the appendix, table A3.4. tACE Ala610-614 was synthesised using the 
tACE ALA For and Rev primers. Ndom 608-614 was produced with the tACE ST _Ndom F and 
tACE ST _Ndom R primers and tACE Pro623Leu were synthesised with the P2LF and P2LR 
primers. The template DNA for these mutants were wild-type tACE. tACE Ala 608-614 was 
produced with the tACE ala2F and tACE ala2R primers. The DNA template used for this 
mutant was the pGEM tACE Ala610-614 mutant so that an additional 2 alanine residues 
were added upstream of residues 608 and 609. tACE N620D was produced with the primers 
P2LDF and P2LD R using pGEM tACE Pro623Leu as the DNA template to produce a double 
mutant containing leucine at position 623 and convert the asparagine 620 to aspartate to 
knock out the glycosylation sequon.  
 
After confirmation of all mutant constructs by DNA sequencing, the entire tACE DNA 
fragment was removed from the respective pGEM –Z11f (-) construct by digesting it with 
BamHI and HindIII, and allowed to ligate with similarly digested mammalian expression 
vector pcDNA 3.1 (-). These pcDNA constructs were transformed into E.coli as previously 
described (Chapter 2, section 2.1.8) and prepared in bulk for CHO-K1 cell transfection by 
growing them in Luria broth. The DNA was extracted using the Qiagen Midi Plasmid 
Preparation Kit (Germany). CHO-K1 cells were transfected as previously described (chapter 
2, section 2.2.3). Shedding assays, ACE activity assays and western blot analysis are detailed 
in chapter 2.  
 
4.2.2 Purification of soluble pcDNA tACE Pro623Leu 
The tACE Pro623Leu transfected CHO-K1 cells were propagated in 150mm
2
 tissue culture 
flasks in growth medium (10% FCS/DMEM/HAMS). Once 100 % confluent the medium was 
changed to minimal medium (2% FCS/DMEM/HAMS). Soluble tACE protein was secreted 
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into the medium and after approximately 2 days the protein-containing medium was 
harvested and stored at -20°C for later use. This was repeated until approximately 350-
375ml of medium was collected. Before the various harvests were pooled the activity was 
checked via ZPHL assays. 
 
tACE Pro623Leu was purified via affinity chromatography using a lisinopril-sepharose 
column (Pantoliano et al., 1984). It was equilibrated first with wash buffer (0.5M NaCl, 
20mM HEPES, pH 7.5, appendix I). All medium and reagents were passed over column with 
the aid of a Minipuls 3 pump (Gilson, France). The pooled medium was passed over the 
column and allowed to bind. The column was washed overnight with 1 litre of wash buffer 
to clear away unbound protein. The flow-through was retained for later analysis. Bound ACE 
was eluted from the column with 50 mM borate buffer, pH 9.5. The elution of ACE from the 
column was monitored at 280nm via a DVW-10 variable wavelength detector (Ross 
Recorders, USA) and fractions containing the protein were pooled and assayed for ACE 
activity to confirm the presence of the correct protein. Purified protein was initially dialysed 
at 4°C overnight in 50mM KPO4, thereafter in 5mM KPO4 for 1 hour to facilitate downstream 
analysis. The protein was concentrated in Amicon
®
 Ultra Spin centrifugal filters (Millipore, 
Cork, Ireland).  Protein concentrations before and after purification were determined via the 
Bradford method (Bradford, 1976).  
 
4.2.3. PNGase F digest and protein preparation 
Approximately 20µg of tACE Pro623Leu was incubated with 5µl of 100 units/ml PNGase F 
(Sigma-Aldrich) and 5µl of 5x denaturing buffer (250mM KPO4 pH. , % “D“ /  a d % β-
mercaptoethonal) at 37°C overnight. The entire reaction volume was loaded onto a 10% SDS 
PAGE alongside an undigested control. The gel was stained with Coomassie (0.2% (w/v) 
Coomassie Blue; 7% (v/v) glacial acetic acid; 50% (v/v) ethanol) and then destained (7% (v/v) 
glacial acetic acid; 50% (v/v) ethanol). The desired band was cut out with a scalpel and cut 
up into 1mm x 1mm x 2mm pieces.  
4.2.4 MALDI MS/MS 
The gel pieces were destained with 200mM NH4HCO3: acetonitrile 50:50 (Romill, Sigma) 
until clear. The gel slices then underwent dehydration and dessication before reduction in 
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5mM triscarboxyethyl phoshine (TCEP, Fluka) in 100mM NH4HCO3 for 30 minutes at 56°C. 
Before a further dehydration step, excess TCEP was removed. Carbamidomethylation of 
cysteines were done with 100mM iodoacetamide (Sigma) in 100mM NH4HCO3 for 30 
minutes at room temperature with no light exposure. This prevents disulphide bonds from 
forming. The gel pieces were dehydrated, washed with 50mM NH4HCO3, and then 
dehydrated again. It was rehydrated in a 20ng/µl trypsin (Promega) solution and digested 
overnight at 37°C.  The resultant trypsin-digested peptides were recovered with 50µl 0.1% 
trifluoroacetic acid (TFA) (Sigma). Thereafter they were dried down, 50µl of water was 
added and then concentrated to 20µl or less which removed residual NH4HCO3. These 
peptides were then ready to be spotted using the dried droplet technique (Dai et al., 1996). 
0.5 µl of the sample was overlaid t i e. The at i  used o sisted of g/ l α–cyano-4-
hydroxycinmamic acid (Fluka) with 20mM NH4H2PO4 (Fluka) in 80% acetonitrile, 0.2% TFA. 
The final concentrations were 5mg/ml of matrix in 40% acetronitrile, 0.1% TFA and 10mM 
NH4H2PO4. 
 
MALDI MS/MS was performed at the CPGR (Cape Town). The 4800 MALDI ToF/ToF (Applied 
Biosystems) was used for all mass spectrometry. The MS spectra were recorded in reflector 
mode, generated with 400 laser shots/spectrum, at a laser intensity of 3800 (arbitrary units) 
and with a grid voltage of 16kV. Internal calibration of peptide containing spots was 




Residues within the stalk region and ectodomain have been extensively studied to 
determine their contribution to the regulation of ACE shedding. Recent evidence has shown 
that the portion of the ectodomain proximal to the stalk region is essential in the shedding 
of rabbit ACE (Chattopadhyay et al., 2008). Mutants were made to investigate the 
contribution of the residues H
610
GEKL in the shedding of human ACE and to investigate the 
contribution of glycosylation to the increase in shedding of the Pro1199Leu polymorphism. 
In order to analyse the role of the rabbit tACE recognition motif in human testis ACE, the 
corresponding residues were mutated to alanines in human tACE using site-directed 
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mutagenesis and its effect analysed via western blot analysis and ACE activity assays. The 
construct tACE Ndom 608-614 provided a control for tACE Ala 608-614; the construct with 7 
alanines (figure 4.2). The following results will elucidate how the alanines contribute to the 
changes in shedding. 
4.3.1 Site-directed mutagenesis and cloning of pcDNA tACE Ala610-614, pcDNA tACE Ala 
608-614, pcDNA tACE Ndom 608-614, pcDNA tACE Pro623Leu and pcDNA tACE N620D 
 
After mutagenesis, successful incorporation/substitutions of residues were analysed by 
restriction endonuclease digestion and agarose gel electrophoresis (chapter 2). tACE Ala 
610-614 has the 5 residues H
610
GEKL mutated to alanines and with the mutation another 
NheI restriction enzyme site was introduced, due to the introduction of the new site 
included via the mutagenic primers. In the wild-type construct there are two present, one 
within the vector sequence and one within the tACE sequence. In figure 4.3, it can be seen 
that restriction digestion with NheI of the wild-type construct (lane 1) would yield two DNA 
fragments of approximately 6.5kb and 1.4kb. The addition of the third site in the mutant 
construct results in the emergence of three bands 5.91kb, 1.4kb, 0.59kb (lane 2) confirming 














Similarly, in figure 4.4, it can be seen that the addition of the BsmI site in the tACE Ala 608-
614 mutant results in two DNA fragments when digested; namely a 5.1kb and a 2.8kb 
1
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Figure 4.3: Restriction digest and plasmid map of pcDNA 3.1 (-) tACE Ala 610-614. On the left is a DNA gel 
of NheI digests of wild-type tACE (lane 1) and tACE Ala 610-614 (lane 2). The plasmid map highlights the 
endogenous restriction enzyme sites pertinent to the construct. The underlined italicised NheI site was 
introduced to aid in the screening of the mutation that was introduced.    
 
    1       2 kb 
7.9kb 7.9 kb 
eI 
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fragment compared to the 7.9kb fragment for the linearised wild-type construct (lane 1), as 
it only has one Bsm I site in the vector sequence. tACE Ala 608-614 was produced by 
conducting site-directed mutagenesis on the pGEM tACE Ala 610-614 DNA template with 
the tACE ala 2F and 2R primers to extend the mutation to 7 alanines.  
 
For the introduction of the N-domain residues at position 608-614, a ScaI site was included 
with the mutation. The two fragments that were produced after digestion with this enzyme 
were 4.56kb and 3.34kb in size (figure 4.5, lane 2), compared to the single DNA band of 
7.9kb (lane 1) in size which represents the linearised form of the wild-type construct as it 








Figure 4.4: Restriction digest and plasmid map of pcDNA 3.1 (-) tACE Ala 608-614. On the left is a DNA gel 
of BsmI digests of wild-type tACE (lane 1) and tACE Ala 608-614 (lane 2). The plasmid map highlights the 
restriction enzyme sites. The underlined italicised BsmI site was introduced to aid in the screening the 
mutation that was introduced. 
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Figure 4.5: Restriction digest and plasmid map of pcDNA 3.1 (-) tACE Ndom 608-614. On the left is a DNA 
gel of ScaI digests of wild-type tACE (lane 1) and tACE Ndom 608-614 (lane 2). The plasmid map highlights 
the restriction enzyme sites pertinent to the construct. The underlined italicised ScaI site was introduced to 
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L mutation mimics the polymorphism that results in increased shedding.  pcDNA 3.1 
(-) tACE has two EcoRI sites, one in the vector sequence upstream of the BamHI site and one 
preceding the HindIII site, which are the restriction sites that flank the tACE DNA insert and 
were used to subclone tACE from pGEM 117 (-) f into pcDNA 3.1 (-). Therefore digestion 
with EcoRI yielded a 2.5kb and a 5.4kb fragment corresponding to the tACE insert and the 
plasmid respectively (figure 4.6, lane 1). The inclusion of another site with the substitution 
of P
623
 with L resulted in the 2.5kb fragment being split into 2kb and 0.5kb fragments.  
 
The enzyme used to screen the mutation for the conversion of N
620
 to D was Eco47III, which 
was present singularly in wild-type tACE. This generates a mutant that had the glycosylation 
site N620 knocked out. Thus digestion with this enzyme for wild-type tACE results in a single 
fragment of 7.9kb in size (figure 4.7, lane 1). In lane 2, the emergence of two fragments 
sized 6.4kb and 1.5kb compares favourably with the introduction of the correct mutation for 








Figure 4.6: Restriction digest and plasmid map of pcDNA 3.1 (-) tACE Pro623Leu. On the left is a DNA gel 
of EcoRI digests of wild-type tACE (lane 1) and tACE Pro623Leu (lane 2). The plasmid map highlights the 
restriction enzyme sites. The underline italicised EcoRI site was introduced to aid in the screening the 
mutation that was introduced.  
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4.3.2 Expression and activity of stalk/proximal ectodomain mutants 
The shedding behaviour of tACE and its mutant derivatives were analysed by measuring 
their ACE activity in the medium and cell lysates and thus the ratio of the ACE activity in the 
medium over the total ACE activity (i.e. medium and cell lysates) acts as an indication of 
how much of the cell-anchored ACE was released from the cell membrane. Western blots 
provided a visual representation of the shedding activity as well as to confirm the size of the 
protein. In addition, the total ACE activity under each condition analysed was calculated. 
Wild-type testis ACE was previously discussed and how it differs from previous reports 
(chapter 3). It was also necessary to highlight the total activity that was present for tACE and 
how the other mutants are affected in this regard as changes in the total activity (the mU of 
ACE activity per millilitre of culture medium produced in one minute) was more evident 
than in the rate of shedding.  
  
With the introduction of the alanines at residues 610-614 (figure 4.9), the rate of shedding is 
not affected if one compares the percentage shed of tACE Ala610-614 to wild-type under 
basal or untreated conditions (figure 4.8). In figure 4.9 B, the shedding of tACE Ala 610-614 
appears to be normal at approximately 30%. However, the western blot analysis (figure 4.9, 
A) shows that there are two forms of the protein, one representing the correctly processed 
form that migrates alongside wild-type tACE and perhaps an underglycosylated band that 
migrates below it. It can be seen that there is a much lower proportion of the correctly 
Figure 4.7: Restriction digest and plasmid map of pcDNA 3.1 (-) tACE N620D. On the left is a DNA gel of 
Eco47III digests of wild-type tACE (lane 1) and tACE N620D (lane 2). The plasmid map highlights the 
restriction enzyme sites pertinent to the construct. The underlined italicised Eco47III site was introduced to 
aid in the screening of the mutation that was introduced.    
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processed form and only the shed form comes from this population. The total activity was 
also much lower than wild-type (figure 4.9, C), which corroborates what was seen in the 
western blot. Therefore the alanine mutation affects the processing greatly and reduces the 
amount of protein available for shedding. The basal shedding of this mutant was higher than 
wild-type so it would seem that what little ACE was available at the cell surface was shed 
quite well, in addition to having a discernible increase in shedding in response to the 
addition of the phorbol ester PDBu. Therefore this mutation affected processing more than 
shedding under the conditions set out here. 
The effects of the alanines at H
610
EGKL were exacerbated when the mutation was extended 
a further 2 residues upstream to residues E608 and L609. Under unstimulated conditions, 
the total activity of tACE Ala 608-614 (figure 4.10, C) was reduced to 1.5mU/ml/min 
compared to tACE Ala 610-614 (2.5mU/ml/min, figure 4.9, C) and greatly reduced compared 
to tACE wild-type (14mU/ml/min, figure 4.8, C). Basal shedding was markedly diminished, 
but the phorbol response was still highly apparent (figure 4.10, B). The western blot again 
showed that the shed protein in the medium samples migrated with the fully processed 
form that also migrated alongside the wild-type ACE (figure 4.10, A). The cell lysates had 
two protein bands and the greater proportion of the membrane-bound form was migrating 
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Figure 4.8: Shedding analysis of pcDNA tACE. A) Western blot: Lane 1: control, medium; lane 2: 1µM 
PDBu added medium; lane 3:  50µM TAPI added medium; lane 4: control, cell lysate; lane 5: 1µM PDBu, 
cell lysate; lane 6: 50µM TAPI, cell lysate. B) Activity assays showing percentage shed ACE of total ACE 
activity. C) Total activity. Data represented are mean ±SEM, n=2. 
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lower than the normal wild-type form.    
  
 
Figure 4.9: Shedding analysis of pcDNA tACE Ala610-614. A) Western blot: Lane 1: control, medium; lane 
2: 1µM PDBu medium; lane 3:  50µM TAPI medium; lane 4: control, cell lysate; lane 5: 1µM PDBu, cell 
lysate; lane 6: 50µM TAPI, cell lysate; lane 7: w.t tACE medium; lane 8: w.t. tACE cell lysate. B) Activity 
assays showing percentage shed ACE of total ACE activity. C) Total activity. Data represented are mean 
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Figure 4.10: Shedding analysis of pcDNA tACE Ala 608-614. A) Western blot: Lane 1: control, medium; lane 
2: 1µM PDBu added medium; lane 3:  50µM TAPI added medium; lane 4: control, cell lysate; lane 5: 1µM 
PDBu, cell lysate; lane 6: 50µM TAPI, cell lysate; lane 7: w.t tACE medium; lane 8: w.t. tACE cell lysate. B) 
Activity assays showing percentage shed ACE of total ACE activity. C) Total activity. Data represented are 
mean ±SEM, n=2. 
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The effect alanines have on shedding and processing is not replicated when the residues 
608-614 are converted to the corresponding N-domain residues and not alanines. According 
to the western blot, expression of tACE NdomST 608-614 in CHO-K1 cells (figure 4.11, A) 
resulted in a greater proportion of the ACE protein that was in the correctly processed form 
as well as was shed normally. Overall activity and basal shedding is slightly lower than wild-
type but still comparable. This would imply that the N-domain residues have the necessary 
















In addition, the total activity under basal conditions is somewhat restored as it is 3-fold that 
of the tACE Ala 610-614 and 5-fold that of tACE Ala 608-614 (figure 4.10, C). These results 
would suggest the residues H
610
EGKL proposed by Chattophadhay et al., (2008) as a 
sheddase recognition motif has an effect on shedding in human tACE as well as processing. 
The 2-residue extension of this mutation upstream reduced basal shedding even more, and 
cellular processing was negatively affected. The presence of N-domain residues at these 
positions, however, allowed for the maintenance of processing and shedding occurred as 
1             2          3         4            5           6           7          8 
B 
Figure 4.11: Shedding analysis of pcDNA tACE NdomST 608-614. A) Western blot: Lane 1: control, 
medium; lane 2: 1µM PDBu added medium; lane 3: 50µM TAPI added medium; lane 4: control, cell lysate; 
lane 5: 1µM PDBu, cell lysate; lane 6: 50µM TAPI, cell lysate; lane 7: w.t tACE medium; lane 8: w.t. tACE 
cell lysate. B) Activity assays showing percentage shed ACE of total ACE activity. C) Total activity. Data 
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normal. This indicates that this motif is important for shedding and processing, but in 
relation to previous work, this is not the sole recognition motif of ACE. 
4.3.3 Characterisation of pcDNA tACE Pro623Leu 
 
Previous work has shown that the presence of L instead of P at position 1199 (sACE) or 623 
(tACE) increases shedding up to 5-fold in serum and 1.5 fold in vitro (Eyries et al., 2001; 
Kramers et al., 2001). The explanation for this increase was that leucine creates a more 
flexible loop allowing access to the cleavage site by the sheddase. We made this mutation in 
human tACE to ascertain whether the increase in shedding was rather due to the 
glycosylation of the sequeon Asn-Trp-Thr (NWT) upstream of P
623
. This motif is the final 
potential glysosylation site within tACE, but usually remains unglycosylated due to the P that 
follows the sequon (Yu et al., 1997). Mass spectral analysis of purified and de-glycosylated 
tACE Pro623Leu was performed to test whether the increase in shedding of the P to L 
polymorphism was due to glycosylation and whether the cleavage site changed.  
 
4.3.3.1 Determination of increased shedding of tACE Pro623Leu 
 
 tACE Pro623Leu was expressed in CHO-K1 cells and the effects of this mutation on shedding 
were determined.  The mutation increased basal shedding to 35% (figure 4.12, B). There was 
only a 15% increase above wild-type tACE (figure 4.6), yet within the range observed 
previously (Eyries et al., 2001a). Shedding of the P
623
L mutant did not display the same 
magnitude increase in shedding as was found in serum (Eyries et al., 2001b; Kramers et al., 
2001). Western blot analysis confirmed that there was an increase in basal shedding over 
wild-type (figure 4.10, A). This confirmed that basal shedding was increased when this 






























4.3.3.2 Purification, treatment and preparation of soluble tACE Pro623Leu  
To determine the presence of glycosylation at position N620 and to explore the role of 
glycosylation in the increase in shedding of the Pro
623
Leu polymorphism, the tACE 
Pro623Leu protein was purified (appendix A4.1, A4.2), deglycosylated and analysed via SDS-
PAGE. After a shift in size was confirmed on the gel, the protein was eluted from the gel, 
underwent reduction and cysteine protection, and then an in-gel trypsin digest was 
performed, where after it was subjected to MALDI analysis. The serine protease, trypsin, 
cleaved the protein after every lysine and arginine resulting in distinct peptides that were 
measured via mass spectrometry. Figure 4.13 illustrates the shift in migration of the protein 






Figure 4.12: Shedding analysis of tACE Pro623Leu. A) Western blot: Lane 1: control, medium; lane 2: 1µM 
PDBu added medium; lane 3:  50µM TAPI added medium; lane 4: control, cell lysate; lane 5: 1µM PDBu, cell 
lysate; lane 6: 50µM TAPI, cell lysate; lane 7: w.t tACE medium; lane 8: w.t. tACE cell lysate. B) Activity 
assays showing percentage shed ACE of total ACE activity. Data represented are mean ±SEM, n=2. 
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Besides removing the glycan side chains and causing a change in mass, the deamidation of 
the aspa agi e at the sta t of the gl a  a ke  se ue e  o e ts the As  (N) to an Asp 
(D) when the glycans were removed and caused a gain in mass of 1Da. If no glycosylation 
occurred then the expected mass of the fragment in that region would have been 
1705.85Da. If glycosylation occurred then the N would have been converted to a D after 
deglycosylation with PNGase F. The deglycosylated mass of 1706.84Da was observed in the 
resultant mass spectra (Figure 4.14). This confirmed glycosylation occurred at the N
620
. The 
cleavage site was also determined from the mass spectrometry data. 








Figure 4.14: MALDI-ToF/MS spectra showing observed masses of peptides from trypsin digestion of purified 
tACE Pro623Leu. The encircled masses highlights the observed masses.  
Figure 4.13: SDS PAGE of Pro623Leu tACE: Lane 1: the migration of the protein in its undigested form, lane 
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In table 4.1 the sequences and masses are listed. The peptide corresponding to 1014.6 
(residues 628-637) was produced by the tryptic digest. The peptide which corresponded to 
1200.6 was observed, which represents a fragment that consists of residues 628-639. This 
peptide ends at Ser639, suggesting this peptide was the result of another cleavage event 
other than the trypsin digests. Therefore, the cleavage site at which tACE Pro623Leu was 












 Sequence AA no. MS/MS 
confirmed 
1706.844  1706.83                       LGWPQYDWTLNSAR 614-627 yes 
  1705.85 LGWPQYNWTLNSAR  614-627 no 
1014.500 1014.47 SEGPLPDSGR 628-637 yes 
1200.604 1200.578 SEGPLPDSGR VS 628-639 yes 
 
Thus MALDI analysis confirmed that the putative glycosylation site became glycosylated 
when P
623 
was converted to L. Table 4.1 summarises the masses observed, to confirm that 
the N-glycosylation site 7 was glycosylated when P
623
 was mutated to L. The cleavage site 




 suggesting an alternative sheddase may be 
cleaving this mutant or the sheddase is recognising an alternate site because of 







Table: 4.1 Observed masses of peptides identified via mass spectrometry compared to expected masses 
based on the sequence of the fragments expected. 
614                                                                                                                                                                   651 
 LGWPQYDWTLNSAR SEGPLPDSGRVSFLGLDLDAQQAR 
1706.8 1014.47
1200.60
tACE Pro623Leu Cleavage 
site  
Wild-type tACE cleavage site  
Figure 4.15: Sequence of peptides identified up till the transmembrane region. Arrows highlight the 
cleavage sites. The sizes of the observed masses are indicated for each peptide fragment.   
 




4.3.4 Characterisation of pcDNA tACE N620D 
 
4.3.4.1 Western blot and enzyme activity 
To confirm that it is indeed the glycosylation of site 7 N620 which results in the increase in 
shedding of tACE Pro623Leu, the glycosylation site itself was knocked out. With leucine still 
present at position 623, N
620
 was converted to D, removing the side chain necessary for 



















If the glycosylation was responsible for the increase in shedding of tACE Pro623Leu, then 
the basal shedding would have reverted to wild-type levels. However, from the shedding 
analysis of pcDNA tACE N620D (figure 4.16), it is evident the shedding had not reverted to 
wild-type levels, but shedding had increased even more to 56 %. Basal shedding was so high 
it was comparable to phorbol-activated shedding. This indicates the removal of the 
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Figure 4.16: Shedding analysis of pcDNA tACE N620D. A) Western blot: Lane 1: control, medium; lane 2: 
1µM PDBu added medium; lane 3:  50µM TAPI added medium; lane 4: control, cell lysate; lane 5: 1µM 
PDBu, cell lysate; lane 6: 50µM TAPI, cell lysate; lane 7: w.t tACE medium; lane 8: w.t. tACE cell lysate. B) 
Activity assays showing percentage shed ACE of total ACE activity. Data represented are mean ±SEM, n=2. 
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glycosylation site does not decrease shedding and confirms that the change from proline to 
leucine, causes the initial increase in shedding. The removal of the glycosylation site actually 
promotes a further increase in basal shedding; suggesting that the glycosylation site formed 
down regulates the effect of the leucine in the stalk region (figure 4.17). These results highly 
suggest the ectodomain boundary proximal to the stalk region and the cleavage site affects 






The regulation of ACE shedding has been extensively studied by mutating or deleting 
sections of the cytoplasmic tail (Chubb et al., 2002), transmembrane region; stalk region 
(Schwager et al., 2001, 1999, 1998) or ectodomain (Sadhukhan et al., 1998; Woodman et al., 
2006, 2005). After such exhaustive studies across the ACE protein to identify the ACE 
sheddase recognition motif, it was necessary to further investigate the proposed 
recognition motif put forward in Chattopadhay et al., (2008). 
 
There are several other ectoproteins that contain a sheddase recognition motif in their stalk 
regions. Most notably a 5 residue motif (P
161
QLQE) in CSF-1; a disulphide linked, 
homodimeric glycoprotein; was found through deletion studies and substitution mutants 
Figure 4.17: Schematic representation and summary of the mutations made in the stalk region of tACE and 












•Glycosylation site removed 
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(Deng et al., 1996). Stalk length and steric accessibility were also responsible for its ADAM 
17-dependant shedding (Deng et al., 2000, 1998, 1996; Horiuchi et al., 2007). The shedding 
of L-selectin on the other hand was regulated more by the EGF domain (Zhao et al., 2001) 
than the postulated 5-residue motif K
327
EGDY in the stalk region. Alanine mutations of these 
residues maintained shedding but deletion abrogated shedding, probably due to the 
reduction in stalk length (Migaki et al., 1995). Deletion studies of the non-collagenous 
domain NC-16A in the juxtamembrane of the transmembrane protein collagen XVII, implied 
the change in the net charge affects shedding and a negative net charge was required for 
optimal shedding activity (Franzke et al., 2004). It was found this region consisted of coiled-
coil heptads and harboured a sheddase recognition and cleavage site. Mutagenesis of this 
region caused shedding to increase and was no longer ADAM-mediated, signifying its 
importance in shedding regulation (Nishie et al., 2012). 
 
Previous work involved extensive investigations into the contribution of the stalk region to 
shedding. Most notably the stalk length was shown to be critically important and a stalk 
length of approximately 11 residues usually resulted in a shed protein (Ehlers et al., 1996; 
Schwager et al., 2001, 1998). The results presented in this chapter add weight to the 
proposal that this region is important for shedding. However, they were not in complete 
agreement with Chattopadhay et al. (2008). Substitution with the alanines has shown to 
affect processing of ACE greatly. The mutant tACE Ndom 608-614 (figure 4.10), strongly 
suggests that the N-domain residues are sufficient to maintain processing and shedding as 
this mutant was active and correctly processed. The western blot illustrates correct 
processing and shedding rates are relatively normal. Previous mutants made in this region 
were reported in Woodman et al., (2006), with larger N-domain substitutions into the 
proximal region of the tACE ectodomain. This mutant, SomNBcl (table 4.2) was still shed and 
correctly processed. After these investigations and other studies into deletion mutants of 
the stalk region of human tACE (Chubb et al., 2002; Ehlers et al., 1996; Pang et al., 2001; 
Schwager et al., 1999, 1998), the focus was shifted to the distal ectodomain as these 
numerous studies did not yield a viable sheddase recognition motif candidate as many 
alterations merely caused a shift in the shedding kinetics, but did not abrogate it.  
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The studies into the contribution of the juxtamembrane stalk have been extensive and 
exhaustive. A Ser/Thr rich region causing O-glycosylation modulated shedding and cleavage, 
but did not abolish it (Schwager et al., 1999). Likewise, the introduction of an EGF-domain 
causing disulphide bridges did not abolish shedding (Schwager et al., 1998). The EGF-domain 
from factor IX did not abolish shedding either (Schwager et al., 2001), even though 
disulphide bonding occurred. ACE-Δ  a d ACE-Δ  e e deletio  uta ts of the stalk 
made C-terminal to the cleavage site and did not affect shedding, as the cleavage site 
remained the same as wild-type (Ehlers et al., 1996). Corresponding with these results, 
alanine mutations from residues 651-655 (rabbit tACE) and 649-655, affected shedding and 
processing (Chattopadhyay et al., 2008). Deletions of the juxtamembrane stalk N-terminal to 
the cleavage site such as ACE-Δ  (Schwager et al., 1999) and ACE-Δ  (Chubb et al., 2002) 
resulted in shed proteins, albeit at a different rate. The ACE-Δ  utatio  i t odu ed a 
glycan and this resulted in a change in cleavage site. The mutant ACE- Δ  as a  esidue 
deletion 7 residues N-terminal of the cleavage site and this resulted in an inactive and 
incorrectly processed protein (Chubb A., PhD thesis 2001). In light of the numerous 
substitution and deletion stalk mutants that were analysed, there were specific residues 
deleted within ACE-Δ  resulted in such an effect, as the larger deletion in another area 
(ACE-Δ  did ot demonstrate a deleterious effect. The minimum stalk length required is 
more than adequate in this mutant, so accessibility to stalk cannot be the reason for its lack 
of shedding. More importantly, the residues T605-615 (table 4.2) clearly affect the 
processing of this mutant. It is therefore clear that the proposed rabbit tACE recognition 
motif forms part of this region.  
 
The 5 residue alanine substitution mutation was made in human tACE Ala 610-614, (which 
corresponds to human tACE numbering) and a seven residue substitution was made to 
include residue E608 and L609, these two residues were different in rabbit tACE as well as 
the N-domain (figure 4.2). Mutation of the five residues resulted in changes in processing 
and western blot analysis illustrated these two forms of the protein were present in the cell 
lysate (figure 4.9). Only the higher molecular weight band corresponding to the correctly 
processed form was shed and this was present in the medium. The rate of shedding was 
similar to wild-type in the tACE Ala 610-614, however total activity was reduced. The tACE 
Ala 608-614 (figure 4.10) mutant displayed exaggerated traits of the five alanine mutant. 
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Shedding was greatly affected and total activity (control conditions) was 10 times lower 
than that of wild-type, suggesting the seven alanines in this position greatly affected 
processing and activity. The results produced from the current study in human tACE argue 
that the motif H
610
GEKL has more of an effect on the processing and transportation of ACE. 
 
 
Table 4.2: Alignment of proximal ectodomain and stalk sequences of various tACE mutants and chimeric 
constructs. Highlighted in blue is the rabbit tACE sheddase recognition motif, in purple are N-domain residues, 
highlighted in green is the P
623
, residues in yellow are insertions from other proteins, highlighted in grey is the 
MDP sequence. Underlined in red are N-domain residues.   
Construct Stalk sequence   Shed Reference 
wtACE SYFKPLLDWLRTENELHGEKLGWPQYNWTPNSARSEGPLPDSGRVSFLGLDLDAQQARVGQWLL Y Ehlers et 
al., 1996 
ACE-Ndom KYFQPVTQWLQEQNQQNGEVLGWPEYQWHPNSARSEGPLPDSGRVSFLGLDLDAQQARVGQWLL N Pang et 
al., 2001 
SomNBcl KYFQPVTQWLQEQNQQNGEVLGWPEYQWHPNSARSEGPLPDSGRVSFLGLDLDAQQARVGQWLL Y Woodman 
et. al. 
2006 








ACE-24 SYFKPLLDWLRTENELHGEKLGWPQYNWTPNSAR........................VGQWLL Y 
ACE-47 SYFKPLLDWLR...............................................VGQWLL N 
ACE-6 SYFKPLLDWLRTENELHGEKLGWPQYN......RSEGPLPDSGRVSFLGLDLDAQQARVGQWLL Y 
ACE-11 SYFKPLLDWLRTENELHGEKLG...........RSEGPLPDSGRVSFLGLDLDAQQARVGQWLL Y Chubb et 
al., 2002 




ACE-R627 SYFKPLLDWLRTENELHGEKLGWPQYNWTPNSA.SEGPLPDSGRVSFLGLDLDAQQARVGQWLL Y 
ACE-JGL SYFKPLLDWLRTENELHGEKLGWPQYNWTPNS.VTVTHGTSSQATTSSQTTTHQATARVGQWLL Y Schwager 
et al., 
1999 
ACE-LDL SYFKPLLDWLRTENELHGEKLGWPQYNWTPNSHQALGDVAGRGNEKKPSSV......RVGQWLL Y Ehlers et 
al., 1996 
ACE-EGF ELHGEKLGWPQYNWTPNSECLDNNGGCSH..VCNDLKIGYECLCPDGFQLVAQRRCERVGQWLL Y Schwager 
et al., 
1998 
MDP-STM SNHAQVPGEEPIPLGQLEASCRTNYGYWTPNSARSEGPLPDSGRVSFLGLDLDAQQARVGQWLL Y Pang et 
al., 2001 
MDP-TM AELLRRQWTEAEVRGALADNLLRVFEAVEQASNHAQVPGEEPIPLGQLEASCRTNYGYWLLLFL N 
Rabbit tACE NYFKPLMDWLLTENGRHGEKLGWPQYTWTPNSARSEGSLPDSGRVNFLGMNLDAQQARVGQWVL Y  
641-7A NYFKPLMDWLLAAAAAAAEKLGWPQYTWTPNSARSEGSLPDSGRVNFLGMNLDAQQARVGQWVL N/P Chattopad
hay etal., 
2008 
641-5A NYFKPLMDWLLAAAAAHGEKLGWPQYTWTPNSARSEGSLPDSGRVNFLGMNLDAQQARVGQWVL N/P 
651-5A NYFKPLMDWLLTENGRHGEKLAAAAATWTPNSARSEGSLPDSGRVNFLGMNLDAQQARVGQWVL Y 
649-7A NYFKPLMDWLLTENGRHGEAAAAAAATWTPNSARSEGSLPDSGRVNFLGMNLDAQQARVGQWVL Y 
646-5A NYFKPLMDWLLTENGRAAAAAGWPQYTWTPNSARSEGSLPDSGRVNFLGMNLDAQQARVGQWVL N 
tACE Ala 
610-614 







*Y a d N de otes es  a d o  respectivel . 




The block alanine mutations within the rabbit tACE region of 641-647 and 641-645, were not 
transported to the membrane in HeLa cells (table 4.2) (Chattopadhyay et al., 2008, rabbit 
tACE numbering). The 5 residue alanine mutation from residues 651-655 was transported 
and shed, but it was the 5 residue alanine substitution at 646 (646-5A) that caused 
abrogation of shedding only, while still being transported to the cell surface. Table 4.2 





 present. Therefore, if we were to add the results of the study presented in 
this thesis, it would support the theory that these residues are critical for ACE processing 
and transportation foremost. It would appear that a deletion of this region, as in ACE-Δ  
(Chu , PhD Thesis, ), disrupts the processing machinery completely and yields an 
inactive protein. Substitution of the HGEKL motif to alanines possibly removes the side-
chains necessary to illicit correct processing interactions, but maintains sufficient structure 
so as to allow a proportion of active ACE to the cell surface to be shed. Substitution to N-
domain residues was sufficient for correct processing and only a small reduction in the rate 
of shedding and activity was seen. A critique of the Chattopadhyay et al., (2008) study is 
that a faint band was visible in the medium after 6 hours suggesting that perhaps the rate of 
shedding is highly diminished but not arrested. More convincingly though is that the same 
mutation in the double-domain sACE caused a major reduction in shedding. This suggests 
that this motif regulates the same sheddase mechanisms in tACE and sACE.  
 
A possible explanation for the seemingly contradicting evidence for the proposed shedding 
recognition motif between rabbit and human tACE is probably due to the initial expression 
of the rabbit tACE proteins in yeast (Pichia pastoris) instead of mammalian cells. Rabbit tACE 
expressed in yeast share most of the kinetic and shedding hallmarks of human tACE, but 
many mutants not expressed in mammalian cells are expressed in yeast. For example it was 
shown a rabbit tACE mutant with only one N-linked glycosylation site intact was not actively 
expressed in HeLa cells, yet adequately expressed in yeast (Sadhukhan and Sen, 1996). 
Human tACE requires at least two N-linked glycosylation sites present to be successfully 
expressed in CHO-K1 cells (Gordon et al., 2010). These data suggest yeast has less stringent 
requirements for glycosylation, processing and transport, and the rabbit tACE mutants are 
more likely to be successfully expressed in yeast. However, the final lead chimeric mutants 
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from Chattopadhyay et al., (2008) were tested in HeLa cells to guarantee adequately 
processing in a mammalian cell line.  It could also be possible that rabbit tACE has less 
stringent processing requirements and may better tolerate alterations in its stalk than 
human tACE.  
 
To extend the discussion further, we could ask if the motif is the substrate or target of 
another system. Briefly, it may be proposed that these 5-7 residues under discussion play a 
role in directing the transport of tACE through the ER and Golgi so as to facilitate correct 
glycosylation. An in vivo example of this happening in ACE is the polymorphism in the C-
domain of sACE resulting in renal tubule dysgenesis, which was caused by an R substitution 
at Q1069, leading to absence of plasma ACE (Danilov et al., 2010). In vitro studies indicated 
that this mutation caused trafficking and transportation deficiencies, where proteosome 
inhibitors and lowered growth temperature could rescue ACE back to the cell surface by 
encouraging correct trafficking through the ER and Golgi.  
 
Limitations of this study are that due to the extensive research already committed to these 
questions, the motif that was discussed here has been previously overlooked with respect 
to its importance because of the use of N-domain residue substitutions instead of alanines 
(table 4.2). This was done to overcome the problem caused by deletion mutants. The 
strengths of the study presented here explored the shedding capabilities under stimulated 
and inhibited conditions whereas the rabbit ACE study was confined to basal conditions 
only. Our study quantified the effects of the mutations on the rate of shedding, the activity 




L polymorphism supports the body of evidence towards the importance of the 
juxtamembrane stalk in the regulation of shedding. We have shown that the conversion of 
P
623
 to L causes a 1.5 fold increase in shedding, glycosylation of the putative N-linked 
glycosylation site seven of the C-domain and a shift in the cleavage site. These results 
support studies done previously by Kramer et al., (2001) and Eyries et al., (2001), which 
demonstrated a leucine in this position caused an increase in shedding. To confirm whether 
the glycosylation of site seven is the direct cause of the increase in shedding, the N at 620 
was knocked out to prevent attachment of the glycosaccharides. This surprisingly did not 
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restore shedding to wild-type levels, but instead increased shedding even more to 2.5 fold 
of wild-type ACE. This serves to prove that it is indeed the loss of the proline and the 
incorporation of leucine, directs the increase in cleavage. Eyries et al., (2001) suggested due 
to the fact that the stalk is now less structured and flexible, it may be more accessible to the 
sheddase. Moreover, we have shown that the glycans at N
620
 actually down-regulates the 
potential increase in shedding that the introduction of leucine causes.  
 
Previously, studies into glycosylation in the stalk and its effect on shedding indicated the 
addition or removal of O-glycosylated regions modulated shedding but did not abrogate it 
(Schwager et al., 1999). The deletion of 6 residues in the stalk resulted in the creation of an 
N-linked glycosylation site, and the resultant glycan caused a shift in the cleavage site. 
Interestingly, the cleavage site determined for this mutant was one residue away from the 
cleavage site found in the P
623
L mutant (figure 4.15), suggesting an N-linked glycan in the 
stalk possibly interacts and directs the ACE sheddase in such a way resulting in cleavage of 




 site. To ascertain whether it is the 
glycan that causes the increase in shedding, we converted the N
620
; which is necessary for 
glycan formation; to D. Here it was presented that deletion of the glycans promoted 
shedding even further (figure 4.16) and basal shedding was comparable to that of 
stimulated shedding. This clearly illustrate it is the presence of the L at 623 that promotes 
shedding and not the presence of the resultant glycan N-terminal to the site at 620. The fact 
such a mechanism is in place, is quite elegant, if we relate this back to the in vivo situation 
of the Pro1199Leu polymorphism. If there were no glycosylation site preceding the proline 
then a polymorphism at this site resulting in excess plasma ACE may have had a more 
serious clinical consequence if shedding were to occur at such a high rate without the glycan 
down-regulating it, as is the case in sarcoidosis (Lieberman, 1975). These residues are clearly 
important to the shedding and processing of ACE as a mutation of the N
620
 (residue 631 
according to Alfalah et al., 2001) to Q, resulted in increased shedding. However, this 
occurred in the ER and was mediated by a DCI-sensitive serine protease. The sheddase 
involved in the cleavage of tACE N620D was inhibited by the metalloprotease inhibitor TAPI, 
suggesting it is the metalloprotease ACE sheddase usually responsible for shedding that is 
present and not the serine protease which was sequestered in the ACE NQ mutant (Alfalah 
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et al., 2001). It also verifies that it is not the mutation of the N itself caused the increase in 
shedding, but rather the removal of the glycan at N
620
 in conjunction with the L at 623.  
 
We can thus conclude that when the rabbit tACE recognition motif (Chattopadhyay et al., 
2008) is mutated to alanines in human testis ACE, it disrupts processing and transport 
foremost and the corresponding N-domain residues substituted at this site had no effect on 
the shedding of ACE. The main findings here definitely extend the body of work outlining the 
significance of the juxtamembrane stalk of the ectoproteins discussed. Questions still 
requires definitive answers are 1) whether a sheddase recognition motif still resides 
somewhere in the distal ectodomain; 2) whether there is communication between the distal 
and the proximal ectodomain; and 3) what the contribution of dimerisation, disulphide 
bonds and signalling is (Gordon, PhD thesis, 2011). 
  
 
CHAPTER 5: The evaluatio  of ACE ectodo ai  sheddi g usi g stalk 





The shedding of ACE is regulated at multiple stages and is likely to play a role in the various 
physiological processes in the body. We have systematically investigated the different regions 
of ACE and their contribution to shedding and have learnt a substantial amount about the 
cellular environment required for shedding to occur. We know that a requisite of shedding is a 
stalk of minimal length (Ehlers et al., 1997, 1996) and accessibility by the sheddase. Certain 
studies have also shown a requirement for ACE to be anchored in the membrane in order to be 
cleaved (Ehlers et al., 1997; Sadhukhan et al., 1999). For example, it was shown that for ADAM 
9 to cleave ACE, it required a catalytic domain as well as being tethered to the membrane 
(English et al., 2012). 
 
 In this thesis, our investigations of the substrate requirements for the shedding of ACE first 
considered the contribution of specific ectodomain surface helices in the regulation of 
shedding. Precedent for a role in shedding by helical motifs distal to the cleavage site has 
previously been shown in the cytokine TNF-α (Zheng et al., 2004). As secondary structure 
alterations in ACE did not have a significant effect on its shedding (Chapter 3), we therefore 
studied the ectodomain proximal to the membrane, the juxtamembrane stalk region, as well as 
distinct residues within the stalk and those surrounding the cleavage site (Chapter 4). We found 
that residues in the proximal ectodomain and stalk were essential for the processing of ACE, as 
opposed to merely affecting its shedding.  
 
To further investigate the role of the stalk region in ACE shedding, soluble peptides that mimic 
the ACE stalk were used to: 1) simulate the shedding conditions of ACE, and 2) establish an 
experimental system that could be used to characterise ACE shedding and its cognate 
sheddase. Soluble peptides consisting only of the stalk region could also be used to determine 
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whether the ACE sheddase requires a sheddase recognition domain within the ectodomain in 
addition to its interaction with the stalk cleavage site. 
 
The knowledge we have acquired about the cleavage site and stalk region was used in the 
development of a continuous Fluorescence Resonance Energy Transfer (FRET) assay, to 
measure cleavage of the ACE stalk peptide by the, as yet, unidentified ACE sheddase. FRET 
technology employs a peptide containing fluorescence donor and acceptor pairs such as the 
ortho-aminobenzoic (Abz) group at the amide terminal and the ethylene diamine-2,4-
dinitrophenyl (EDDnp) group at the carboxyl terminal. Intact peptides emit no fluorescence as 
the acceptor (EDDnp) group quenches fluorescence emitted by the donor (Abz), however after 
cleavage of the peptide, the acceptor group is no longer in close enough proximity to absorb 
the fluorescence, thus the resultant fluorescence emission can be measured using a 
fluorometer. Our peptide sequence of choice was a nine residue sequence spanning the 
cleavage site of ACE, flanked by these Abz and Dnp groups (figure 5.1). This technology also 
allows for the further characterisation of cleavage products and site(s) by high pressure liquid 
chromatography (HPLC) fractionation and mass spectrometry. Thus the cleavage products may 













Abz EDDnp N A S R S E Q G P 
Abz N A S R EDDnp S  E Q G P 
Donor  Acceptor  
Enzyme 
Fluorescence generated by donor group 
 
Excitation wavelength   320nm 
Emission wavelength    420 nm 
Figure 5.1: Schematic representation of fluorescence resonance energy transfer (FRET) technology employed in 
the ACE sheddase assays. The green highlighted residues of the stalk peptide ep ese t the P  a d P ’ esidues 
Arg(R) and Ser(S), between which physiological cleavage is said to occur. No fluorescence is generated prior to 
cleavage as donor fluorescence is absorbed by the acceptor group. Post cleavage the groups are separated from 
each other and the acceptor is no longer able to absorb fluorescence emitted by donor. This is what is measured 
via the fluorometer.  
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Internally quenched peptides or FRET peptides with the Abz and EDDnp groups have been used 
successfully in analysing the hydrolysis of substrates by ACE (Araujo et al., 1999; Bersanetti et 
al., 2004; Carmona et al., 2006). While these assays were usually performed with purified ACE 
enzyme, ACE fluorogenic peptides have also been used in a cell culture based assay to measure 
ACE activity on the cell surface (Sabatini et al., 2007). This assay exploited the fact that ACE is a 
membrane-bound ectoprotein, whose active site is exposed to the extracellular milieu. It was 
possible to detect ACE activity on the cell surface of cultured cells without lysis of the cells. 
Aortic smooth muscle cells which had endogenous ACE as well as ACE-transfected CHO-K1 cells 
were grown in 12-well plates and incubated with fluorescent ACE substrate (Sabatini et al., 
2007). It was important to establish the cell number and type to use so as to quantify the 
amount of enzyme used in the assay. Furthermore, HPLC was used to confirm cleavage 
products from the substrate hydrolysis.  This method was shown to be a novel and effective 
way to study the processes involved in the activity of ACE at the cell surface with soluble 
peptides. It was also shown, that the activity observed was due to ACE at the cell surface and 
not soluble ACE as the supernatants were assayed as well.  Assaying ACE in situ allows for 
deductions to be made about what other possible interactions are occurring with ACE and 
other molecular entities around the cell membrane (Sabatini et al., 2007).  
 
Soluble ACE stalk peptides have been previously used to develop an assay able to monitor the 
purification process of the ACE sheddase from tissue or cell lysate (R. Domingo, PhD thesis, 
2011). CHO-K1 cell lysates were incubated with the ACE fluorogenic stalk peptide and the 
cleavage site was determined by liquid chromatography-mass spectrometry (LC-MS). 
Interestingly, cleavage occurred at the E-G bond (figure 5.2) in this synthetic peptide, and not at 
the physiologically determined R-S cleavage site  (Ramchandran et al., 1994; Woodman et al., 
2000). The LC-MS data suggested that there might be non-specific endogenous 
aminopeptidases in the cell lysate hydrolysing the resultant cleavage products (R. Domingo, 
PhD thesis, 2011). A similar approach using a fluorogenic capped Pro-TNF-α stalk peptide was 
successfully used to isolate ADAM17 from tissue samples (Black et al., 1997). 
 










    
 
 
Based on the success of the ACE stalk fluorogenic assay using cell lysates, we decided to adapt it 
to be used with cell cultures. There is a requirement for ACE and its sheddase to be anchored in 
the membrane (Parvathy et al., 1997; Sadhukhan et al., 1999), making such a cell-based assay 
more physiologically relevant, while circumventing lysis of the cells and exposure of the peptide 
substrates to proteases released from the intracellular milieu. Furthermore, a cell-based assay 
facilitates downstream analyses such as HPLC and MALDI by simplifying the sample preparation 
and eliminating the need to remove cellular debris from the lysate.  
 
To further characterise the endogenous ACE sheddase, a set of ACE stalk analogues were 
designed with various substitutions in the P  a d P ’ positio s. While the ACE sheddase does 
not have a preferential cleavage site sequence that drives shedding (Beldent et al., 1993), the 
sheddase may be influenced by particular residues available to it within the stalk region (Ehlers 
et al., 1996). The cell assay was also used to analyse different peptides and the e z e’s S1 and 
S ’ subsite preferences. Similar peptide studies were performed with ADAM17 and ADAM 10 to 
ascertain which residues conferred selectivity (Caescu et al., 2009). The authors proposed that 
changes in the P ’ positio  might influence substrate recognition (Caescu et al., 2009), and 
found that ADAM 17 prefers aliphatic hydrophobic residues (Jin et al., 2002), whereas ADAM 10 
prefers larger residues such as leucine (Krstenansky et al., 2004).  
 
  




Figure 5.2: Wild-type ACE stalk FRET peptide. Arrows indicate the expected physiological cleavage site (black) 
and the synthetic cleavage site (white) determined by cleavage with CHO-K1 lysates. The expected sizes are 
indicated for each cleavage event (Domingo, PhD thesis, 2011).    
725.29Da 
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Over and above the impact of varying assay conditions, the possibility of non-specific 
aminopeptidase activity and amino acid preferences at the cleavage site, we also needed to 
investigate whether the fluorophores could affect cleavage at the endogenous ACE cleavage 
site. For example Jin et al., (2002) proposed that with the cleavage of Pro-TNF-α peptides, 
specificity of the candidate protease might be affected by steric hindrance of the capping 
groups. Cleavage of the capped and uncapped peptides of the Pro-TNFα stalk peptide p odu ed 
the same cleavage site, but the stalk peptides were cleaved at different rates by recombinant 
ADAM 17 protein.  
 
Therefore, the aim of this chapter was to further evaluate the ectodomain shedding of ACE 
using a cell-based assay and synthetic peptides that mimic the juxtamembrane stalk region of 
ACE.  
 
The objectives of this section were: 
1. To establish a cell-based assay for the cleavage of the synthetic ACE stalk FRET peptides.  
2. To investigate the involvement of aminopeptidases in the cleavage of ACE stalk 
peptides.   
3. To determine the cleavage site of the various stalk peptides in the cell-based assay.  
4. To dete i e the effe t of P  a d P ’ substitutions on the proteolytic cleavage of the 
various ACE stalk peptides.  
5. To determine the effect of peptide capping on cleavage.  
6. To investigate the hydrolysis of longer uncapped peptides that may include 















5.2 Materials and Methods 
 
 
5.2.1 Cell culture  
CHO-K1 cells were used as they have been previously shown to have ACE sheddase activity 
(Ehlers et al., 1991a) and to cleave synthetic ACE stalk peptides (Domingo, PhD thesis, 2011). 
Cells were grown and maintained as previously described in Chapter 2.   
 
5.2.2 Peptides 
Peptides (gift from A. Carmona) were made by the solid-phase methodology using Fmoc-
Lys(Dnp)-OH, with details described previously (Hirata et al., 1995). Peptides were dissolved in 
100% DMSO and diluted to a stock solution of 5 mM and stored at 4°C. Working stock solutions 
were diluted in a buffer of choice to 100 µM (Domingo, PhD thesis, 2011). 
 
5.2.3 Cell-based fluorogenic assay 
This method was conducted in accordance to Sabatini et al. (2007). CHO-K1 cells were plated in 
6, 24 or 48-well plates and cells were grown overnight to confluence in 10% FSC/DMEM/HAMS.  
Cells were washed twice with Ha k’s Bala ed Salt Solutio  HBSS) buffer (140mM NaCl, 0.1M 
CaCl2, 0.63mM MgSO4, 1mM Na2HPO4, 6.1mM glucose, 10µM ZnCl2, pH7.4) and assays were 
conducted in this buffer, in duplicate. Unless otherwise stated, 10µM of fluorogenic substrate 
was used. Peptides were diluted appropriately in HBSS buffer and added to cells. The uncapped 
peptides e e diluted to M i  HBSS uffer. l of the dilutio  as i u ated fo   o   
hours on CHO-K1 cells in 6-well plates. Uncapped peptides were diluted in Optimem®(Gibco) 
for the 18 hour incubation to prevent cells undergoing stress.  The cell culture plates were 
incubated at 37°C with 85% humidity and 5% carbon dioxide (CO2) at variable intervals. After 
the appropriate incubation time, 125-250µl of the cell culture supernatants were transferred to 
a 96-well microtitre plate (Nunc Corp). Fluorescence was read on a Cary ECLIPSE Fluorescence 
Spectrophotometer (Varian, Walnut Creek, CA) at excitation and emission wavelengths  of 
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320 and 420nm respectively, using 10 nm wide entrance and exit slits and a photomultiplier 
tube (PMT) voltage of 800 (V).  Peptides from the cell culture were resolved via HPLC.  
 
5.2.4. Continuous fluorogenic stalk peptide assay  
 
The continuous fluorogenic assays were conducted in 96-well plates. Cells were harvested in 
Triton lysis buffer (1 % Triton X-100, 50mM HEPES pH 7.5, 0.5M NaCl, 1mM 
phenylmethylsulphonyl fluoride (PMSF)) and centrifuged at high speed in a microfuge to 
sediment cell debris. The protein content was quantitated using the Bradford method via the 
Bio-Rad Protein Assay Dye Reagent Concentrate (Bio-Rad Laboratories, USA) (Bradford, 1976) 
a o di g to a ufa tu e ’s i st u tio s. Lysates were also heat inactivated at 72°C for 15 
minutes and included as negative controls with all assays. Ten µg of CHO-K1 cell lysate was 
added to 2.5-5µM of substrate in 50 mM Tris, 5 µM ZnCl2, 0.01% Brij 35, pH 9.0. Brij was used as 
a substitute for glycerol as it reduces the background fluorescence. Reactions were monitored 
over 12-18 hours at room temperature and fluorescence read continuously on a Cary ECLIPSE 
Fluorescence Spectrophotometer (Varian, Walnut Creek, CA) at excitation and emission 
wavelengths  of 320 and 420 nm respectively, using 10nm wide entrance and exit slits and a 
PMT voltage of 800 (V). Fluorogenic stalk peptides (Table 5.2) were incubated with CHO-K1 cell 
lysates in a 96-well plate and the assay was conducted according to the protocol detailed above 
(section 5.2.4). The increase in fluorescence was measured continuously in a fluorometer, and a 
graph of fluorescence emitted versus time was generated. The change in fluorescence was 
calculated over one hour from time points taken within the linear region of the graph, 
representing the initial velocity of the hydrolysis of the peptide (Cornish-Bowden, 1995).  
 
5.2.5 Chromatography of peptides using HPLC 
Cleavage products from the various assays were separated by HPLC. A 250 x 4.6mm Jupiter 
5µM C18 reverse-phase column (Phenomenex, CA) was used with a SpectraSERIES P200 
Gradient Pump. An elution gradient of 0.1% trifluoroacetic acid (TFA) to 0.1% TFA / 75% 
acetonitrile was used. Products were detected at wavelengths 215nm and 354nm via 
Spectrasystem UV/VIS Detector (Spectra-Physics, Freemont, CA) and data were analysed using 
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the EX Ch o ™ Ch o atog aph  Data S ste . The a ele gth of  as used to dete t 
carboxyl-terminal products containing the 2, 4-dinitrophenol ethylenediamine (DNP) moiety. 
The uncapped peptides were analysed on the Agilent 1260 Infinity system using a 50 x 4.6mm 
Poroshell 120, 2.7µM C18 reverse-phase column (Agilent, USA). An elution gradient of 0.1% 
trifluoroacetic acid (TFA) to 0.1% TFA / 75% acetonitrile was used. Products were detected at a 
wavelength of 214nm and data were analysed using the Agilent ChemStation Software (2004).  
          
5.2.6 MALDI mass spectrometry (MS) 
Cleavage products were prepared for MALDI by purification and desalting using ZipTip® Pipette 
Tips (Millipore, USA) containing C18 resin. Samples (0.5µl) were spotted onto MALDI plates 
twice. The at i  used o sisted of g/ l α –cyano-4-hydroxycinmamic acid (Fluka) with 
20mM NH4H2PO4 (Fluka) in 80% acetonitrile, 0.2% TFA. The final concentrations were 5mg/ml of 
matrix in 40% acetronitrile, 0.1% TFA and 10mM NH4H2PO4. MALDI MS/MS was performed at 
the Centre for Proteomics and Genomics Research (CPGR, Cape Town) on a 4800 MALDI 
ToF/ToF (Applied Biosystems). The MS spectra were recorded in reflector mode, generated with 
400 laser shots/spectrum at a laser intensity of 3800 (arbitrary units) and with a grid voltage of 




5.3 Results  
 
5.3.1. Development of a cell-based ACE sheddase assay  
 
All p e ious atte pts to use solu ilised e doge ous ACE sheddase f o  ell li es a d tissue 
ha e failed to lea e e a e- ou d ACE (Sadhukhan et al., 1999). This i di ates that the e is 
a e ui e e t fo  the sheddase to e a ho ed i  the e a e fo  effe ti e ACE lea age. It 
as thus h pothesised that a ell- ased assa  si ila  to that used  Sabatini et al., (2007) 
ould i u e t this p o le  a d a cell-based ACE sheddase assay was developed to evaluate 
the activity of the sheddase in the presence of inhibitors and stimulators.  
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The ACE stalk peptide (Abz-NSARSEGPQ-EDDnp) was incubated with CHO-K1 cells in culture and 
change in fluorescence was measured. Preliminary results were promising as they indicated an 
increase in fluorescence units (FU) with an increase in substrate concentration (figure 5.3, A) 
and time (figure 5.3, B). Interestingly, a measurable change in fluorescence was observed within 
a 6-hour period compared to that of the continuous assay (cell lysates), which required 10-18 













ACE sheddi g is ha a te isti all  i hi ited  the the h d o a ate i hi ito , TAPI, a d 
sti ulated  the pho ol este  PDBu (Chubb et al., 2004; Ehlers et al., 1997, 1995). To 
i estigate if Abz-NSARSEGPQ-EDDnp exhibited similar i hi itio  a d sti ulatio  p ofiles ithi  
the ell- ased assa , ells e e i u ated ith the ACE stalk peptide i  the p ese e of TAPI o  
PDBu a d esulti g fluo es e e as o ito ed. The e as a s all, ut ot sig ifi a t, i ease 
i  ea  fluo es e e u its i  the p ese e of PDBu, ho e e  i u atio  ith  µM TAPI had 
o effe t o  su st ate h d ol sis figu e . , A . I u atio  of CHO-K  ells ith the P o-TNF-α 
stalk peptide esulted i  a -fold i ease i  ea  fluo es e e o pa ed to the ACE stalk 
peptide, ho e e  TAPI a d PDBu also had o effe t o  the P o-TNF-α stalk peptide figu e . , 
B . This i plies that the e ha is s i ol ed i  lea i g the fluo oge i  ACE stalk peptide a  
 
Figure 5.3: Cleavage of ACE wild-type fluorogenic stalk peptide (Abz-NSARSEGPQ-EDDnp) in CHO-K1 cells. A) 
Increasing concentrations of the ACE wild-type fluorogenic stalk peptide were incubated on the cell surface of 
CHO-K1 cells in HBSS buffer for 6 hours, and resulting fluorescent units (FU) were measured. B) 10µM of ACE 
stalk peptide was incubated for increasing time periods. Assay was conducted in a 24-well plate. Supernatants 
were transferred to 96-well plate and fluorescence measured on fluorometer. Data represented are the mean 
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ha e so e diffe e es o pa ed to that of the lea age of the ild-t pe e a e- ou d 
e top otei .  
To further validate the cell-based assay, the inhibition of ACE activity in the CHO-K1 cell assay 
was investigated. Figure 5.5 shows a 2-fold reduction in tACE activity in the presence of 
lisinopril as described previously (Sabatini et al., 2007). Hydrolysis of the ACE stalk peptide in 







Figure 5.5: The effect of lisinopril on ACE activity in the cell assay. The ACE inhibitor lisinopril was pre-
incubated on tACE-expressing CHO-K1 cells for 5 minutes and ACE subtsrate Abz-LFK-Dnp was added and 
incubated for 10 minutes at 37°C. One ml of the supernatant was removed and fluorescence measured. Data 
represented are the mean ±SEM, n=2, p=0.05.  
* 
Figure 5.4: Cleavage of stalk peptides with regulators of shedding. A) 1µM PDBu or 100µM TAPI were added to 
5µM ACE stalk peptide and incubated on the surface of CHO cells for 6 hours in a 24-well plate. B) Same 
conditions as in A, except assay was performed in a 48-well plate and included the TNF-α stalk peptide. Data 
represented are mean ±SEM, n=3.  
B A 
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cell culture in the presence of the hydroxamate inhibitor TAPI, revealed no significant decrease 
in the cleavage of fluorogenic substrate (figure 5.6). 
  
To dete i e the i ol e e t of etallo- o  se i e p oteases i  the h d ol sis of the ACE stalk 
peptide, ells e e i u ated ith the etallop otease i hi ito  EDTA o  the se i e p otease 
i hi ito  PMSF. The g aph i  figu e .  ep ese ts the effe t of i easi g o e t atio s of 
EDTA o  PMSF o  the lea age of the ACE stalk peptide. A % de ease a  e see  ith the 
additio  of µM of EDTA, ith o fu the  de ease o se ed at M EDTA, hile the se i e 
p otease i hi ito  PMSF had o effe t o  su st ate h d ol sis. This o fi s that 








Figure 5.7: Inhibition of cleavage of the fluorescent stalk peptide by broad-range inhibitors.  Fluorescent units 
(FU) of stalk peptide cleavage in presence of …Inhibition of hydrolysis of ACE stalk peptide (2.5µM) by EDTA 
(metalloprotease inhibitor) and PMSF (serine protease inhibitor). Assay was conducted in 48-well plate.  Data 
represented are the mean ±SEM, n=3, p=0.05** 
**  








Figure 5.6:  Pre-incubation of the sheddase inhibitor TAPI with CHO-K1 cells.  100µM of TAPI was pre-
incubated with CHO-K1 for 1 hour. 5µM of fluorescent ACE stalk peptide was added and supernatants were 
collected and fluorescence read after 6 hours. Assay was performed in a 24-well plate. Data represented are 
the mean ±SEM, n=3.  
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etallop otease a ti it  is i ol ed i  the stalk peptide lea age, hile se i e p otease a ti it  
does ot pla  a ole. I te esti gl , e e  at a lo  o e t atio  of stalk peptide . µM , the 
additio  of EDTA did ot o pletel  a olish the lea age, i di ati g that so e of the h d ol sis 
ust e due to o - etallop otease lea age. This ould also e plai  h  the h d o a ate 
i hi ito , TAPI, had o effe t, suggesti g that the p otease espo si le fo  lea i g the peptide 
a  e a etallop otease ut does ot espo d spe ifi all  to the h d o a ate lass of 
i hi ito s. Thus, the p otease espo si le fo  lea i g the stalk peptides u de  these ell assa  
o ditio s is likel  to e diffe e t to the ACE sheddase espo si le fo  lea i g e a e-
a ho ed ACE, o  alte ati el , the e ould pote tiall  e additio al p oteases i ol ed i  the 
lea age of the fluo oge i  stalk peptide.   
 
5.3.2 The evaluation of aminopeptidase hydrolysis of the ACE stalk peptide  
  
Cleavage of the wild-type ACE stalk peptide exposed to CHO-K1 cells in culture did not display 
the same characteristics of shedding as transfected ACE. To determine which other proteases 
may be responsible for the cleavage of the ACE stalk peptides in the cell assay, the effect of the 
aminopeptidase inhibitor, bestatin, on peptide hydrolysis was investigated. The cell assay was 
performed in the presence of 100 µM bestatin (figure 5.8).  Eventhough there seems to be a 
decrease in fluorescence, bestatin had no significant effe t o  peptide lea age e e  at M 
(results not shown)), indicating that aminopeptidase activity was not involved in the cleavage of 
the ACE stalk peptide.  
 
To determine the cleavage site of the ACE stalk peptide under cell assay conditions, HPLC and 
MS were employed as described in sections 5.2.5 and 5.2.6 (Appendix figure A5.1 illustrates the 
workflow for the experiments used to determine the cleavage site of the stalk peptides). The 
ACE stalk peptide at t0 eluted from the HPLC column as a single peak corresponding to that of 
the uncleaved peptide (figure 5.9A). In figure 5.9B, the incubation of stalk peptide with CHO-K1 
cells for 6 hours resulted in the formation of a second peak, representing a cleavage product 
eluting at 23 minutes. It is also clear from this figure that there is a large proportion of 
uncleaved peptide still present in the sample. These products could be visualised as product 
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peaks on the HPLC as the spectrophotometer was able to detect the EDDnp C-terminal moiety 
at 354nm. Fractions eluted from the column were collected in 1 ml aliquots, and their 
fluorescence measured on a fluorometer at excitation and emission wavelengths of 320nm and 
420nm, to detect the presence of the Abz group. One fraction, corresponding to the 
approximate 15-minute elution, displayed fluorescence at this wavelength, and this fraction as 
well as fractions corresponding to the cleaved (24 minutes) and uncleaved (23 minutes) 
products were stored for MS analysis. Similarly, samples from the bestatin time course were 
subjected to HPLC to ascertain the resultant cleavage products. Results indicate that the 
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Figure 5.8: Effect of aminopeptidase inhibitor bestatin on the cleavage of the fluorogenic ACE stalk peptide. 
Assay was conducted in a 6-well plate, using 5µM of substrate and 100µM over 6 hours, in duplicate.  




















The cleavage site at 6 hours (no bestatin) was determined by analysing the HPLC fractions using 
mass spectrometry. The [M+H]
+
 ion corresponding to the uncleaved peptide was identified as 
1272.54 (figure 5.10). The masses that were found for the cleaved products were m/z 782.36, 
corresponding to Abz-NSARSE (eluted at 15 minutes) and m/z 509.21, corresponding to GPQ-
EDDnp (eluted at 23 minutes; figure 5.11). These masses compare well with the calculated 
masses (figure 5.10 and table 5.1), and indicate that the primary cleavage occurs between the E 
and G and not the expected R and S, and that that no secondary trimming of cleavage products 
occurs. 
 
Figure 5.9: HPLC chromatogram of 10µM of wild-type fluorogenic ACE stalk peptide incubated on the surface 
of CHO-K1 cells in a 6-well plate for 6 hours. A) uncleaved stalk peptide at t0 incubation with CHO-K1 cells B) 
stalk peptide after 6 hours incubation with CHO-K1 cells. Chromatogram of 354nm wavelength to monitor the 
















 1272.54Da.  Abz- NSARSEGPQ-EDDnp 
 1153.50Da.           NSARSEGPQ-EDDnp 
 1039.46Da.              SARSEGPQ-EDDnp 
  952.42Da                  ARSEGPQ-EDDnp 
   881.39Da.                   RSEGPQ-EDDnp   
   725.29Da                       SEGPQ-EDDnp   
   638.25Da                         EGPQ-EDDnp   
   509.21Da.                           GPQ-EDDnp   
   452.19Da.                              PQ-EDDnp   
355.14 Da                                 Q-EDDnp 
N-terminal ladder:   
1272.54Da.  Abz-NSARSEGPQ-EDDnp 
1064.48Da   Abz-NSARSEGPQ 
 936.42Da.  Abz-NSARSEGP 
 839.36Da.  Abz-NSARSEG 
 782.34Da.  Abz-NSARSE 
 653.30Da.  Abz-NSARS 
 566.27Da.  Abz-NSAR    
 410.17Da.  Abz-NSA 
 339.13Da.  Abz-NS 
Figure 5.10:  The theoretical m/z masses of potential cleavage products of the wild-type ACE fluorogenic 
stalk peptide. The N-terminal ladder represents all b-ions that may be detected and the C-terminal ladder 
represents the all the y-ions that may be detected via MALDI.  




The fractions from the time course experiment which aimed to describe the contribution of 
aminopeptidases to the cleavage of the wild-type fluorogenic ACE stalk peptides, were also 
submitted for mass spectrometric analysis. From these data we can identify all peptide 
products that emerge over the incubation period. The molecular ions at m/z 725.29 and 509.21 
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Figure S.l1: MALDI-TeF spectra of 3 f ract ions purified f rom the HPLC of the cleaved w ild-type ACE 
stalk pe ptide . The major product peaks have been highlighted. Ca lculated masses are indicated for 
f raction 15 minutes, 23 minutes and 24 minutes. 
CHAPTER 5: The evaluation of ACE ectodomain shedding using stalk peptide mimetics 
109 
 
identified in the product peak collected at 24 minutes (table 5.1 and figure 5.12) correspond to 
the C-terminal fragments SEGPQ-EDDnp and GPQ-EDDnp, respectively. The molecular ion at 
m/z 725.29 corresponds to the SEGPQ-EDDnp product detected at 4 hours (no bestatin), 4 
hours (100µM bestatin) and 6 hours (500µM bestatin) (table 5.1). In addition, the molecular ion 
at m/z 782.34 corresponding to the N-terminal fragment (Abz-NSARSE) was observed at every 
time point. 
 























4hour 14 min   782.34   
23 min 1272.51     




14 min   782.35   
23 min      
24-25min  509.19   725.28 
6hour 14 min   782.35 
(very low) 
  
23 min      




14 min   782.34   
23 min  509.21    




14 min   782.34   
23 min  509.22   725.25 
24-25min 1272    725.27 
  
These results confirm that even in the presence of an excess of the aminopeptidase inhibitor 
bestatin, there is specific cleavage at the E-G bond and not the expected R-S bond, and that the 
GPQ-EDDnp product is not the result of secondary aminopeptidase activity. Therefore, even 
with an excess of bestatin (500µM), the products with m/z of 509.21 and 782.34 were 
observed, providing further evidence that the E-G bond is the favoured cleavage site of the ACE 
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stalk peptide. A secondary minor cleavage site at the R-S bond was also observed (as evidence 
by the presence of the m/z of 509.21 ion), which agrees with the physiological cleavage of ACE.  
 
 
5.3.3 The effect of the P1 a d P1’ residues on the cleavage of the ACE stalk peptide  
 
We next investigated the effect of the P  o  P ’ esidues in the ACE stalk peptides on cleavage. 
A range of peptides were made where the P1 (R) o  P ’ (S) residue positions of the endogenous 
stalk peptide, or both, were substituted with the hydrophobic residues Y, W or F, to examine 
the impact of these specific residues in the cleavage of the stalk peptides (Table 5.2).  The 
Figure 5.12: MALDI-ToF/ MS of fractions from cell based assay with wild-type fluorogenic ACE peptide and 
the aminopeptidase inhibitor bestatin.  These represent the 6 hour time point with the highest 











6h 500µM Bestatin  
Fraction 14 min 
6h 500µM Bestatin 
Fraction 23-24min 
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peptides are referred to by the single-letter amino acid residues present in the predicted P1 
a d P ’ g oups, for example RS represents the wild-type peptide Abz-NSARSEGPQ-EDDnp.  
  
Table 5.2: Fluorogenic ACE stalk peptide mimetics. 
Peptide  Name Alteration 
Abz-NSARSEGPQ-EDDnp Wild-type stalk peptide  
Abz-NSAFSEGPQ-EDDnp  F in P1 position 
Abz-NSARFEGPQ-EDDnp  F i  P ’ positio  
Abz-NSAFFEGPQ-EDDnp  F i  P  a d P ’ positio  
Abz-NSARWEGPQ-EDDnp  W i  P ’ positio  
Abz-NSAWSEGPQ-EDDnp  W in P1 position 
Abz-NSAYSEGPQ-EDDnp  Y in P1  
Abz-ESNIKVLPQ-EDDnp CD 4 CD4 stalk sequence 
Abz-LAQAVRSSSQ-EDDnp  Pro-TNFα Pro-TNFα stalk se ue e 
*Peptides e e  desig ed ased o  p edi ted o  o  theo eti al P  a d P ’ sites i.e R-S bond. This occurred before 
the cleavage site was determined to be at E-G. The P  a d P ’ postio s ill still e di ussed ased o  the p edi ted 
position.  
 
The fluorogenic peptides were incubated with CHO-K1 cell lysate in the 96-well plate 
continuous assay (section 5.2.4). Flourogenic peptides with hydrophobic groups in the 
theo eti al P ’ positio , such as RW and RF, were cleaved more efficiently than the wild-type RS 
peptide (figure 5.13). FF, YS and FS all displayed negligible increases above the background 
fluorescence of the uncleaved peptide, while CD4 and WS peptides were not cleaved at all. 
These data support the suggestion  that an R residue at the P1 position is favoured in ACE 
shedding (Ehlers et al., 1996). Ho e e , the e ui e e ts of the P ’ esidue see  to e less 
rigid and bulky W and F residues seem to facilitate cleavage at this position.  
  




The peptides were then analysed using the cell-based assay. It was immediately evident that 
the cell assay produces a very different cleavage pattern to the CHO-K1 lysate assay (figure 
5.14). In the cell assay; the peptides that showed the lowest cleavage in the cell lysate 96-well 
plate continuous assay, such as WS, YS, FS and FF; have much higher fluorescence than RS, RW, 













Figure 5.13: Cleavage site mutants of the fluorogenic ACE stalk peptides in a 96-well plate assay. Stalk 
peptide mutants were incubated with CHO-K1 cell lysates in a 96-well and analysed continuously as detailed 
previously in 5.2.3. FU/hour were calculated from the linear region of the fluorescence curve. WS, YS, FS, FF, 
RS, RW and RF represent the theoretical P1 and P1` sites based on the endogenous ACE stalk cleavage site 
peptides.  The CD4 peptide represents the stalk sequence of the cytokine CD4. Data represents mean±SEM, 
assays were conducted in duplicate and experiments were repeated twice.  




































To characterise the cleavage sites of the different peptides incubated in the cell-based assay, 
cleavage products were subjected to MS analysis. Data from the MALDI-ToF M/S were analysed 
for the presence of specific masses corresponding to the calculated masses of potential 
products for each peptide (table 5.3).  
 
The C- and N-terminal cleavage products of the wild-type RS peptide were identified as the 
molecular ions at m/z 509.17 and m/z 782.28, which correspond to the GPQ-EDDnp and Abz-
NSARSE fragment, respectively (table 5.3). Similarly, RF was cleaved to produce the C- and N-
terminal fragments GPQ-EDDnp (m/z 509.17) and Abz-NSARFE (m/z 842.33). The RW peptide 
produced two sets of fragments indicating that cleavage occurred between both the theoretical 
P ’ - P ’ (E/G) and P ’ - P ’ (W/E) residues; producing the fragments GPQ-EDDnp (m/z 509.18) 
and Abz-NSARWE (m/z 881.34) as well as EGPQ-EDDnp (m/z 638.21) and Abz-NSARW (m/z 
752.38). These results demonstrate that the main cleavage site for all of these three peptides 
occurs between the E and G (theoretical P ’ - P ’) residues.  
  
Figure 5.14: Cleavage site mutants of the fluorogenic ACE stalk peptide in a cell-based fluorogenic assay. The 
graph represents the fluorescence after 6 hours when the fluorogenic peptides were incubated with intact 
CHO-K1 cells at 37°C. Assays were conducted in a 48-well plate with 5µM peptide. WS, YS, FS, FF, RS, RW, RF 
represent the theoretical P1 and P1` sites of the ACE peptides.  The CD4 and TNFα peptides represent the stalk 
sequences of cytokine CD4 and Pro-TNFα respectively. Fluorescence was normalised against background 
fluorescence of uncleaved peptide. Data represents mean±SEM, assays were conducted in triplicate, 
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The four remaining peptides, FF, FS, WS and YS, all produced a prominent cleavage product 
corresponding to GPQ-EDDnp (m/z 509. , agai  desig ati g the P  a d P ’ esidues as E and 
G. It is important to note that these four peptides also had observable masses in the uncleaved 
control samples (m/z 509.18 and 725.25) matching the cleavage products. These results 
indicate some level of degradation, however, the wild-type (RS) and t o P ’ uta t stalk 
peptides RF and RW displayed no degradation products in the uncleaved samples and the 
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Table 5.3: Cleavage products obtained from the various stalk peptides. Calculated and observed masses 
determined via MALDI-ToF M/S for uncleaved (control) and cleaved samples (6 hour exposure to CHO-K1 cells). 
Samples were prepared according to the outline (appendix, figure A5.2). Masses corresponding to peptides FF, FS, 
WS and YS are underlined and have potassium (K) adducts (+38).  

















Abz-NSARSEGPQ-EDDnp  1272.54 1272.45   
                      GPQ-EDDnp   509.21 509.17 
Abz-NSARSE   782.34 782.28  
     
Abz-NSARFEGPQ-EDDnp 1332.56 1332.49   
                      GPQ-EDDnp   509.21 509.17 
Abz-NSARFE   842.38 842.33 
     
Abz-NSARWEGPQ-EDDnp  1371.58 1371.49   
                        GPQ-EDDnp   509.21 509.18 
                      EGPQ-EDDnp   638.25 638.21 
Abz-NSARWE   881.39 881.34     
Abz-NSARW   752.35 752.30 
     
Abz-NSAFSEGPQ-EDDnp  1263.51 1301.38   
                      GPQ-EDDnp  509.17  509.19 
                 SEGPQ-EDDnp  725.25  725.27 
     
Abz-NSAFFEGPQ-EDDnp  1323.54 1362.41   
                      GPQ-EDDnp 509.21 509.1779  509.189 
     
Abz-NSAWSEGPQ-EDDnp  1302.52 1340.45   
                       GPQ-EDDnp              509.21 509.19  509.18 
                  SEGPQ-EDDnp  725.28   
     
Abz-NSAYSEGPQ-EDDnp  1279.50 1317.41   
                       GPQ-EDDnp  509.187  509.19 
                   SEGPQ-EDDnp  725.27   
     
Abz-ESNIKVLPQ-EDDnp  
(CD4 stalk) 
1354.68 1354.63   
     
Abz-LAQAVRSSSQ-EDDnp 
(Pro-TNF-α stalk  
1373.6 1373.62   
Abz-LAQAVR   776.44 776.42 
                         SSQ-EDDnp   529.20 529.99 
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The CD4 peptide incubated on CHO-K1 cells (figure 5.14) displayed no distinct products with 
molecular ions corresponding to any of the calculated masses, indicating that no specific 
cleavage of this peptide occurred (table 5.3). However, an increase in fluorescence after 6 hours 
of incubation with cells was observed (figure 5.14) illustrating that there may be cleavage due 
to non-specific protease activity. 
 
Incubation of CHO-K1 cells with the Pro-TNF-α peptide (figure 5.14) produced two fragments 
identified as SSQ-EDDnp (m/z 529.99) and Abz-LAQAVR (m/z 776.42) (table 5.3), with a similar 
cleavage site to that of the ACE stalk peptides where primary cleavage occurs 3 residues from 
the C-terminus. Interestingly, there were no molecular ions denoting cleavage at the 
physiological A-V cleavage site. Therefore, cleavage of all the fluorogenic stalk peptides, 
including those in the cell-based assay does not appear to be sequence-specific. 
 
5.3.4 The effect of peptide capping on cleavage  
  
5.3.4.1 Cleavage of a non-capped stalk peptide 
 
To determine whether the presence of the fluorogenic capping groups altered the cleavage 
position of the stalk peptides, we analysed peptides lacking these fluorogenic groups using the 
same cell assay as was used for the capped peptides (table 5.4). Interestingly, HPLC revealed no 
cleavage products were present with only a single peak eluting at 10.6 minutes corresponding 
to the intact peptide NSARSEGPQ (figure 5.15). 
 
Table 5.4: Uncapped ACE stalk peptides  
Sequence  Length  Abbreviation Rationale 
 
                                          NSARSEGPQ 
9 WT Fluorophores omitted only, same length  
  
ELHGEKLGWPQYNWTPNSARSEGPQ 
25 RM Peptide sequence extended at the N-
terminus to include putative 


















Figure 5.15: HPLC chromatograms of the uncapped NSARSEGPQ ACE stalk peptide. M of peptide i  HBSS 
buffer) was incubated on the surface of CHO-K1 for 6 hours, and resulting fluorescence measured. A) WT 
uncapped ACE stalk peptide incubated for 0 hours on cells B) WT uncapped ACE stalk peptide incubated for 6 
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5.3.4.2 Analysis of cleavage of longer peptides incorporating putative secondary sheddase 
recognition motifs 
 
To probe whether a longer stalk peptide may be more susceptible to specific cleavage by the 
ACE sheddase, we extended the peptide N-terminally by 9 residues to include the entire 
juxtamembrane stalk as well as part of the proximal ectodomain. This ectodomain region has 
previously been shown to play a role in directing the cleavage of rabbit ACE (chapter 4, 
Figure 5.16: HPLC chromatograms of the 25 residue long uncapped ACE stalk peptide. M of peptide as 
incubated on the surface of CHO-K1 for 6 hours, diluted in HBSS buffer A) RM uncapped ACE stalk peptide 
incubated for 0 hours on cells B) RM uncapped ACE stalk peptide incubated for 6 hours on cells C) HBSS buffer 
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Chattopadhyay et al., 2008). The resulting 25-residue peptide (RM) (table 5.4) was incubated 
for 6 hours with CHO-K1 cells in the cell assay and resolved using HPLC. The unlceaved RM 
peptide eluted at 6.98 minutes, however no new product peaks were observed when the 
reaction was analysed with HPLC (figure 5.16) implying that the fluorohpore groups have some 
sort of impact on the cleavage of the fluorogenic stalk peptides. Similar results were obtained 
for both of the 9- and 25-residue uncapped peptides even after an extended incubation period 




Peptide Cleavage  % substrate remaining 
  6 hours  18 hours 
NSARSEGPQ No  100% 100% 
ELHGEKLGWPQYNWTPNSARSEGPQ No  100% 100% 
Abz-NSARSEGPQ-EDDnp Yes  89 % 52% 
 
  
The 18-hour incubations in the cell assay were prepared for mass spectrometry as previously 
described and a representative figure of the MALDI-ToF results is shown in figure 5.17. It is clear 
that after 18 hours of incubation, the m/z ions of the 9- (944.41) and 25- (2880.12) residue 
uncapped stalk peptides are in agreement with the calculated values of the intact peptides.  
 
Thus, the fluorogenic capping groups seem to have a marked influence on the cleavage of the 
stalk peptides. While no cleavage was observed in the uncapped peptides even after an 
extensive incubation of 18 hours, the fluorescently capped peptides were cleaved efficiently 
under similar conditions, albeit at unexpected positions. We see a mass of m/z 509.15 that 




Table 5.5: Cleavage of uncapped peptides. Peptides were incubated for 6 and 18 hours on CHO-K1 in the minimal 
media Optimem®. Percentage of substrate remaining is indicated where cleavage was observed. 
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5.4 Discussion  
 
This study set out to define the minimal requirements needed to direct the shedding of ACE by 
investigating the role of its stalk region in this process. The original analysis of fluorogenic ACE 
NSARSEGPQ-NH2 
944.46  
Figure 5.17: MALDI-ToF spectra of the 18-hour incubation of peptides with CHO-K1 cells.  Calculated masses 
are indicated for each peptide. The top panel shows the 9-residue wild-type fluorogenic peptide. In bold the 
dominant cleavage product corresponding to m/z 509.15 is shown and the intact peptide corresponding to 
m/z 1272.4242. The second panel represents the 9-residue uncapped peptide and an observed m/z mass of 
944.41 is seen which corresponds to the intact peptide. The lower panel represents the 25-residue uncapped 
peptide, with an observed mass (2880. 12) corresponding to that of the uncleaved species (2880.3).   
ELHGEKLGWPQYNWTPNSARSEGPQ-NH2 
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stalk peptides demonstrated that they were cleaved by CHO-K1 cell lysate, but at a very slow 
rate (R. Domingo, PhD thesis, 2011).  
 
A cell-based assay initially used to evaluate ACE substrates in cell culture (Sabatini et al., 2007) 
was adapted to investigate the hydrolysis of the ACE stalk peptide. While the rate of shedding 
of full-length ACE expressed in different cell lines is increased via the addition of the phorbol 
ester, PDBu, and inhibited by the hydroxamate inhibitor, TAPI, the addition of these effectors 
made no change to the cleavage of the wild-type fluorogenic ACE stalk peptide (figure 5.4A). 
Moreover, pre-incubation with TAPI, still did not inhibit cleavage of the ACE stalk peptide 
(figure 5.6). However, under the conditions described by Sabatini et al. (2007), the activity of 
ACE in the cell-based assay could be inhibited by lisinopril. The reason for the discrepancy 
between inhibition of ACE activity and inhibition of sheddase activity could be that with using 
tACE transfected cell lines the protein is being overexpressed at a high rate.  CHO-K1 cells, on 
the other hand, generate an endogenous sheddase/protease with an unknown level 
proteolytic?  activity  (Ehlers et al., 1996, 1995, 1991b). Alternatively, the peptides might be 
cleaved by proteases other than metalloproteases.  .  
 
Soluble ACE hydrolyses its substrates with similar efficiency to full-length ACE that includes the 
transmembrane and cytoplasmic domains. Studies carried out with the sheddase, ADAM 17, 
and a soluble peptide representing the TNF-α stalk (Dnp-SPLAQAVRSSSR-NH2) (Caescu et al., 
2009; Doedens et al., 2003; Jin et al., 2002) showed that this peptide was cleaved by 
recombinant ADAM 17 as well as cell lysates. Moreover, the cleavage products generated when 
using cell lysate expressing endogenous levels of protein were considerably lower than when 
purified recombinant ADAM 17 was used. Studies done with TNF-α stalk peptides sho ed that 
there was no difference in cleavage site when a capped versus an uncapped peptide was 
analysed using recombinant ADAM 17 ( Jin et al., 2002). However, when untransfected cell lines 
with endogenous ADAM 17 levels were used, the peptide (Dabcyl- SPLAQAVRSSSR –Edans) was 
not cleaved (Becker et al., 2002). Similarly cleavage of a TNF-α stalk peptide D p-
SPLAQAVRSSSR) by untransfected monocytic cells (DRM) was limited compared to cleavage by 
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recombinant purified ADAM 17 (Doedens et al., 2003). This indicates that peptide hydrolysis by 
recombinant proteins are more specific than using untransfected cell lines expressing 
endogenous levels of the protein of interest.  
 
To determine if the cleavage of stalk peptides was the result of a specific class of protease, we 
incubated the peptides with EDTA, known to inhibit metalloproteases and previously shown to 
inhibit the solubilisation of ACE from tissue, as well as the serine protease inhibitor, PMSF 
(Naim, 1996; Oppong and Hooper, 1993). PMSF had no effect on cleavage and EDTA resulted in 
50 % inhibition (figure 5.6), suggesting that proteases other than metalloproteases were also 
contributing to the cleavage of the peptide. 
Mass spectral data revealed that the same cleavage site was observed with all the ACE stalk 
peptides tested. Becker et al., (2002) have previously shown that cleavage of both fluorogenic 
and non-fluorogenic TNF-α stalk peptides by recombinant human ADAM 17 resulted in 
hydrolysis of the expected Ala-Val bond (the observed cleavage site in full-length TNF-α). 
However, incubation with HUVEC cells, HMC-1, and peripheral blood lymphocytes (PBL) 
resulted in no identifiable cleavage products. No stimulation was seen and no inhibition by the 
hydroxamate inhibitor TAPI-2 occurred. These assays relied on untransfected cells and 
endogenous levels of proteins, leading to inconclusive results. The important difference 
between the Becker et al. (2002) study and the results presented here is that they observed 
complete degradation of their peptide using cell lysates and their starting material disappeared 
completely and the cleavage site was not determined, while the ACE stalk peptides were not 
completely degraded and that a defined and consistent cleavage site was observed.  
 
The cleavage site resulting from both the cell lysate (R. Domingo, PhD thesis, 2011) and cell 
assay methods (figure 5.11) did not agree with the physiological cleavage site. This initial 
characterisation of the cell-assay showed that the cleavage of the ACE stalk peptide was not 
susceptible to stimulation and inhibition (by phorbol esters or hydroxamate inhibitors 
respectively) (figure 5.4 and 5.6). Moreover, fractionation of the supernatant from the cell 
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assay resulted in the identification of, not only the C-terminal fragment found before 
(R.Domingo, PhD thesis, 2011), but also the corresponding N-terminal fragment. This was the 
first unequivocal evidence that specific cleavage of ACE stalk peptides occurs at the E-G bond 
(figure 5.11) irrespective of system used i.e. the cell-based or cell lysate assay.  
 
In the presence of the aminopeptidase inhibitor, bestatin, the ACE stalk peptide was still 
preferentially cleaved at the E-G bond, however; there was also a secondary minor cleavage at 
the R-S bond (figure 5.7).  These data confirmed that aminopeptidases do not play a role in the 
cleavage of the fluorogenic ACE stalk peptide. Numerous studies have revealed multiple 
cleavage sites for specific substrates that undergo ectodomain shedding. For example, the 
cleavage site of an ectoprotein such as ACE or L-selectin may vary depending on the sheddase 
recruited under basal or stimulated conditions (Schwager et al., 1998; Zhao et al., 2001). ACE 2 
is another excellent example of a sheddase substrate that produces differing cleavage products, 
under different conditions (Iwata et al., 2009).    
 
The mutations in the theoretical P  a d P ’ positio s of the ACE stalk peptide showed that 
irrespective of changes in the residues targeted by the sheddase, the peptides were cleaved at 
the same position (table 5.3) i.e. three as opposed to five residues from the C-terminus.  When 
the P ’ serine was mutated to a tryptophan or phenylalanine, cleavage was enhanced in the cell 
lysate assay. However, when the P1 arginine was mutated to W, Y and F, cleavage was no 
longer observed. This indicates that the R in the theoretical P1 position is fa ou ed a d the P ’ 
position modulates cleavage rates. Interestingly, previous work has shown that mutation of the 
R
627
 in the stalk of full-length tACE does not knock out shedding completely, but modulates the 
shedding and cleavage site. In this case, the cleavage site shifted 10 and 13 residues C-terminal 
to R
627
 and was cleaved at R-V and F-L, respectively (Chubb, PhD thesis, 2001). Results from the 
stalk peptide mutants assayed with cell lysates agree with what has been established in 
membrane-bound ACE. The peptide with a double mutation at both the P  a d P ’ positio s, 
was cleaved much less efficiently than peptides ith P ’ utatio s alone. Most notably, the 
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TNF-α stalk peptide was cleaved at the same position as the ACE stalk peptides (3 residues from 
the C-terminus, table 5.3) and not at the previously reported A-V site (Jin et. al. 2002).  
 
Work by Domingo (2011) used a TNF-α stalk peptide capped with the Abz fluorescent donor 
and the EDDnp quenching groups (table 5.5) which differs from the peptide analysed by Jin et 
al. (2002), which had a 9,10-diphenylanthracene (Dpa) quenching group at the C-terminus. 
Using recombinant ADAM 17 it was found that the kcat/kprime (a easu e of the e z e’s 
catalytic efficiency) of ADAM17 with this EDDnp-peptide was 35-fold lower than that with the 
Dpa groups. It was suggested that the EDDnp quenching group lowered the affinity of the 
substrate by 4-fold and that the chemistry of the Dpa group allowed for increased hydrogen 
bonding within the catalytic site (Jin et al., 2002). Another study using the acceptor/ donor 
groups FAM (6- carboxyfluorescein) and TAMRA (6-carboxytetramethylrhodamine) respectively 
(Alvarez-Iglesias et al., 2005), reported real-time measurements on the surface of live cells. The 
advantage of these peptides were validated using recombinant ADAM 17 and ADAM 10 in 
conjunction with peptides utilizing other fluorophores to compare specificity and efficiency of 
each capping pair. The Kcat/Km was higher for FAM-TAMRA groups than the MCA-Dnp groups, 
indicating that FAM-TAMRA peptides are cleaved more efficiently (table 5.5). This implies that 
other fluorophores are not as sensitive and specific as FAM-TAMRA.  
 





kcat kcat/KM Reference 
Abz-        LAQAVRSSSR   -Dpa A-V 
 
Abz –Dpa 21.6 s-1  Jin et.al., 2002 
                 LAQAVRSSSR   0.34 s
-1
   Jin et.al., 2002 












 Amour et.al., 1998 






 R. Domingo, PhD 
thesis, 2011 
              SPLAQAVRSSSR A-V 
(rhADAM17) 
   Becker et.al., 2002 




  Becker et.al., 2002 
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The use of soluble peptides to determine cleavage site preferences has been well studied over 
the years. Jin et al., 2002 showed the consistency of TACE cleaving at the A-V bond, while a 
screen of a peptide library with ADAM 8, known to cleave myelin basic protein (MBP) showed 
that asi  esidues at the P  a d P ’ positio s i eased cleavage efficiency (Naus et al., 2006; 
Schlomann et al., 2002). Cleavage by ADAM 33 was  shown to favour an APP substrate with V, A 
and Q at the P3, P  a d P ’ positio s espe ti el  (Zou et al., 2005). It was found that a 
minimum of nine specific residues were necessary for recognition as well as cleavage. Another 
extensive study was conducted to determine amino acid preferences for cleavage sites and to 
use these preferences as a means to differentiate between putative sheddases (Caescu et al., 
2009). It was found that hydrophobic residues such as L and V were common in the P ’ site for 
ADAM 17 specific peptides and the preference of a valine residue at the P ’ position 
distinguishes ADAM 17 from ADAM 10 substrates. These studies all suggest that sheddases are 
constrained to cleave at preferred sites within the juxtamembrane region.  
 
Unlike ACE, the CD4 protein has been shown to not be cleaved from the cell membrane. 
Interestingly, Sadhukhan et al. (1998) have shown that a construct containing the CD4 stalk 
region with an ACE ectodomain was in fact cleaved, alluding to the potential presence of a 
sheddase recognition motif within the ectodomain of ACE. We therefore also included the 
peptide Abz-ESNIKVLPQ-EDDnp, based on the sequence for the CD4 stalk region, in our assays, 
but found no cleavage (table 5.3). The results confirmed that the CD4 stalk sequence was not 
sufficient for cleavage to occur and illustrates that the small amount of fluorescence observed 
from the CD4 peptide was due to undefined proteases (figure 5.14). This is in line with our 
results that both TAPI and phorbol esters had no effect on the cleavage of the ACE stalk peptide 
(figure 5.4) and that EDTA does not knock out shedding completely (figure 5.7). This suggests 
that the proteases/sheddases responsible for cleaving the ACE stalk peptides in our assays, 
probably require certain minimal sequence specificities to direct cleavage, but without adhering 
to the physiological cleavage site. Furthermore, they are not fully inhibited by broad range 
metalloprotease inhibitors that inhibit the shedding of ACE in CHO-KI cells, again reiterating the 
role of non-metalloproteases in the cleavage of the peptides. 





A limitation of this study is that the fluorogenic ACE stalk peptide was cleaved at an alternative 
site compared to the expected endogenous cleavage site. This emphasises that our 
experimental model is not optimised to target the correct protease in CHO-K1 cells, which is a 
sheddase that is sensitive to TAPI inhibition and stimulated by phorbol esters. Furthermore, the 
use of uncapped peptides with no fluorogenic groups revealed no cleavage, suggesting that 
these shortened soluble sequences are not sufficient for hydrolysis by the ACE sheddase. The 
uncapped peptides also has no fluorogenic groups with which to monitor the cleavage and 
there is a reliance on HPLC and MALDI/MS to analyse cleavage products. This reduces the 
ability to make the assay amenable to high throughput usage. From these results, we can see 
that the cell-based assay may not be the optimal way to study the shedding activities that are 
specifically responsible for the cleavage of membrane-bound ACE in CHO-K1 cells.  
 
Removal of the fluorogenic capping groups rendered the 9-residue ACE stalk peptide 
uncleavable under the 6-hour cell assay conditions. Extending the N-terminus by 16 residues 
did not result in cleavage, suggesting that the additional sequence from the juxtamembrane 
stalk and proximal ectodomain does not help facilitate hydrolysis of the peptide. Even after 18 
hours incubation, neither of the uncapped peptides were cleaved and the capped fluorogenic 
peptide was cleaved, albeit not at the expected physiological site. This reemphasises the need 
for the ACE sheddase substrate to be anchored in the lipid bilayer of the cell membrane In 
contrast, 20 amino acid long mimetic peptides of the ACE2 (ACE homologue) juxtamembrane 
region provided soluble substrates of sufficient length to create secondary structures necessary 
for efficient cleavage by the ACE2 sheddase, ADAM 17. These were successfully used to 
determine the cleavage site of the ACE2 cognate sheddase, ADAM 17, in cell culture (Iwata et 
al., 2009; Lai et al., 2009).  
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A critical finding from this study is that the protease present in CHO-K1 cells cleaving the 
fluorogenic wild-type ACE stalk peptide favours the E-G site, and not the expected R-S site 
favoured by the ACE sheddase in endogenous ACE cleavage. An encouraging feature of the cell-
based assay developed for this study is that it can be used to study proteolysis using soluble 
peptides where the cleavage sites of peptides incubated on the cell surface can be investigated 
by either purifying products via HPLC or conducting a manual clean up with Zip–tip C18 reverse 
phase resins. With the latter method, we were able to perform conventional MALDI-ToF to 
analyse the resulting peptide products. This method also circumvented the requirements to 
ultracentrifuge samples and analyse samples with LC-MS, as was necessary with the CHO-K1 
lysate samples. 
 
In summary, the fluorogenic ACE stalk peptides were cleaved 3 residues from the C-terminus 
and the fluorogenic groups present influenced how the peptide was cleaved. There was also a 
p efe e e fo  e tai  esidues i  the P  a d P ’ positio s, with the protease cleaving these 
peptides and favouring hydrophobic residues within the P1’ positio , hile ot tole ati g su h 
residues in the P1 position. The cleavage of these fluorogenic peptides was not regulated by 
known stimulators or inhibitors of ACE shedding, making it more difficult to identify the cognate 
sheddase. It was examined whether it was sufficient for the sheddase only to be anchored in 
the membrane and cleave a soluble peptide substrate, but in the case of an ACE sheddase, 
there is a requirement for the substrate to be tethered to the membrane as well. In all 
likelihood, the ACE sheddase requires more stringent conditions in order to cleave the ACE stalk 
as well as the ACE stalk peptide used in this study. 
 
The requirement of having the substrate and ACE sheddase attached to the membrane, ties in 
with the premise that there exists a complex interplay of regulatory proteins involved in 
shedding, suggesting that other proteins might participate in the shedding process. A key 
example of such a multifactorial shedding machinery is the annexins, which have been shown 
to interact with ADAM 17 to modulate the shedding of the ProAREG, an EGFR ligand precursor 
(Nakayama et al., 2012). Another well-documented example is the tyrosine receptor Eph, shed 
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by ADAM 10, which needs to be bound by its ligand that is expressed by an adjacent cell. This 
complex creates a favourable conformation to expose an ADAM 10 recognition site (Janes et 
al., 2009, 2005). The shedding of L-selectin is negatively controlled by calmodulin bound to its 
cytoplasmic domain (Gifford et al., 2012), and interestingly, ACE has been shown to be 
associated with calmodulin via its cytoplasmic tail and this association is another measure of 
shedding control (Chattopadhyay et al., 2005).  More recently it was discovered that a member 
of the rhomboid family of proteins, iRhom2, is responsible for controlling the maturation of 
ADAM 17 ensuring it reaches the cell surface in its correct form (Adrain et al., 2012; Issuree et 
al., 2013; McIlwain et al., 2012). This demonstrates that there is another tier of regulation at 
the sheddase maturation or processing level, adding further complexity to the shedding 
process.  
 
In conclusion, the use of soluble peptides of varying lengths for the characterisation of the ACE 
sheddase in CHO-K1 cells is not ideal. This is likely due to the requirement for the substrate of 
the ACE sheddase to be attached to the membrane. Other systems that present the substrate in 
its appropriate environment and conformation for the ACE sheddase need to be explored and 
adapted for further analysis of the shedding of this enzyme.  These alternatives will be 







CHAPTER 6: Conclusions and Future work  
 
 
Testis and somatic ACE both play vital roles throughout the body, with the most commonly 
described being in fertility and blood pressure regulation, respectively. Both isoforms of ACE 
are subject to ectodomain shedding, but we have very little knowledge about the 
physiological role for this process. This dissertation aimed to characterise the 
conformational structures inherent to ACE which direct cleavage secretion by the as yet 






region in the distal ectodomain of tACE, which was initially thought to 
possess the secondary binding site or recognition motif (Woodman et al., 2006), was 
investigated using the 3D structure of ACE to predict potential protein-protein interaction 
sites. The structural boundaries of ACE was adhered to so as to maintain active and correctly 
processed proteins. The swop-over mutants of three ectodomain surface regions were 
made and shown to be catalytically active (chapter3). However, none of these mutations 
abolished shedding completely, suggesting that a single controlling recognition motif was 
not harboured within these regions. This indicated that shedding is rarely coordinated by a 
single region or interaction. This result confirmed that alterations made to surface helices 
and motifs near the cleavage site affected cleavage subtly and that ACE is part of a 
sophisticated shedding mechanism. Furthermore, the sheddase exosite, might consist of 
non-consecutive residues of the distal and proximal ectodomain as is the case for KitL2 
(Kawaguchi et al., 2007). 
 
Secondly, possible secondary binding of the sheddase to the proximal ectodomain was 




was replaced with alanines in human tACE and found to 
cause a reduction in tACE activity, processing as well as shedding. When the mutation was 
extended by two residues on the N-terminal side, a more pronounced disruptive effect on 
the cellular processing in terms of processing and activity was observed. This illustrates that 
the alanines caused a change in conformation of the proximal ectodomain and did not 
directly affect a secondary binding site of the sheddase with the substrate. A key result was 




obtained when these 7 residues were converted to the corresponding ones from the N-
domain. Eventhough there was a slight decrease in shedding, the processing was not 
affected, demonstrating that N-domain residues were able to maintain shedding and 
activity in contrast to alanines. 
 
Thirdly, the mechanism by which the P
623
L polymorphism affected ACE shedding was 
investigated. Our initial hypothesis proposed that the loss of proline allowed the preceding 
N
620
WT glycosylation sequon to be glycosylated. This resulted in a change in stalk 
conformation and improved access by the sheddase and an increase in shedding. However, 
on the contrary, when the glycosylation was removed by mutating N
620
, even higher 
shedding was observed. This established that the flexibility that the leucine provides the 
stalk, is made more prominent by the lack of glycans and is the first indication that the 
reduction in glycosylation around the cleavage site may increase access to the sheddase. 
Therefore, the ACE sheddase needs a membrane-bound substrate to cleave at its preferred 
site. The correct conformation of the substrate provide and assemble the requisite 
secondary binding sites it needs to identify it as being a substrate requiring proteolytic 
release from the membrane.  
 
In light of these findings, further analysis of the CC-domain mutant (Woodman et al., 2005) 
is needed as this mutant was cleaved in the linker region as well as in the stalk.  This could 
be due to a decrease in the extent of glycosylation of the residues surrounding the linker, 
leading to better access by the sheddase.  In addition, there is ongoing work being 
conducted in our laboratory on minimally glycosylated sACE mutants for crystallization trials 
and structure-function studies (Anthony et al., 2012). Shedding assays on these minimally 
glycosylated sACE mutants will help elucidate the effect of glycosylation on shedding.  
 
The dimerisation of ACE might also play an integral part in shedding, which is affected by the 
conformational changes triggered by the disulphide-linked dimerisation between C-domains 
and non-covalent interactions (e.g. glycosylation) between N-domains (K. Gordan, PhD 
thesis, 2011). Therefore, the role of disulphide bonding has to be further investigated. The 
redox environment has proved to be highly influential in shedding regulation and PDI 
inhibitors have demonstrated to modulate shedding (Borroto et al., 2003; Willems et al., 




2010). In addition, the HVR of ADAMs, regarded to be the candidate exosite, is prone to 
disulphide bonding (Takeda et al., 2012) as well. Therefore, future shedding analysis should 
include investigations into the roles of disulphide bonding and the redox environment.  
 
Sheddase recognition sites on substrates (Deng et al., 1996; Iwata et al., 2009; Nishie et al., 
2012; Zhao et al., 2001) as well as  exosites on sheddases have been identified  
(Stawikowska et al., 2013; Takeda et al., 2012, 2006). In addition to the redox environment 
and secondary binding sites of sheddases, other forms of regulation have been identified. 
Recently, an ADAM 17 specific regulatory protein was discovered which was responsible for 
its trafficking and activity (Adrain et al., 2012; Issuree et al., 2013; McIlwain et al., 2012). 
Considering that the 5-residue motif in the stalk of ACE had such an impact on its 
processing, it would be interesting to determine if ACE-specific regulatory proteins exist that 
play a similar role to the one identified and characterized by Adrain et al. (2012).  
 
Finally, shedding conditions of ACE were simulated in a cell-based assay (Chapter 5). The 
soluble fluorogenic ACE stalk peptides utilised were cleaved at the E-G bond, and not at the 
physiological R-S site. Cleavage site mutants showed that the peptide was cleaved at the 
same site (E-G bond) irrespective of sequence, but in order to be cleaved the peptide had to 
mimic a stalk sequence that is cleaved physiologically. . This result prompted the analysis of 
non-fluorogenic peptides, which proved that the fluorogenic groups directed cleavage of the 
peptide, since uncapped peptides were not cleaved. Lengthening the peptide to include part 
of the proximal ectodomain did not render the substrate cleavable. This investigation 
proved that the ACE sheddase requires a substrate which is membrane-bound.  
 
Even though we have shown that soluble peptides are not an ideal substrate for the 
endogenously expressed ACE sheddase, the cell-based assay has benefits over the cell lysate 
assay. Cleavage of the substrates are easily identifiable by HPLC, samples require minimal 
clean-up for follow-on procedures and require more accessible equipment as opposed to 
the lysate assay which required ultracentrifugation and LC-MS.  
 
Above all, suggested future work, the ACE sheddase has to be identified. A spectrum of 
ADAMs may be overexpressed alongside ACE to determine if they are involved in the 




shedding of ACE, with the exclusion of ADAM 17, 10 and 9, since they have been shown not 
be involved in basal or phorbol ester stimulated shedding (English et al., 2012; Hooper and 
Turner, 2000; Parvathy et al., 1998; Sadhukhan et al., 1999). If the cell assay is to be used 
with the cell lines overexpressing various ADAM proteins, stalk peptides with alternative 
fluorogenic capping groups should be used that do not promote cleavage at non-
physiological  sites.  
One of the aims of establishing a cell-based assay was so it could be used in the purification 
of the ACE sheddase. Unfortunately, the ACE sheddase is not amenable to cleaving a soluble 
stalk peptide and it was not possible to reproduce the cleavage site and shedding inhibition 
conditions of cell-bound ACE. Innovative proteomic techniques could be attempted to 
circumvent these issues. For example, ACE may be expressed with a biotin tag at its C-
terminus so that it may be immobilized on a streptavidin-coated plate. Thereafter fractions 
from ACE sheddase containing tissue homogenate may be passed-over, which should be 
able to cleave immobilized ACE. The biotin may be positioned at varying distances to 
replicate the membrane environment.  
 
In conclusion, this thesis has demonstrated that ACE undergoes regulated proteolytic 
release from the membrane and is influenced by the structural binding sites in the 
ectodomain as well as stalk, with the stalk requiring a defined level of flexibility and 
accessibility. In addition, the stalk sequence in the form of a soluble synthetic peptide of 
varying lengths is not sufficient to be cleaved by a membrane-anchored ACE sheddase. 
These insights provide an invaluable foundation for future investigations into the 









A1.1 ACE activity reagents 
 
3M NaCl:  
Dissolve 17.53g NaCl in 100ml distilled water. Autoclave to sterilise.  
0.28 M NaOH 
Dissolve 2.8g NaOH in 250ml of distilled water. Autoclave to sterilise. 
 
o-phthaldialdehyde 
Dissolve 24mg in 1ml methanol. Make up fresh each time and cover in foil to protect from light.  
 
3N HCl 
Add 24.8ml 37% HCl to 75.2ml distilled water.  
 





Dissolve in distilled water of which the final volume should be 200ml.  
 
20mM Z-FHL stock solution 
Dissolve 220mg Z-FHL (Sigma) dissolved in 2ml 0.28M NaOH and made up to a 20ml final 
volume with distilled water. Divided aliquots were stored at -20°C. 
 
1mM Z-FHL working solution 
15ml of distilled water was added to 4ml of 5X KHPO4 buffer, to which 20µl of 10mM ZnSO4 was 
added as well as 1ml of 20mM Z-FHL. Solution was stored at 4°C. 
 
A1.2. Reagents for protein purification 
Wash buffer 
 20ml   1M HEPES pH 7.5   (20mM) 
 250ml  2M NaCl   (500mM) 








1.55g  Boric acid   (50mM) 
pH to 9.5 
Make up to 500ml with distilled water.  
 
Dialysis solution (specifically for PNGase digest) 
First solution 
20ml   0.5M KPO4 pH 8   (5mM) 
 2ml  100mM PMSF (in EtOH) 
 Make up to 2L with distilled water.  
 
Second solution  
200ml   0.5M KPO4 pH 8   (50mM) 
 2ml  100mM PMSF (in EtOH) 
Make up to 2L with distilled water. 
 
A2 Standard curves 
 
A2.1 HL standard curve 
A 5mM HL (Sigma, USA) stock solution in distilled water was prepared and diluted to a 0.5mM 
working solution in 1X potassium phosphate buffer. 30µl aliquots of HL in increasing 
concentrations were prepared and placed in a 96-well plate in triplicate. Assay conditions was 
described in Chapter 2, section 2.6, beginning with the addition of 0.4M NaOH. The curve was 
determined by linear regression analysis using GraphPad Prism 4.0 software. 
  
Figure A2.1: Standard curve of HL (nmoles) versus fluorescence intensity. 















A.2.2 Protein Concentration   
                                                                                                                                                                                                          
Protein concentrations of purified ACE or cell lysates were determined using a standard curve 
of increasing IgG concentrations.  
 
 
 Figure A2.2: Standard curve for Bio-Rad protein assay of IgG (g/ml) versus OD595nm 








Table A3.1: Primers used in the overlap PCR mutagenesis of the α-helix 7 of tACE. Underlined letters are 
indicative of the restriction enzyme site created and bold letters represent the bases changed in order to 
create the restriction site and/or to minimize self-complementarity of the primer.  
 
Primer name     RE site  Nucleotide Sequence 
Mid For               EheI           5'-GACACGGGCGCCTACTGGCGATCCTGGTACAACACACCATCCCTGGAGC-3' 
Mid Rev              EheI           5'-GTTGTACCAGGATCGCCAGTAGGCGCCCGTGTCTACATAGCCATTGAGCCG-3'  
BglII For                  5'-CCAGATCTGACGAATGTGATGG-3'  





















Table A3.4: Primers used in site-directed mutagenesis of the proximal ectodomain and stalk region of tACE. 
Underlined letters are indicative of the restriction enzyme site created and bold letters represent the bases 
changed in order to create the restriction site and/or to minimize self-complementarity of the primer.  
Primer name   Nucleotide sequence  RE site  Tm Primer 
length 
tACE ALA For 
tACE ALA Rev 
’-GAGAACGAGCTAGCTGCGGCGGCGGCGGGCTGGCC- ’ 
’-GGCCAGCCCGCCGCCGCCGCAGCTAGCTCGTTCTC- ’ 





 BsmI 81.7 36 
tACE ST _Ndom F 
tACE ST _Ndom R 
5'-CTCCGCACGGAGAACCAACAGAATGGGGAAGTACTGGGCTGGCCGC- ’ 
5'-GCGGCCAGCCCAGTACTTCCCCATTCTGTTGGTTCTCCGTGCGGAG-3' 















Table A3.2: Primers used in the overlap PCR mutagenesis of the α-helix 8 of tACE. Underlined letters are 
indicative of the restriction enzyme site created and bold letters represent the bases changed in order to 
create the restriction site and/or to minimize self-complementarity of the primer. 
 
Primer name  RE site     Nucleotide Sequence 
H8 For             SphI       5’-TGTACGAGACACCATCCTTCGAGGACGATCTGGAACACC- ’ 
H8 Rev             SphI      5’-GGTTGATGTGCTGGGCTCCGTATCGGCGATGC- ’  
 










Primer name  RE site          Nucleotide Sequence 
AQH For  AgeI          5'-CACTACGGGGACCGGTACATCAACCTG- ’ 




















































Figure A4.1: ZFHL activity assays of tACE Pro623Leu. The first 4 bars represent activity of the medium 
harvested from bulk growth flasks. The medium was pooled and purified using the Lisinopril-
sepharose column. The most active fractions were subsequently pooled and concentrated on an 
































































µM of ACE stalk peptide i  a - ell plate of CHO ells i  HBSS uffer 
Su je ted super ata ts to HPLC 
Colle ted l fra tio s    
Fra tio s o tai i g lea age produ ts a alysed ia MALDI 
I u atio  for  hours at °C ±  µM estati / 
Ti e ourse o er  hours at °C 
Fra tio s ere read o  fluoro eter  a d   
to ide tify fluores i g A z- o tai i g fra tio   
 Figure A5.1: Schematic workflow diagram of the process to determine cleavage site of ACE stalk peptide 
using the cell assay.  
µM of stalk peptide i  a - ell plate of CHO ells i  HBSS uffer 
i u ated for  hours at °C  
Clea age produ ts o fir ed ia i reasi g fluores e e a d/or HPLC 
Super ata ts ere prepared for MALDI usi g )ipTip® Pipette Tips   
Clea age produ ts a alysed ia MALDI 
Figure A5.2: Schematic workflow diagram of the process to determine cleavage site of stalk peptide using the 































The cleavage of the fluorogenically capped 9-residue peptide was investigated under the same 
conditions as the uncapped peptides. The sample represented in figure A5.4A, was sampled after 15 
minutes of adding peptide and therefore we can see the presence of a cleavage product by this time. 
The uncleaved peptide elutes at 6.690 minutes and the cleavage product elutes at 6.315 minutes. In 
figure A5.4B, after 6 hours the peak area of the product peak at 6.315 minutes had increased by 
approximately 6-fold. Figure A5.4C represents the buffer control, which accounts for the other peaks 






6 hours  
500µM Bestatin 
6 hours  
100µM Bestatin 
6 hours 
Figure A5.3: The HPLC chromatograms monitored at 354nm of the ACE sheddase cell assay using the 











































Figure A5.4: HPLC chromatograms of the fluorescent 9 residue ACE stalk peptide. μM of peptide as 
incubated on the surface of CHOKI for 6 hours, diluted in HBSS buffer A) Fluorescent ACE stalk peptide incubated 
for 0 hours on cells B) Fluorescent ACE stalk peptide incubated for 6 hours on cells C) HBSS buffer only incubated 
for 6 hours. Recorded wavelength was at 214nm. 
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